| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1001 |
Evaluation of Home Medication Review in Community Out Reach Program
|
Naik, V.
|
|
2013
|
16 |
7 |
p. A708-
1 p.
|
artikel
|
| 1002 |
Evaluation of Telemedicine Program (Ithaca): Innovation in the Treatment of Arterial Hypertension Increasing the Compliance and Adherence in the Second Year of Its Implementation (2011-2012)
|
Sicras, A.
|
|
2013
|
16 |
7 |
p. A518-
1 p.
|
artikel
|
| 1003 |
Evaluation of the Burden of Illness of Colorectal Cancer Among Veteran Patients in the United States
|
Wang, L.
|
|
2013
|
16 |
7 |
p. A392-A393
nvt p.
|
artikel
|
| 1004 |
Evaluation of the Burden of Illness of Skin Cancer Among Veteran Patients United States
|
Wang, L.
|
|
2013
|
16 |
7 |
p. A392-
1 p.
|
artikel
|
| 1005 |
Evaluation of the Cost-Effectiveness of the Capsaicin Patch Qutenzatm for the Treatment of Peripheral Neuropathic Pain in the United Kingdom
|
Trueman, D.
|
|
2013
|
16 |
7 |
p. A383-
1 p.
|
artikel
|
| 1006 |
Evaluation of the Herpes Zoster Impact as Comorbidity Factor in 5 Pathologies French Hospital Care Among Adults Aged 50 and Older
|
Blein, C.
|
|
2013
|
16 |
7 |
p. A503-
1 p.
|
artikel
|
| 1007 |
Evaluation of the Length of Hospital Stay for Patients with Atrial Fibrillation
|
Volz, F.
|
|
2013
|
16 |
7 |
p. A536-
1 p.
|
artikel
|
| 1008 |
Evaluation of the Policies Implemented to Monitor Prescription and Reduce Pharmaceutical Expenditure at the University General Hospital of Patras, Greece
|
Tsiata, K.
|
|
2013
|
16 |
7 |
p. A467-
1 p.
|
artikel
|
| 1009 |
Evaluation of the Potential Efficacy of Ivabradine in Health Care of the Republic of Belarus
|
Kozhanova, I.
|
|
2013
|
16 |
7 |
p. A515-
1 p.
|
artikel
|
| 1010 |
Evaluation of the Psoriasis Area and Severity Index (PASI) as Patient Relevant Outcome in the Benefit Assessment of Psoriasis Therapies
|
Gutknecht, M.
|
|
2013
|
16 |
7 |
p. A603-
1 p.
|
artikel
|
| 1011 |
Evaluation of Treatment Patterns and Clinical Trials Published on Patients Diagnosed with Insomnia: A Literature Update
|
Greene, N.
|
|
2013
|
16 |
7 |
p. A722-A723
nvt p.
|
artikel
|
| 1012 |
Evaluation of Variable Relevance and Accessibility to Support Personalized Medicine in Breast Cancer
|
Udomaksorn, S.
|
|
2013
|
16 |
7 |
p. A393-
1 p.
|
artikel
|
| 1013 |
Evidence-Based Methods in Food Sciences and Nutrition
|
Quignot, N.
|
|
2013
|
16 |
7 |
p. A617-
1 p.
|
artikel
|
| 1014 |
Evidence Thresholds in the Absence of Effective Alternatives: The Case of Intermittent Compression in Critical Limb Ischemia
|
Moran, P.
|
|
2013
|
16 |
7 |
p. A515-
1 p.
|
artikel
|
| 1015 |
Evolución Clínica De Una Cohorte De Pacientes Con Enfermedad Renal Crónica Intervenidos En Un Programa De Salud Renal
|
Paz, J.J.
|
|
2013
|
16 |
7 |
p. A697-
1 p.
|
artikel
|
| 1016 |
Evolución Del Consumo Y Ventas De Antibióticos En Chile 1998-2012
|
Villagra, G.
|
|
2013
|
16 |
7 |
p. A715-
1 p.
|
artikel
|
| 1017 |
Evolución En El Uruguay De Tazas De Utilización De Cateterismo Cardíaco Diagnostico Par a Cardiopatía Congénita En Menores De 18 Años (1995-2012)
|
Lombide, I.
|
|
2013
|
16 |
7 |
p. A708-
1 p.
|
artikel
|
| 1018 |
Evolução Do Uso De Medicamentos Genéricos No Tratamento De Doenças Crônicas – Pbm Brasileira
|
Salles, G.R.D.
|
|
2013
|
16 |
7 |
p. A707-
1 p.
|
artikel
|
| 1019 |
Evolution of Molecular Diagnostic Test Usage in Solid Tumours in Western Europe: Ambition Study (Analysis of Molecular Biomarker Tests in Oncology)
|
Ricarte, C.
|
|
2013
|
16 |
7 |
p. A393-
1 p.
|
artikel
|
| 1020 |
Evolution of Oral Anticancer Treatments Use in France from 2004 – 2012: Re-Actor Study (Retrospective Analysis of Cancer Treatments Given Orally)
|
Benjamin, L.
|
|
2013
|
16 |
7 |
p. A425-
1 p.
|
artikel
|
| 1021 |
EVPI Curves in Practice
|
Jeppsson, K.
|
|
2013
|
16 |
7 |
p. A591-
1 p.
|
artikel
|
| 1022 |
Examination of Pelvic Floor Muscle Function After Pelvic Floor Muscle Training and Using Cube Pessary
|
Hock, M.
|
|
2013
|
16 |
7 |
p. A337-
1 p.
|
artikel
|
| 1023 |
Examining the Burden of Illness of the United States Veteran Patients Diagnosed with Alzheimer’s Disease
|
Wang, L.
|
|
2013
|
16 |
7 |
p. A332-
1 p.
|
artikel
|
| 1024 |
Examining the Burden of Illness of Veteran Patients Diagnosed with Obesity in the United States
|
Wang, L.
|
|
2013
|
16 |
7 |
p. A377-
1 p.
|
artikel
|
| 1025 |
Examining the Burden of Illness of Veteran Patients with Prostate Cancer in the United States
|
Wang, L.
|
|
2013
|
16 |
7 |
p. A402-
1 p.
|
artikel
|
| 1026 |
Examining the Effects of a Functional Restoration and Pain Management Program Among Chronic Pain Patients in the Texas Workers Compensation System: Pilot Study – Part I
|
Nwokeji, E.D.
|
|
2013
|
16 |
7 |
p. A553-
1 p.
|
artikel
|
| 1027 |
Examining the Relationship Between Country-Level Factors and Vaccine Wastage: A Data Driven Model of Session Sizes in Bangladesh, Mozambique, India (Uttar Pradesh), and Uganda
|
Yang, W.
|
|
2013
|
16 |
7 |
p. A344-A345
nvt p.
|
artikel
|
| 1028 |
Expanding the Measurement of Treatment Benefit in Rheumatoid Arthritis: The Role of the Patient-Reported Outcome Consortium’s RA Working Group
|
Naegeli, A.N.
|
|
2013
|
16 |
7 |
p. A569-
1 p.
|
artikel
|
| 1029 |
Experiencia Inicial Con Un Nuevo Tipo De Documento De Evaluación De Tecnología Sanitaria: “Informes De Mesa De Ayuda”
|
Alcaraz, A.
|
|
2013
|
16 |
7 |
p. A679-
1 p.
|
artikel
|
| 1030 |
Explaining the Increased Health Care Expenditures Among Individuals with Co-Occurring Chronic Obstructive Pulmonary Disease and Gastroesophageal Reflux Disease: A Cost-Decomposition Analysis
|
Ajmera, M.R.
|
|
2013
|
16 |
7 |
p. A501-
1 p.
|
artikel
|
| 1031 |
Exploratory Structural Equation Models: A Simulation Study Exploring Geomin and Target Rotation Techniques on Variations of ESEM Models
|
Sen, R.
|
|
2013
|
16 |
7 |
p. A588-
1 p.
|
artikel
|
| 1032 |
Exploring Dependence on Others in Alzheimer’s Disease
|
Rapp, T.
|
|
2013
|
16 |
7 |
p. A553-
1 p.
|
artikel
|
| 1033 |
Exploring Gender Differences in Population-Based Prevalences of Cardiovascular Diseases in Chile After the Health Care Reform of 2005
|
Dressler, C.
|
|
2013
|
16 |
7 |
p. A708-
1 p.
|
artikel
|
| 1034 |
Exploring Income Inequality in Self-Reported Health Status in Chile After the Health Care Reform of 2005
|
Cabieses, B.
|
|
2013
|
16 |
7 |
p. A679-A680
nvt p.
|
artikel
|
| 1035 |
Exploring the Burden of Illness of Hereditary Angioedema in the United Kingdom
|
Helbert, M.
|
|
2013
|
16 |
7 |
p. A381-
1 p.
|
artikel
|
| 1036 |
Exploring the Feasibility of the Instrument Used in Determination of Willingness-To-Pay Per Quality-Adjusted Life-Year in Malaysia
|
Lim, Y.W.
|
|
2013
|
16 |
7 |
p. A596-A597
nvt p.
|
artikel
|
| 1037 |
Exploring the Identification of Multiple Sclerosis Incident Cohorts in Claims Databases: Methodology and Challenges
|
Capkun-Niggli, G.
|
|
2013
|
16 |
7 |
p. A582-
1 p.
|
artikel
|
| 1038 |
Exploring the Key Decision Drivers Provided by HTA Agencies Accepting Submissions with ICERs Higher Than the Threshold
|
Goodrich, K.
|
|
2013
|
16 |
7 |
p. A480-
1 p.
|
artikel
|
| 1039 |
Exploring the Key Decision Drivers Provided by HTA Agencies Rejecting Submissions with ICERs Lower Than the Threshold
|
Walsh, S.C.M.
|
|
2013
|
16 |
7 |
p. A482-
1 p.
|
artikel
|
| 1040 |
External Validation of the Syreon Diabetes Model
|
Zsólyom, A.
|
|
2013
|
16 |
7 |
p. A590-
1 p.
|
artikel
|
| 1041 |
Extrapolating Survival in a Heterogeneous Patient Population with Metastatic Melanoma; A Case Study of Integrating Statistical and Clinical Consideration
|
Majer, I.M.
|
|
2013
|
16 |
7 |
p. A594-
1 p.
|
artikel
|
| 1042 |
Factores Predictores De Obstrucciones Coronarias Significativas En Pacientes Adultos Con Cineangiocoronariografías Realizadas En Uruguay Financiadas Por El Fondo Nacional De Recursos
|
Fernandez, G.
|
|
2013
|
16 |
7 |
p. A671-
1 p.
|
artikel
|
| 1043 |
Factorial Invariance of the Whoqol-Old Across Gender, Age, and Resident Area in Taiwan
|
Yao, G.
|
|
2013
|
16 |
7 |
p. A602-
1 p.
|
artikel
|
| 1044 |
Factors Associated with Absenteeism in Rheumatoid Arthritis Patients in Employment: Results of a Survey Among French Patients
|
Fagnani, F.
|
|
2013
|
16 |
7 |
p. A570-A571
nvt p.
|
artikel
|
| 1045 |
Factors Associated with Compliance with Palivizumab Prophylaxis in the Canadian RSV Evaluation Study for Synagis (CARESS) Registry (2005-2012)
|
Paes, B.A.
|
|
2013
|
16 |
7 |
p. A368-
1 p.
|
artikel
|
| 1046 |
Factors Associated with Early Response to Olanzapine and Clinical and Functional Outcomes of Early Responders Treated for Schizophrenia in China
|
Ye, W.W.
|
|
2013
|
16 |
7 |
p. A544-
1 p.
|
artikel
|
| 1047 |
Factors Associated with Pain Persistence in Patient with Depression During a 3 –Month Follow-Up Period
|
Novick, D.
|
|
2013
|
16 |
7 |
p. A544-
1 p.
|
artikel
|
| 1048 |
Factors Associated with Poor Adherence in Patients Initiating Medication for Major Depressive Disorder: Interim Results from a Prospective, Longitudinal Study
|
Lenderking, W.R.
|
|
2013
|
16 |
7 |
p. A550-
1 p.
|
artikel
|
| 1049 |
Factors Driving Inequality in Prostate Cancer Survival: A Population Based Study
|
Burns, R.
|
|
2013
|
16 |
7 |
p. A398-
1 p.
|
artikel
|
| 1050 |
Factors Related to Adherence After a Multifactorial Intervention to Improve It in Patients with Chronic Obstructive Pulmonary Disease (COPD). Icepoc Study
|
Leiva-Fernandez, F.
|
|
2013
|
16 |
7 |
p. A373-A374
nvt p.
|
artikel
|
| 1051 |
Fatores Associados À Compra De Medicamentos Em Brasília: Uma Análise Econométrica Com Dados Transversais De Base Populacional
|
Andrade, C.H.C.D.
|
|
2013
|
16 |
7 |
p. A674-A675
nvt p.
|
artikel
|
| 1052 |
Faulty Connections: Can Criticisms of Network Meta-Analysis in Nice Submissions Be Avoided?
|
Martin, A.
|
|
2013
|
16 |
7 |
p. A608-
1 p.
|
artikel
|
| 1053 |
Feasibility of a Survey on the Willingness-To-Pay for Colorectal Cancer Screening Using Social Networks
|
Hessel, F.P.
|
|
2013
|
16 |
7 |
p. A423-
1 p.
|
artikel
|
| 1054 |
Feasibility of Medicines Review to Reduce Potentially Inappropriate Medicines in the Elderly: The OPTI-SCRIPT Cluster Randomized Controlled Trial
|
Clyne, B.
|
|
2013
|
16 |
7 |
p. A485-
1 p.
|
artikel
|
| 1055 |
Feasibility of Use of Medical Transcription Data for Real World Evidence Generation in the United States: A Pilot Study of Patients with Systemic Lupus Erythematosus Initiated on Belimumab
|
Narayanan, S.
|
|
2013
|
16 |
7 |
p. A584-
1 p.
|
artikel
|
| 1056 |
Financial Incentives in Health Care: Evidence of Unintended Consequences
|
Jensen, S.O.
|
|
2013
|
16 |
7 |
p. A463-
1 p.
|
artikel
|
| 1057 |
First Russian Type 2 Diabetes Mellitus Simulation Model with Discrete Events Modeling. Health-Economic Analysis
|
Kolbin, A.
|
|
2013
|
16 |
7 |
p. A437-A438
nvt p.
|
artikel
|
| 1058 |
Fixed Reference Pricing or Benefit Assessment of Established Products – from the Frying Pan into the Fire?
|
Vosgerau, S.
|
|
2013
|
16 |
7 |
p. A489-
1 p.
|
artikel
|
| 1059 |
Following the Western HTA Model in Latin America: A Self-Fulfilling Prophecy?
|
Kirpekar, S.
|
|
2013
|
16 |
7 |
p. A679-
1 p.
|
artikel
|
| 1060 |
Follow-On Health Care Costs in Patients with Acute Coronary Syndrome (ACS)
|
Berger, A.
|
|
2013
|
16 |
7 |
p. A521-A522
nvt p.
|
artikel
|
| 1061 |
Formulations of Amphotericin B for the Treatment of Fungal Infections in Patients with HIV/AIDS
|
Costa, J.O.
|
|
2013
|
16 |
7 |
p. A667-
1 p.
|
artikel
|
| 1062 |
Framework for Evidence Assessment Based on Grade and Application to HPV Vaccination in Males in the European Health Care Context
|
Siebert, U.
|
|
2013
|
16 |
7 |
p. A327-
1 p.
|
artikel
|
| 1063 |
Frecuencia Y Costos De Hospitalización En Una Población De Pacientes En Dialisis En Colombia
|
Sanabria, M.
|
|
2013
|
16 |
7 |
p. A698-
1 p.
|
artikel
|
| 1064 |
Frequency of Lower Urinary Tract Symptoms in Men and Women in Hungary – Results of an Open Label Questionnaire Study from 2012
|
Brodszky, V.
|
|
2013
|
16 |
7 |
p. A635-
1 p.
|
artikel
|
| 1065 |
From Clinical Trial to Real-World Evidence: A Systematic Approach to Identifying Data Sources for Observational Research
|
Parasuraman, B.
|
|
2013
|
16 |
7 |
p. A583-A584
nvt p.
|
artikel
|
| 1066 |
From “Generic Scheme” to “Brand-Generic Scheme”: The Effect of New Policy (2003-2004) on Efficiency of Iranian Pharmaceutical Industry
|
Hashemi Meshkini, A.
|
|
2013
|
16 |
7 |
p. A680-
1 p.
|
artikel
|
| 1067 |
Full Cost of Plasma from Voluntary Non Remunerated Donors in Italy
|
Zaniolo, O.
|
|
2013
|
16 |
7 |
p. A385-A386
nvt p.
|
artikel
|
| 1068 |
Functional Observation with TTO in Chronic Diseases
|
Kövér, K.
|
|
2013
|
16 |
7 |
p. A597-
1 p.
|
artikel
|
| 1069 |
Functional Outcomes with Aripiprazole Once-Monthly in Two Double-Blind, Placebo- and Active-Controlled Studies (Aspire US 246 and Aspire EU 247) for the Treatment of Schizophrenia
|
Fleischhacker, W.W.
|
|
2013
|
16 |
7 |
p. A550-
1 p.
|
artikel
|
| 1070 |
Further Validation of a New Questionnaire to Measure Satisfaction with Medical Care in Patients with Atrial Fibrillation (SAFUCA) in Spain
|
Ruiz, M.A.
|
|
2013
|
16 |
7 |
p. A535-
1 p.
|
artikel
|
| 1071 |
Future Costs Inclusion in Published Economic Evaluations: What Is the Current Situation?
|
Gros, B.
|
|
2013
|
16 |
7 |
p. A580-
1 p.
|
artikel
|
| 1072 |
G-Ba Assessments of Oncology Trials: Is Increased Overall Survival a “Must Have”?
|
Schuchardt, M.
|
|
2013
|
16 |
7 |
p. A429-
1 p.
|
artikel
|
| 1073 |
Generating and Maintaining Momentum in Post-Authorisation Studies
|
Vinken, A.
|
|
2013
|
16 |
7 |
p. A612-
1 p.
|
artikel
|
| 1074 |
Generating the Cost-Effectiveness Frontier When Costs and/or Benefits Are Correlated Across Strategies
|
Teljeur, C.
|
|
2013
|
16 |
7 |
p. A589-
1 p.
|
artikel
|
| 1075 |
Generic Substitution in Ireland – The Views of Key Stakeholders
|
O’Leary, A.
|
|
2013
|
16 |
7 |
p. A460-
1 p.
|
artikel
|
| 1076 |
Geographical Inequalities in the Access to and Utilization of Home Care (Nursing) Services in Hungary
|
Cs. Horváth, Z.
|
|
2013
|
16 |
7 |
p. A463-A464
nvt p.
|
artikel
|
| 1077 |
Global Variations in Biologics Access and Rheumatoid Arthritis Treatment Costs
|
Miles, G.
|
|
2013
|
16 |
7 |
p. A559-
1 p.
|
artikel
|
| 1078 |
GLP1 and Insulin Glargine Treatment Patterns Among Type 2 Diabetes Patients in Major EU Markets
|
Divino, V.
|
|
2013
|
16 |
7 |
p. A453-
1 p.
|
artikel
|
| 1079 |
Glycemic, Lipid, and Blood Pressure Control Among Type 2 Diabetes Mellitus Patients in Dubai
|
Szabo, S.M.
|
|
2013
|
16 |
7 |
p. A432-
1 p.
|
artikel
|
| 1080 |
Grade for Quality Assessment of Efficacy and Effectiveness Studies on Anti-TNFs Treatment of Rheumatoid Arthritis
|
Taino, B
|
|
2013
|
16 |
7 |
p. A613-
1 p.
|
artikel
|
| 1081 |
Graphic Health Warnings on Cigarette Packs in Qatar: Pre-Implementation Awareness and Perception Among the General Public
|
Awaisu, A.
|
|
2013
|
16 |
7 |
p. A723-
1 p.
|
artikel
|
| 1082 |
Growth Mixture Modeling (GMM) to Determine Treatment Effects of Canagliflozin Versus Sitagliptin on Weight-Related Quality of Life (WRQoL) in Subjects with Type 2 Diabetes Mellitus (T2DM)
|
Stull, D.E.
|
|
2013
|
16 |
7 |
p. A447-
1 p.
|
artikel
|
| 1083 |
Guidance for Partnership Working Between CatSalut and the Pharmaceutical Industry
|
Gilabert, A.
|
|
2013
|
16 |
7 |
p. A486-A487
nvt p.
|
artikel
|
| 1084 |
Guiding Principles for Effective Private Health Insurance in Emerging Markets
|
Shankar, R.
|
|
2013
|
16 |
7 |
p. A682-
1 p.
|
artikel
|
| 1085 |
Haemophilia A: Annual Cost Comparison Between FL-rFVIII and BDD-rFVIII in France: We Should Compare the Cost Per Patient Instead of the Price Per Unit
|
Haarmann, H.
|
|
2013
|
16 |
7 |
p. A380-A381
nvt p.
|
artikel
|
| 1086 |
Handling Variability in Time Endpoints in Multi-Centre Time and Motion (T&M) Studies: A Case Study of Erythropoiesis-Stimulating Agents for Anaemia Management in 13 Centres in Italy
|
Kritikou, P.
|
|
2013
|
16 |
7 |
p. A609-
1 p.
|
artikel
|
| 1087 |
Harmonizing Measurement of Adherence Across the 4-Item and 8-Item Morisky Medication Adherence Scale Using Cross-Sectional Data from Patients Treated for Irritable Bowel Syndrome
|
Pedersini, R.
|
|
2013
|
16 |
7 |
p. A604-
1 p.
|
artikel
|
| 1088 |
Head to Head Economic Evaluation of Two Genomic Profiles of Recurrence Risk for Breast Cancer, Mammaprint Versus Oncotype DX, in Spain
|
Crespo, C.
|
|
2013
|
16 |
7 |
p. A416-A417
nvt p.
|
artikel
|
| 1089 |
Health and Economic Burden of Tobacco Use in Seven Latin American Countries: Results from a Microsimulation Health Economic Model (HEM)
|
Pichon Riviere, A.
|
|
2013
|
16 |
7 |
p. A723-A724
nvt p.
|
artikel
|
| 1090 |
Health and Social Care Resource Use by Individuals with Fragile X Syndrome: Results of Two Delphi Panels
|
Barry, S.J
|
|
2013
|
16 |
7 |
p. A382-
1 p.
|
artikel
|
| 1091 |
Health Care Cost Avoidance Due to Insulin Glargine for Type 2 Diabetic Patients in Hong Kong as Compared to NPH Insulin
|
Lee, K.K.
|
|
2013
|
16 |
7 |
p. A451-
1 p.
|
artikel
|
| 1092 |
Health Care Cost of Controlled Versus Uncontrolled Type 2 Diabetes Patients in Greece
|
Hatzikou, M.
|
|
2013
|
16 |
7 |
p. A436-
1 p.
|
artikel
|
| 1093 |
Health Care Cost of Type 2 Diabetes Patients in Greece: Sub-Population Analysis
|
Rombopoulos, G.
|
|
2013
|
16 |
7 |
p. A436-
1 p.
|
artikel
|
| 1094 |
Health Care Costs Associated with Chronic Hepatitis C Infection in Europe
|
Lingohr-Smith, M.
|
|
2013
|
16 |
7 |
p. A348-
1 p.
|
artikel
|
| 1095 |
Health Care Costs of HIV in the Czech Republic. A Single Center Analysis
|
Skoupa, J.
|
|
2013
|
16 |
7 |
p. A349-
1 p.
|
artikel
|
| 1096 |
Health Care Resources Utilization and Associated Costs in Patients with COPD with or without Asthma: A Retrospective, Population-Based Observational Study
|
Sicras, A.
|
|
2013
|
16 |
7 |
p. A370-
1 p.
|
artikel
|
| 1097 |
Health Care Resources Utilization in Alzheimer’s Disease: An Analysis with the Quebec Provincial Drug Reimbursement Program Database
|
Lachaine, J.
|
|
2013
|
16 |
7 |
p. A622-
1 p.
|
artikel
|
| 1098 |
Health Care Resource Usage, Treatment and Costs Among Patients with Hip Fracture in the United Kingdom
|
Lambrelli, D.
|
|
2013
|
16 |
7 |
p. A561-
1 p.
|
artikel
|
| 1099 |
Health Care Resource Use and Direct Costs Associated with Fragile X Syndrome (FXS) in the United States
|
Vekeman, F.
|
|
2013
|
16 |
7 |
p. A621-
1 p.
|
artikel
|
| 1100 |
Health Care Resource Utilization and Adherence to Antiretroviral Treatment (ART) by HIV Patients: An Analysis with the Quebec (Canada) Public Drug Plan Database
|
Lachaine, J.
|
|
2013
|
16 |
7 |
p. A361-
1 p.
|
artikel
|
| 1101 |
Health Care Resource Utilization and Cost Among Natalizumab Initiators with Multiple Sclerosis in the United States
|
Bonafede, M.M.
|
|
2013
|
16 |
7 |
p. A621-
1 p.
|
artikel
|
| 1102 |
Health Care Resource Utilization and Costs Associated with Atypical Antipsychotics Use in Children and Adolescents with Attention Deficit/Hyperactivity Disorder in Quebec, Canada
|
Lachaine, J.
|
|
2013
|
16 |
7 |
p. A546-
1 p.
|
artikel
|
| 1103 |
Health Care Resource Utilization and Costs Associated with Treatment of Polish Acromegalic Patients with Lanreotide Autogel 120 Mg – A Retrospective Observational Cohort Analysis
|
Orlewska, E.
|
|
2013
|
16 |
7 |
p. A438-
1 p.
|
artikel
|
| 1104 |
Health Care Resource Utilization and Direct Medical Costs Among Patients with Schizophrenia in Tianjin, China
|
He, X.
|
|
2013
|
16 |
7 |
p. A545-
1 p.
|
artikel
|
| 1105 |
Health Care Resource Utilization and Expenditures of Incident Breast Cancer Patients in the Netherlands: Retrospective Analysis of Health Insurance Data
|
Tariq, L.
|
|
2013
|
16 |
7 |
p. A426-
1 p.
|
artikel
|
| 1106 |
Health Care Resource Utilization Costs Related to Anaemia Management in Chronic Kidney Disease Non-Dialysed Patients: A Retrospective Clinical and Administrative Database Analysis
|
Degli Esposti, L.
|
|
2013
|
16 |
7 |
p. A634-
1 p.
|
artikel
|
| 1107 |
Health Care Utilization and Expenditures of Osteoporosis Patients Treated with Oral Bisphosphonate in Tianjin, China
|
Yu, Q.
|
|
2013
|
16 |
7 |
p. A560-
1 p.
|
artikel
|
| 1108 |
Health Care Utilization Following Newly-Diagnosed Type-2 Diabetes in Sweden: A Follow-Up of 38,956 Patients in a Real Clinical Setting
|
Sabale, U.
|
|
2013
|
16 |
7 |
p. A451-
1 p.
|
artikel
|
| 1109 |
Health Economic Analyses in Medical Nutrition: A Systematic Literature Review
|
Walzer, S.
|
|
2013
|
16 |
7 |
p. A471-
1 p.
|
artikel
|
| 1110 |
Health Economic Analysis of Pneumococcal Vaccination – Example from Bulgaria
|
Manova, M.
|
|
2013
|
16 |
7 |
p. A587-
1 p.
|
artikel
|
| 1111 |
Health-Economic Assessment of the Use of Catheter-Based Renal Denervation in Patients with Resistant Hypertension in Mexico
|
Ceballos, R.M.
|
|
2013
|
16 |
7 |
p. A705-
1 p.
|
artikel
|
| 1112 |
Health Economic Benefits of Sensor Augmented Insulin Pump Therapy in Colombia
|
Gomez, A.
|
|
2013
|
16 |
7 |
p. A690-
1 p.
|
artikel
|
| 1113 |
Health-Economic Comparison of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for the Treatment of Adult Type 1 Diabetes in Kazakhstan
|
Roze, S.
|
|
2013
|
16 |
7 |
p. A439-
1 p.
|
artikel
|
| 1114 |
Health-Economic Comparison of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for the Treatment of Type 1 Diabetes in Kazakhstan Children
|
Roze, S.
|
|
2013
|
16 |
7 |
p. A439-A440
nvt p.
|
artikel
|
| 1115 |
Health Economic Evaluation of a Complementary Biomarker for Hypothetical Prostate Cancer Screening in Germany
|
Meier, F.
|
|
2013
|
16 |
7 |
p. A406-
1 p.
|
artikel
|
| 1116 |
Health Economic Evidence for Medical Nutritions: Are These Interventions Value for Money?
|
Walzer, S.
|
|
2013
|
16 |
7 |
p. A468-
1 p.
|
artikel
|
| 1117 |
Health Economic (HE) Data Requirements and Availability in the European Union. Results of a Survey
|
Skoupa, J.
|
|
2013
|
16 |
7 |
p. A480-
1 p.
|
artikel
|
| 1118 |
Health Economic Modelling of Sequential Therapies for Rheumatoid Arthritis: A Systematic Review
|
Tosh, J.
|
|
2013
|
16 |
7 |
p. A565-
1 p.
|
artikel
|
| 1119 |
Health Economics Assessment of Rilpivirine Versus Comparators as First-Line Antiretroviral Therapies in HIV-1 Patients with a Viral Load (VL) ≤100,000 Copies/mL in France
|
Cognet, M.
|
|
2013
|
16 |
7 |
p. A359-
1 p.
|
artikel
|
| 1120 |
Health Economics Assessment of the Cnamts Sophia Diabetic Patient Support Programme: Results of the First 4 Years
|
Aguadé, A.S.
|
|
2013
|
16 |
7 |
p. A449-
1 p.
|
artikel
|
| 1121 |
Health Insurance Cost of Epilepsy in Hungary: A Cost of Illness Study
|
Oberfrank, F.
|
|
2013
|
16 |
7 |
p. A546-
1 p.
|
artikel
|
| 1122 |
Health Outcomes and Economic Burden of Post-Knee Replacement Surgery in Osteoarthritis Patients: Comparison with Matched Controls
|
Pignot, M.
|
|
2013
|
16 |
7 |
p. A569-A570
nvt p.
|
artikel
|
| 1123 |
Health Outcomes at 6 to 120 Months Since Heart Transplant in Spain: Clinical Status, Health Related-Quality of Life and Utility Assessment
|
Cuervo, J.
|
|
2013
|
16 |
7 |
p. A533-
1 p.
|
artikel
|
| 1124 |
Health Outcomes of Female Anabolic-Androgenic Steroid Users
|
Noone, J.
|
|
2013
|
16 |
7 |
p. A339-A340
nvt p.
|
artikel
|
| 1125 |
Health Related Quality of Life and Device-Acceptance in Patients with Implantable Cardioverter-Defibrillators and Telemonitoring
|
Leppert, F.
|
|
2013
|
16 |
7 |
p. A535-
1 p.
|
artikel
|
| 1126 |
Health-Related Quality of Life and Utility in Patients with Diabetic Foot Syndrome - An EQ-5D Survey in Poland
|
Sobol, E.
|
|
2013
|
16 |
7 |
p. A445-A446
nvt p.
|
artikel
|
| 1127 |
Health Related Quality of Life at Six Months Post Discharge in Patients with Heart Failure
|
Escobar, A.
|
|
2013
|
16 |
7 |
p. A535-
1 p.
|
artikel
|
| 1128 |
Health Related Quality of Life by Line of Therapy in Imatinib-Resistant or Imatinib-Intolerant Patients with Chronic Myeloid Leukemia Treated with Bosutinib Measured by EQ-5D
|
Whiteley, J.
|
|
2013
|
16 |
7 |
p. A387-
1 p.
|
artikel
|
| 1129 |
Health-Related Quality of Life (HRQL) in Chronic Hepatitis C (CH-C) Patients Treated with Sofosbuvir Containing Interferon-Free Regimens
|
Younossi, Z.M.
|
|
2013
|
16 |
7 |
p. A500-
1 p.
|
artikel
|
| 1130 |
Health Related Quality of Life (HRQL) in Parkinson’s Disease: The Impact of ‘On’ and ‘Off’ Time
|
Kerr, C
|
|
2013
|
16 |
7 |
p. A625-
1 p.
|
artikel
|
| 1131 |
Health-Related Quality of Life (HRQoL) in Patients Treated by Novel Oral Anticoagulants (NOACs): Reduced Version of the Sawicki Questionnaire
|
Rodríguez-Aguilella, A.
|
|
2013
|
16 |
7 |
p. A599-
1 p.
|
artikel
|
| 1132 |
Health-Related Quality of Life in Brazilian Obese Patients Submitted to Bariatric Surgery: A Systematic Literature Review
|
Vasconcellos, J.F
|
|
2013
|
16 |
7 |
p. A388-
1 p.
|
artikel
|
| 1133 |
Health-Related Quality of Life in Patients Along First Year Poststroke in Spain
|
Álvarez Sabín, J.
|
|
2013
|
16 |
7 |
p. A536-
1 p.
|
artikel
|
| 1134 |
Health Related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease in North India
|
Negi, H.
|
|
2013
|
16 |
7 |
p. A376-
1 p.
|
artikel
|
| 1135 |
Health-Related Quality of Life in Patients with Type 1 Diabetes and Impaired Hypoglycaemia Awareness: The Role of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension
|
McBride, M.
|
|
2013
|
16 |
7 |
p. A448-
1 p.
|
artikel
|
| 1136 |
Health-Related Quality of Life of Hemodialysis Patients in Indonesia
|
Perwitasari, D.A.
|
|
2013
|
16 |
7 |
p. A699-
1 p.
|
artikel
|
| 1137 |
Health-Related Quality of Life of Patients on Opiate Replacement Therapy
|
Adams, R.
|
|
2013
|
16 |
7 |
p. A551-
1 p.
|
artikel
|
| 1138 |
Health Related Quality of Life of Patients with Bladder Cancer in Hungary
|
Brodszky, V.
|
|
2013
|
16 |
7 |
p. A635-
1 p.
|
artikel
|
| 1139 |
Health Related Quality of Life-Outcome in National Care - Real World Data from the German Psoriasis-Registry “Psobest”
|
Purwins, S.
|
|
2013
|
16 |
7 |
p. A511-
1 p.
|
artikel
|
| 1140 |
Health Seeking Behavior Among Members of the Households; Case of Gucha South District, Kisii County, Kenya
|
Mogere, D.M.
|
|
2013
|
16 |
7 |
p. A676-
1 p.
|
artikel
|
| 1141 |
Health State in Patients with Atrial Fibrillation on New Oral Anticoagulants as Assessed with the New EQ-5D-5L Questionnaire: Prefer in AF Registry
|
Brüggenjürgen, B.
|
|
2013
|
16 |
7 |
p. A533-
1 p.
|
artikel
|
| 1142 |
Health State (QALY) Values for Multiple Sclerosis: A Report Using Data from the United Kingdom South West Impact of Multiple Sclerosis (SWIMS) Study
|
Green, C.
|
|
2013
|
16 |
7 |
p. A625-
1 p.
|
artikel
|
| 1143 |
Health-State Utilities in Measuring Health-Related Quality of Life Among Patients with Rheumatoid Arthritis in Taiwan
|
Tang, C.H.
|
|
2013
|
16 |
7 |
p. A568-
1 p.
|
artikel
|
| 1144 |
Health State Utility Values in Advanced Non-Small Cell Lung Cancer Patients
|
Chevalier, J.
|
|
2013
|
16 |
7 |
p. A419-
1 p.
|
artikel
|
| 1145 |
Health Technology Assessment: Is It the Right Piece for the Jordanian Health Care Puzzle?
|
Al Rabayah, A.A.
|
|
2013
|
16 |
7 |
p. A429-
1 p.
|
artikel
|
| 1146 |
Health Technology Assessment of Companion Diagnostic Biomarkers as Gatekeepers for Personalized Medicine Market Access
|
Spinner, D.S.
|
|
2013
|
16 |
7 |
p. A376-
1 p.
|
artikel
|
| 1147 |
Health Technology Assessment of Contrast-Enhanced Ultrasound (CEUS) Techniques
|
Dozsa, C.
|
|
2013
|
16 |
7 |
p. A415-
1 p.
|
artikel
|
| 1148 |
Health Technology Assessment of High-Value Therapies
|
Hegyi, R.
|
|
2013
|
16 |
7 |
p. A491-
1 p.
|
artikel
|
| 1149 |
Health Technology Assessment Report for Positron Emission Tomography in Patients with Cancer
|
Alcaraz, A.
|
|
2013
|
16 |
7 |
p. A667-
1 p.
|
artikel
|
| 1150 |
Health Technology Assessments of Medical Devices: Is Help Out There?
|
Green, W.
|
|
2013
|
16 |
7 |
p. A483-
1 p.
|
artikel
|
| 1151 |
Health Transformation Program Impact on Import and Local Pharmaceutical Consumption in Turkey
|
Ufuktepe, B.
|
|
2013
|
16 |
7 |
p. A461-
1 p.
|
artikel
|
| 1152 |
Health Utilities Index (Hui®): Population Reference Statistics
|
Horsman, J.R.
|
|
2013
|
16 |
7 |
p. A595-
1 p.
|
artikel
|
| 1153 |
Hemangioma Family Burden: Creation of a Specific Questionnaire
|
Taieb, C.
|
|
2013
|
16 |
7 |
p. A509-
1 p.
|
artikel
|
| 1154 |
Hepatitis a Vaccine Policy Process in 6 Countries – Factors Influencing Potential Adoption
|
Foley, K.
|
|
2013
|
16 |
7 |
p. A364-
1 p.
|
artikel
|
| 1155 |
Hepatitis C Virus Infection Treatment Completion: An Analysis of the Quebec Provincial Reimbursement Program Database
|
Lachaine, J.
|
|
2013
|
16 |
7 |
p. A361-
1 p.
|
artikel
|
| 1156 |
Hepatocellular Carcinoma: An Epidemiological and Management Survey-Based Analysis in Italy
|
Cicchetti, A.
|
|
2013
|
16 |
7 |
p. A494-
1 p.
|
artikel
|
| 1157 |
Herpes Zoster in Europe: A Review of Evidence Documenting Humanistic, Economic and Societal Burden
|
McCool, R.
|
|
2013
|
16 |
7 |
p. A622-
1 p.
|
artikel
|
| 1158 |
High Dosages of Statins in High Cardiovascular Risk Patients in a Real World Setting: Treatment Patterns and Outcomes
|
Degli Esposti, L.
|
|
2013
|
16 |
7 |
p. A512-A513
nvt p.
|
artikel
|
| 1159 |
High Economic Burden of Moderate to Severe Psoriatic Arthritis on Paid Work and Household Productivity: Baseline Results from the Rapid-PSA Study
|
Kavanaugh, A.
|
|
2013
|
16 |
7 |
p. A566-
1 p.
|
artikel
|
| 1160 |
HIV Regulatory Practices and Their Influence Over Reimbursement Decisions
|
Rubinstein, J.
|
|
2013
|
16 |
7 |
p. A365-
1 p.
|
artikel
|
| 1161 |
Holistic Data Generation and Synthesis for HTA Assessment: Bringing Together Comparative Effectiveness Research, Personalised Medicine and Patient-Centred Outcomes Research
|
Langham, S.
|
|
2013
|
16 |
7 |
p. A616-
1 p.
|
artikel
|
| 1162 |
Hormonal Receptor Positive, HER2 Negative Metastatic Breast Cancer (MBC HR+HER2-): Pre and Post-Progression Costs Under the Public Health Care System (SUS) and Societal Perspectives in Brazil
|
Haas, L.C.
|
|
2013
|
16 |
7 |
p. A404-
1 p.
|
artikel
|
| 1163 |
Hospital Admissions Related to Tuberculosis in Brazil: Epidemiological and Economic Profile, from the Public Health Care Perspective
|
Amaral, L.M.
|
|
2013
|
16 |
7 |
p. A347-
1 p.
|
artikel
|
| 1164 |
Hospital Resources Consumption Associated with Trastuzumab Treatment in Breast Cancer in Portugal
|
Andrade, S.
|
|
2013
|
16 |
7 |
p. A418-
1 p.
|
artikel
|
| 1165 |
Hospital Resource Use in Chronic Disease Combinations: Is It Enough to Just Add Them Up?
|
Seah, J.Z.
|
|
2013
|
16 |
7 |
p. A466-
1 p.
|
artikel
|
| 1166 |
Household Feeding Practices for the Sick Under Five Children; Gucha South District-Kisii County, Kenya
|
Mogere, D.M.
|
|
2013
|
16 |
7 |
p. A676-
1 p.
|
artikel
|
| 1167 |
How Burdensome Is Completion of Electronic Patient-Reported Outcomes (ePRO)? Item Completion Times and Qualitative Evidence from Studies in Four Different Health Conditions
|
Arbuckle, R.
|
|
2013
|
16 |
7 |
p. A604-
1 p.
|
artikel
|
| 1168 |
How Can Health Economic Assessment Methods Help Decision Making in Portfolio Development
|
Akpo, H.
|
|
2013
|
16 |
7 |
p. A616-A617
nvt p.
|
artikel
|
| 1169 |
How Complex Is the Competition in Regulated Pharmaceutical Markets?
|
Colak, B.
|
|
2013
|
16 |
7 |
p. A538-
1 p.
|
artikel
|
| 1170 |
How Co-Payment Mechanism Has Changed Patients’ Perception Towards Otc-Type Products?
|
Deger, C.C.
|
|
2013
|
16 |
7 |
p. A453-A454
nvt p.
|
artikel
|
| 1171 |
How Does Hospitalization Impact Insulin Treatment in Diabetes Mellitus? Results of a Retrospective German Database Analysis
|
Schmidt, J.
|
|
2013
|
16 |
7 |
p. A452-
1 p.
|
artikel
|
| 1172 |
How Does Prescription of Generic Drugs Spread Out?: Data Mining and Visualization by Using Prescription Data Form Acute Care Hospitals Nationwide
|
Shimizu, S.
|
|
2013
|
16 |
7 |
p. A460-A461
nvt p.
|
artikel
|
| 1173 |
How Does the Uncertainty Around the Expected ICER Affect Nice Decisions?
|
Barber, R.
|
|
2013
|
16 |
7 |
p. A481-
1 p.
|
artikel
|
| 1174 |
How Do Oncology Drug Prices Vary Across EU5, the United States, and Bric Markets?
|
Patel, P.
|
|
2013
|
16 |
7 |
p. A490-A491
nvt p.
|
artikel
|
| 1175 |
How Do Patients with Chronic Obstructive Pulmonary Disease (COPD) Use Their Inhalers? Common Mistakes. Tecepoc Study
|
Leiva-Fernandez, F.
|
|
2013
|
16 |
7 |
p. A374-
1 p.
|
artikel
|
| 1176 |
How Hypoglycemia Impacts Quality of Life and Treatment Satisfaction in Type 2 Diabetes Mellitus Patients on Basal-Bolus Insulin Therapy?
|
Ionova, T.I.
|
|
2013
|
16 |
7 |
p. A446-
1 p.
|
artikel
|
| 1177 |
How Much Dengue Costs to Brazil? A Retrospective Administrative Claims Analysis from the Public Payer Perspective
|
Silva, M.A
|
|
2013
|
16 |
7 |
p. A347-
1 p.
|
artikel
|
| 1178 |
How Much Does Benign Prostatic Hyperplasia Cost? A Budget Impact Analysis on Italian Patients Treated with 5α-Reductase Inhibitors
|
Povero, M.
|
|
2013
|
16 |
7 |
p. A332-
1 p.
|
artikel
|
| 1179 |
How Should an Antidepressant with Reduced Risk of Sexual Dysfunction Be Positioned in Treatment Strategies for Patients with Major Depressive Disorder?
|
Massetti, M.
|
|
2013
|
16 |
7 |
p. A547-A548
nvt p.
|
artikel
|
| 1180 |
How the Pricing Strategy of 2nd Generation HCV Direct Antiviral Agents Can Affect the Number of Treated Patients in Italy and the National Drug Budget
|
Lanati, E.P.
|
|
2013
|
16 |
7 |
p. A501-
1 p.
|
artikel
|
| 1181 |
How to Determine Size of Patient Population When the Right Data Isn’t There?
|
Stuchiner, A.
|
|
2013
|
16 |
7 |
p. A390-
1 p.
|
artikel
|
| 1182 |
How to Select the Right Cost-Effectiveness Model? A Systematic Review and Stepwise Approach for Transferring an Existing Health Economic Model for Rheumatoid Arthritis
|
van Haalen, H.G.M.
|
|
2013
|
16 |
7 |
p. A590-
1 p.
|
artikel
|
| 1183 |
How University Hospital of Crete Succeeded in Decreasing Cytostatics’ Budget in 2012?
|
Gkogkozotou, V.K.
|
|
2013
|
16 |
7 |
p. A686-
1 p.
|
artikel
|
| 1184 |
How Well Do We Understand the Economic Burden Associated with Dementia? A Focus on Trends in Care Home Costs and Future Perspectives in the United Kingdom
|
Griffiths, M.
|
|
2013
|
16 |
7 |
p. A553-
1 p.
|
artikel
|
| 1185 |
HR-QOL Data in the Amnog Early Benefit Assessment: Industry and IQWIG/GBA Perspective
|
Obradovic, M.
|
|
2013
|
16 |
7 |
p. A422-A423
nvt p.
|
artikel
|
| 1186 |
HTA National Public Policy and Their Socio-Economic Environment: A European Perspective
|
Benoit, C.
|
|
2013
|
16 |
7 |
p. A489-
1 p.
|
artikel
|
| 1187 |
Hypercholesterolemia’s Burden of Disease in Portugal
|
Gouveia, M.
|
|
2013
|
16 |
7 |
p. A540-
1 p.
|
artikel
|
| 1188 |
Iceberg Phenomenon of Heart Failure in Hospitalized Patients: A Multicentric Cross Sectional Study
|
Insua, J.T.
|
|
2013
|
16 |
7 |
p. A702-
1 p.
|
artikel
|
| 1189 |
Identification and Qualitative Assessment of Real World Data Sources: Example of Lymphoma and Multiple Myeloma in Europe
|
Noibi, S.O.
|
|
2013
|
16 |
7 |
p. A583-
1 p.
|
artikel
|
| 1190 |
Identification of the Treatment Pathway of Metastatic Castrate-Resistant Prostate Cancer in Scotland: A Chart Review
|
Maman, K.
|
|
2013
|
16 |
7 |
p. A431-
1 p.
|
artikel
|
| 1191 |
Illustration of the Combined Effect of Patient’s Adherence and Individual Biological Characteristics on Blood Pressure
|
Tousset, E.
|
|
2013
|
16 |
7 |
p. A532-
1 p.
|
artikel
|
| 1192 |
Impacto De La Diabetes Sobre La Productividad En Argentina
|
Asteazaran, S.
|
|
2013
|
16 |
7 |
p. A690-A691
nvt p.
|
artikel
|
| 1193 |
Impacto Do Uso Do Microdebridador Nos Desfechos E Custos Nas Cirurgias Endoscópicas Nasais
|
Costa, J.D.B.
|
|
2013
|
16 |
7 |
p. A723-
1 p.
|
artikel
|
| 1194 |
Impacto Económico Y En Discapacidad Del Incrementro De Utilización De Trombolisis En El Cuidado Agudo De L Ictus Isquémico En Chile
|
Hoffmeister, L.
|
|
2013
|
16 |
7 |
p. A704-
1 p.
|
artikel
|
| 1195 |
Impacto En La Productividad Laboral De Una Cohorte De Pacientes Con Artritis Reumatoide Tratados Con Etanercept (Enbrel®) En Colombia
|
Jauregui, E.
|
|
2013
|
16 |
7 |
p. A718-
1 p.
|
artikel
|
| 1196 |
Impact of Autism Spectrum Disorders on the Family – A National Perspective
|
Vohra, R.
|
|
2013
|
16 |
7 |
p. A553-A554
nvt p.
|
artikel
|
| 1197 |
Impact of Bariatric Surgery on Obese Patients Management and Related Costs: A French National Claims Database Analysis Over the Period 2005 -2011
|
Czernichow, S.
|
|
2013
|
16 |
7 |
p. A382-
1 p.
|
artikel
|
| 1198 |
Impact of Cardiovascular Disease on Labour Force Participation: Bivariate Probit Analysis
|
Civil, E.F.
|
|
2013
|
16 |
7 |
p. A531-
1 p.
|
artikel
|
| 1199 |
Impact of Chronic Pain on Health Care Costs in Chronic Obstructive Pulmonary Disease as Compared to Other Chronic Diseases
|
Mapel, D.
|
|
2013
|
16 |
7 |
p. A369-A370
nvt p.
|
artikel
|
| 1200 |
Impact of Comorbidity Burden on Real-World Health Care Costs of Rheumatoid Arthritis Patients in Turkey
|
Baser, O.
|
|
2013
|
16 |
7 |
p. A555-
1 p.
|
artikel
|
| 1201 |
Impact of Dosage and Seven Other Factors in the Adherence to Oral Medication in People with Diabetes Type 2 in Germany
|
Pleguezuelo, W.itte M
|
|
2013
|
16 |
7 |
p. A445-
1 p.
|
artikel
|
| 1202 |
Impact of Exclusive Hospital Distribution of Biosimilar on Drug Health Care Budget
|
Rémuzat, C.
|
|
2013
|
16 |
7 |
p. A323-
1 p.
|
artikel
|
| 1203 |
Impact of Highly Active Antiretroviral Therapy (HAART) Regimen on Adherence and Risk of Hospitalization in Veterans with HIV/AIDS
|
Rao, G.A.
|
|
2013
|
16 |
7 |
p. A341-
1 p.
|
artikel
|
| 1204 |
Impacto Financiero Del Tratamiento Farmacológico En Pacientes Adultos Con Enfermedad De Gaucher Tipo 1 En México
|
Soto-Molina, H.
|
|
2013
|
16 |
7 |
p. A726-
1 p.
|
artikel
|
| 1205 |
Impact of Major Clinical Events on Utilities in the Context of Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) Treated with Dialysis
|
Davies, E.W.
|
|
2013
|
16 |
7 |
p. A634-
1 p.
|
artikel
|
| 1206 |
Impact of Medicare Part D on Prescription Use, Health Care Expenditures, and Health Services Utilization: National Estimates for Medicare Beneficiaries, 2002 to 2009
|
Cheng, L.I.
|
|
2013
|
16 |
7 |
p. A464-
1 p.
|
artikel
|
| 1207 |
Impact of Medication Adherence on Health Care Cost in Asthma
|
Nagy, B.
|
|
2013
|
16 |
7 |
p. A576-
1 p.
|
artikel
|
| 1208 |
Impact of Medication Adherence on Health Care Cost in COPD
|
Nagy, B.
|
|
2013
|
16 |
7 |
p. A576-
1 p.
|
artikel
|
| 1209 |
Impact of Nocturnal and Daytime Non-Severe Hypoglycaemic Events on People with Diabetes in South Africa
|
Snyman, J.
|
|
2013
|
16 |
7 |
p. A448-A449
nvt p.
|
artikel
|
| 1210 |
Impact of Nursing and Pharmacy Care Between Capecitabine and 5-Fluoruracil Regimens in the Management of Advanced Esophago-Gastric Cancer in Hong Kong
|
Lee, V.W.Y.
|
|
2013
|
16 |
7 |
p. A418-
1 p.
|
artikel
|
| 1211 |
Impact of Patient Weight Trajectory on Cost-Effectiveness of Treatments of Type 2 Diabetes Mellitus (T2DM)
|
Schroeder, M.
|
|
2013
|
16 |
7 |
p. A440-
1 p.
|
artikel
|
| 1212 |
Impact of Pharmacoeconomics Modelling on Reimbursement of Medicines in Serbia
|
Medic, G.
|
|
2013
|
16 |
7 |
p. A468-A469
nvt p.
|
artikel
|
| 1213 |
Impact of Pill-Splitting Training on Drug Physiochemical Properties, Compliance and Clinical Outcomes in Elderly Population: A Cross-Over Cohort Study
|
Lee, V.W.Y.
|
|
2013
|
16 |
7 |
p. A514-
1 p.
|
artikel
|
| 1214 |
Impact of Public Payer Concentration on Public Sector Discounts for Selected Cancer Supportive Care Products in Brazil and Mexico
|
Sandorff, E.
|
|
2013
|
16 |
7 |
p. A687-
1 p.
|
artikel
|
| 1215 |
Impact of Recommended Pharmaceuticals on Cancer Mortality: Analysis of Real-Life Data
|
Wilson, T.
|
|
2013
|
16 |
7 |
p. A428-A429
nvt p.
|
artikel
|
| 1216 |
Impact of Reimbursement of Medicines on Economic Accessibility Level for Working Population in Republic of Moldova
|
Chitan, E.
|
|
2013
|
16 |
7 |
p. A474-
1 p.
|
artikel
|
| 1217 |
Impact of Short Periods with Improved or Worsened INR Control on Life Expectancy and QALYs in Patients with Atrial Fibrillation
|
Lesén, E.
|
|
2013
|
16 |
7 |
p. A328-
1 p.
|
artikel
|
| 1218 |
Impact of Switching on Health Care Costs and Outcomes in Generic Drug Policies
|
Kalo, Z.
|
|
2013
|
16 |
7 |
p. A537-
1 p.
|
artikel
|
| 1219 |
Impact of the German Amnog Evaluation on Drug Prices: Correlation of Rebate?
|
Neeser, K.
|
|
2013
|
16 |
7 |
p. A473-
1 p.
|
artikel
|
| 1220 |
Impact of Treatment Failure on the Total Cost of Triple Therapy Including Boceprevir or Telaprevir Based on the French Early Access Program (ANRS CO20-CUPIC) Study
|
Valladares, A.
|
|
2013
|
16 |
7 |
p. A350-
1 p.
|
artikel
|
| 1221 |
Impact of Using Either Multiplicative or Additive Utility Decrements in Decision Models
|
Cure, S.
|
|
2013
|
16 |
7 |
p. A579-
1 p.
|
artikel
|
| 1222 |
Impact of Value Communication in Decision Making: An Approach to the Treatment of Type 2 Diabetes in Portugal
|
Viriato, D.
|
|
2013
|
16 |
7 |
p. A453-
1 p.
|
artikel
|
| 1223 |
Impact on the Estimated ICER of Including Age-Specific Baseline HRQoL in a Model
|
Teljeur, C.
|
|
2013
|
16 |
7 |
p. A599-
1 p.
|
artikel
|
| 1224 |
Impacto Presupuestal De La Enfermedad Renal Terminal En Colombia Con Un Incremento Del Número De Trasplantes
|
Rosselli, D.
|
|
2013
|
16 |
7 |
p. A697-A698
nvt p.
|
artikel
|
| 1225 |
Implementation of International Chart Review Studies: An Assessment of Key Design and Operational Considerations for Successful Conduct
|
Jean-Mary, J.
|
|
2013
|
16 |
7 |
p. A612-
1 p.
|
artikel
|
| 1226 |
Implications of Global Pricing Policies of Pharmaceuticals for Access the Innovative Drugs: The Case of Trastuzumab in Seven Latin American Countries
|
Pichon Riviere, A.
|
|
2013
|
16 |
7 |
p. A668-A669
nvt p.
|
artikel
|
| 1227 |
Implications of Non-Adherence to Phosphate Binders on Patients’ Phosphate Levels
|
Furniss, S.J.
|
|
2013
|
16 |
7 |
p. A634-
1 p.
|
artikel
|
| 1228 |
Importance of Subgroup Analyses for Health Technology Assessments
|
Aggarwal, S.
|
|
2013
|
16 |
7 |
p. A462-
1 p.
|
artikel
|
| 1229 |
Improvement in Disease Activity Scores Associated with Early Versus Late Initiation of Biologic Therapy in Patients with Rheumatoid Arthritis: Results of a European Chart Review Study
|
Emery, P.
|
|
2013
|
16 |
7 |
p. A557-
1 p.
|
artikel
|
| 1230 |
Improvements in Physical Function, Health Related Quality of Life and Work Productivity in Patients with Rheumatoid Arthritis Treated with Golimumab: Sub-Analysis of Latin American Patients Enrolled in Mulitcentre Phase III Clinical Trials
|
Strusberg, I.
|
|
2013
|
16 |
7 |
p. A718-
1 p.
|
artikel
|
| 1231 |
Incidence of Anastomotic Leaks After Colorectal Surgeries Using Hospital Episode Statistics in the United Kingdom
|
Riebman, J.
|
|
2013
|
16 |
7 |
p. A494-
1 p.
|
artikel
|
| 1232 |
Incidence/Prevalence, Risk Factors and Complications of Type 2 Diabetes Mellitus in Indian Patients: A Systematic Review and Meta-Analysis
|
Likhar, N.
|
|
2013
|
16 |
7 |
p. A434-
1 p.
|
artikel
|
| 1233 |
Incorporating Stakeholder Input into Budget Impact Models to Compare Stem Cell Mobilization Strategies
|
Jensen, I.S.
|
|
2013
|
16 |
7 |
p. A399-
1 p.
|
artikel
|
| 1234 |
Increased Risk of Cancer Incidence Associated with Repeat Medical Imaging: Designing Better Clinical Trial Protocols
|
Zowall, H.
|
|
2013
|
16 |
7 |
p. A428-
1 p.
|
artikel
|
| 1235 |
Incremental Cost Per Quality-adjusted Life Year Gained? The Need for Alternative Methods to Evaluate Medical Interventions for Ultra-rare Disorders
|
Schlander, M.
|
|
2013
|
16 |
7 |
p. A324-
1 p.
|
artikel
|
| 1236 |
Incretin Therapy for Patients with Type 2 Diabetes in Spain: A Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin
|
Ramirez de Arellano, A.
|
|
2013
|
16 |
7 |
p. A439-
1 p.
|
artikel
|
| 1237 |
Indirect and Direct Savings Resulted from Parallel Trade of Pharmaceuticals in Poland – Results of Valuation Sales Data from Public Pharmacies
|
Baran-Lewandowska, I.
|
|
2013
|
16 |
7 |
p. A457-
1 p.
|
artikel
|
| 1238 |
Indirect Comparison Analysis to Evaluate the Clinical Effectiveness of Trastuzumab Emtansine (T-DM1) Versus Other Treatments for HER2-Positive Metastatic Breast Cancer (MBC)
|
Benito Garcia, E.
|
|
2013
|
16 |
7 |
p. A395-
1 p.
|
artikel
|
| 1239 |
Indirect Comparison of Joint Damage Prevention with Adalimumab V. Abatacept, Each in Combination with Methotrexate, in Early Rheumatoid Arthritis
|
Wu, E.Q.
|
|
2013
|
16 |
7 |
p. A555-
1 p.
|
artikel
|
| 1240 |
Indirect Comparison of the Effect of Biologics in Patients with Psoriasis; A Meta-Analysis of Randomized, Double Blind Clinical Trials in Bayesian Framework
|
Brodszky, V.
|
|
2013
|
16 |
7 |
p. A501-A502
nvt p.
|
artikel
|
| 1241 |
Indirect Comparisons of Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: A Systematic Literature Review
|
Claflin, A.B.
|
|
2013
|
16 |
7 |
p. A514-A515
nvt p.
|
artikel
|
| 1242 |
Indirect Costs of Systemic Lupus Erythematosus-Related Absenteeism in Poland: An Analysis Based on Social Insurance Institution Data
|
Golicki, D.
|
|
2013
|
16 |
7 |
p. A386-
1 p.
|
artikel
|
| 1243 |
Indirect Treatment Comparison and Economic Evaluation of Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Atrial Fibrillation in the Netherlands
|
Le, H.H.
|
|
2013
|
16 |
7 |
p. A514-
1 p.
|
artikel
|
| 1244 |
Indirect Treatment Comparison Between Fixed-Dose-Combinations of Losartan/Amlodipine and Valsartan/Amlodipine in Blood Pressure Control
|
Gould, A.L.
|
|
2013
|
16 |
7 |
p. A703-
1 p.
|
artikel
|
| 1245 |
Individually Tailored Elastic Compression Therapy for the Prevention of Post Thrombotic Syndrome
|
Bouman, A.C.
|
|
2013
|
16 |
7 |
p. A527-
1 p.
|
artikel
|
| 1246 |
Inference on Incremental Cost Effectiveness Thresholds Influencing Nice Decisions: A Bayesian Analysis
|
Cao, X.
|
|
2013
|
16 |
7 |
p. A470-
1 p.
|
artikel
|
| 1247 |
Inflammatory Bowel Diseases in Italy: Incidence Trends and Patients’ Characteristics
|
Fornari, C.
|
|
2013
|
16 |
7 |
p. A501-
1 p.
|
artikel
|
| 1248 |
Influence of Anxiety and Depression on 1-Year Health Related Quality of Life in Colorectal Cancer Patients
|
Escobar, A.
|
|
2013
|
16 |
7 |
p. A421-A422
nvt p.
|
artikel
|
| 1249 |
Influence of One Week Education Program on the Knowledge and Approach of Pharmacy Students Towards Diabetes Mellitus
|
Khan, M.S.
|
|
2013
|
16 |
7 |
p. A691-A692
nvt p.
|
artikel
|
| 1250 |
Influence of Patient-Reported Outcomes on HTA Reimbursement Decisions
|
Kulich, K.
|
|
2013
|
16 |
7 |
p. A480-
1 p.
|
artikel
|
| 1251 |
Informing the Affordability of Vaccines with Different Health Care Financing Mechanisms
|
Varghese, L.
|
|
2013
|
16 |
7 |
p. A473-
1 p.
|
artikel
|
| 1252 |
Inhaled Corticosteroids (ICS) in Treatment of Moderate and Severe Asthma in Russian Federation – Comparative Pharmacoeconomic Study
|
Krysanov, I.
|
|
2013
|
16 |
7 |
p. A372-
1 p.
|
artikel
|
| 1253 |
In-Hospital and Long-Term Mortality and Morbidity Burdens in Patients with Acute Coronary Syndromes
|
Zeymer, U.
|
|
2013
|
16 |
7 |
p. A517-
1 p.
|
artikel
|
| 1254 |
Initial Anticoagulation Therapy in Patients with Venous Thromboembolism and Impaired Renal Function: Results of an Observational Study
|
Boettger, B.
|
|
2013
|
16 |
7 |
p. A538-
1 p.
|
artikel
|
| 1255 |
Inpatient Hospital Costs of Febrile Neutropenia (FN) as a Consequence of Chemotherapy (CHT) for Breast Cancer (BC) and Non-Hodgkin Lymphoma (NHL) in Switzerland
|
Mattli, R.
|
|
2013
|
16 |
7 |
p. A405-
1 p.
|
artikel
|
| 1256 |
In-Patient Hospitalizations for Chronic Kidney Disease in the United States
|
Aggarwal, S.
|
|
2013
|
16 |
7 |
p. A631-A632
nvt p.
|
artikel
|
| 1257 |
Instructions for Authors
|
|
|
2013
|
16 |
7 |
p. I-II
nvt p.
|
artikel
|
| 1258 |
Integración De Un Marco Conceptual Para La Evaluación De La Calidad De Servicios Farmacéuticos Hospitalarios Enfocados a La Mejora De La Farmacoterapia
|
Diaz de León-Castañeda, C.
|
|
2013
|
16 |
7 |
p. A674-
1 p.
|
artikel
|
| 1259 |
Integrating the Long-Term Health Burden of Oral Corticosteroids in the Cost-Effectiveness of Omalizumab
|
Faria, R.
|
|
2013
|
16 |
7 |
p. A373-
1 p.
|
artikel
|
| 1260 |
Interim Results from the Burden of Bowel Dysfunction in Spinal Cord Injury Study
|
Mittmann, N.
|
|
2013
|
16 |
7 |
p. A496-
1 p.
|
artikel
|
| 1261 |
International Normalized Ratio (INR) Monitoring and Percent Time in Therapeutic INR Range (TTR) Have Impact on Patient’s Quality of Life? Application of Beta Regressions in a Prospective 3 Months Setting
|
Soini, E.J.
|
|
2013
|
16 |
7 |
p. A535-
1 p.
|
artikel
|
| 1262 |
Interruption/Bridging of VKA Treatment of Patients with Atrial Fibrillation: Analysis of Incidence and Clinical Outcomes Based on a German Claims Based Data Set
|
Wilke, T.
|
|
2013
|
16 |
7 |
p. A517-
1 p.
|
artikel
|
| 1263 |
Introducing the ENCePP Working Group (WG) on Health Technology Assessment (HTA): Enhancing the Generation of Additional Evidence for HTA Processes
|
Sinclair, M.
|
|
2013
|
16 |
7 |
p. A491-
1 p.
|
artikel
|
| 1264 |
Introduction of an Infliximab Biosimilar (CT-P13): A Five-Year Budget Impact Analysis for the Treatment of Rheumatoid Arthritis in Ireland
|
McCarthy, G.
|
|
2013
|
16 |
7 |
p. A558-
1 p.
|
artikel
|
| 1265 |
Introduction of Innovations into the German Statutatory Reimbrusment System – Factors for Success
|
Krensel, M.
|
|
2013
|
16 |
7 |
p. A459-
1 p.
|
artikel
|
| 1266 |
Investigating Safety-Appraoch in Saudi Arabia Ministry of Health Hospitals
|
Alkelya, M.A.
|
|
2013
|
16 |
7 |
p. A471-A472
nvt p.
|
artikel
|
| 1267 |
Investigating the Economic Impacts of New Public Pharmaceutical Policies in Greece
|
Siskou, O.
|
|
2013
|
16 |
7 |
p. A470-
1 p.
|
artikel
|
| 1268 |
Investigating the Impact of Mental Health Status on Health and Social Care Costs of Older People after Acute Hospital Admission
|
Berdunov, V.
|
|
2013
|
16 |
7 |
p. A335-
1 p.
|
artikel
|
| 1269 |
Investigating the Validity of the UKPDS Outcomes Equations in Current Clinical Practice
|
McEwan, P.
|
|
2013
|
16 |
7 |
p. A585-
1 p.
|
artikel
|
| 1270 |
Investigating the Value of Abatacept IV in the Treatment of Rheumatoid Arthritis: A Systematic Review of Cost-Effectiveness Studies
|
Athanasakis, K.
|
|
2013
|
16 |
7 |
p. A563-
1 p.
|
artikel
|
| 1271 |
Investing in European Health R&D – A Pathway to Sustained Innovation and Stronger Economies
|
Pasmans, R.
|
|
2013
|
16 |
7 |
p. A490-
1 p.
|
artikel
|
| 1272 |
IQWIG’s Efficiency Frontier Approach: Fit for Purpose!
|
Sandmann, F.G.
|
|
2013
|
16 |
7 |
p. A473-
1 p.
|
artikel
|
| 1273 |
Is Adjunctive Guanfacine-Extended Release Associated with Changes in Stimulant Adherence Among Children and Adolescents with Attention Deficit/Hyperactivity Disorder in a Managed Care Setting?
|
Gajria, K.
|
|
2013
|
16 |
7 |
p. A552-
1 p.
|
artikel
|
| 1274 |
Is Drug Innovation Still Rewarded in the Top 5 European Pharmaceutial Markets?
|
Reinaud, F.
|
|
2013
|
16 |
7 |
p. A457-
1 p.
|
artikel
|
| 1275 |
Is External Price Referencing an Appropriate Drug Policy from an Efficiency, Equity, and Quality Perspective?
|
Wouters, O.J.
|
|
2013
|
16 |
7 |
p. A458-
1 p.
|
artikel
|
| 1276 |
Is Hospitalized Multi-Morbidity in Adults Determining Costs of Re-Admission? Evidence from a Multicentric Cross Sectional Study in Argentina
|
Insua, J.T.
|
|
2013
|
16 |
7 |
p. A675-
1 p.
|
artikel
|
| 1277 |
Is It Worth Having Orphan Drug Status in Germany Post-Amnog?
|
Radicek, S.
|
|
2013
|
16 |
7 |
p. A391-
1 p.
|
artikel
|
| 1278 |
ISPOR 16th Annual European Congress Author Index
|
|
|
2013
|
16 |
7 |
p. A649-A664
nvt p.
|
artikel
|
| 1279 |
ISPOR 16th Annual European Congress Disclosure Information
|
|
|
2013
|
16 |
7 |
p. A637-A648
nvt p.
|
artikel
|
| 1280 |
ISPOR 4th Latin America Conference Author Index
|
|
|
2013
|
16 |
7 |
p. A732-A735
nvt p.
|
artikel
|
| 1281 |
ISPOR 4th Latin America Conference Disclosure Information
|
|
|
2013
|
16 |
7 |
p. A729-A731
nvt p.
|
artikel
|
| 1282 |
Issues with Cost-Effectiveness Modelling of Diagnostic Tests – Case Study of Ischaemic Cardiomyopathy
|
Thokala, P.
|
|
2013
|
16 |
7 |
p. A527-
1 p.
|
artikel
|
| 1283 |
Is the Use of Esomeprazole in Gastroesophageal Reflux Disease a Cost-Effective Option in Poland?
|
Petryszyn, P.
|
|
2013
|
16 |
7 |
p. A498-
1 p.
|
artikel
|
| 1284 |
It Application for Post Marketing Drug Registries
|
De Rosa, M.
|
|
2013
|
16 |
7 |
p. A679-
1 p.
|
artikel
|
| 1285 |
Item Refinement and Psychometric Testing of a Novel Survey for Evaluating Patient Perception and Preference for Haemophilia a Treatment
|
Teal, S.A.
|
|
2013
|
16 |
7 |
p. A597-
1 p.
|
artikel
|
| 1286 |
Japanese Representation in Leading General Medicine and Basic Science Journals: A Comparison of Two Decades
|
Takahashi, O.
|
|
2013
|
16 |
7 |
p. A477-
1 p.
|
artikel
|
| 1287 |
Juggling Jurisdictions: Methods for Conducting Modular Systematic Reviews?
|
Thompson, J.
|
|
2013
|
16 |
7 |
p. A614-
1 p.
|
artikel
|
| 1288 |
Key Drivers of Pbac Decisions for the Reimbursement of Orphan Drugs on the Life Saving Drugs Program
|
Maguire, B.
|
|
2013
|
16 |
7 |
p. A480-A481
nvt p.
|
artikel
|
| 1289 |
La Protección Financiera Y El Gasto De Bolsillo En Salud De La Población Mexicana 2002-2010
|
Rivera, G.
|
|
2013
|
16 |
7 |
p. A672-
1 p.
|
artikel
|
| 1290 |
La Utilidad Predictiva Del Euroscore Puede Ser Mejorada Al Adicionar Valores De Peptido Natriurético Tipo B O De Hemoglobina
|
Hernàndez-Leiva, E.
|
|
2013
|
16 |
7 |
p. A703-
1 p.
|
artikel
|
| 1291 |
Length of Stay and Outcomes for Adolescents Treated for Substance Use Disorder: An Analysis of Dose Respose Using Propensity Scores
|
Ciesla, J.
|
|
2013
|
16 |
7 |
p. A694-
1 p.
|
artikel
|
| 1292 |
Level and Factors Impacting the Patient Dissatisfaction in the Primary Care Visits Based on the Cross-Section Measurement – a Prospective Finnish Study
|
Soini, E.J.
|
|
2013
|
16 |
7 |
p. A336-
1 p.
|
artikel
|
| 1293 |
Level of Asthma Control and Health Care Utilization in Latin America
|
Montealegre-Golcher, F.
|
|
2013
|
16 |
7 |
p. A725-
1 p.
|
artikel
|
| 1294 |
Lifetime Cost-Effectiveness of Concomitant Aortic Valve Replacements in France and the United Kingdom
|
Pradelli, L.
|
|
2013
|
16 |
7 |
p. A531-
1 p.
|
artikel
|
| 1295 |
Lifetime Cost-Effectiveness of Isolated and Concomitant Aortic Valve Replacements in Germany
|
Pradelli, L.
|
|
2013
|
16 |
7 |
p. A531-
1 p.
|
artikel
|
| 1296 |
Lifetime Cost-Effectiveness of Isolated Aortic Valve Replacements Associated with the Mini-Invasive Implantation of a New Sutureless and Collapsed Valve in France and United Kingdom
|
Pradelli, L.
|
|
2013
|
16 |
7 |
p. A530-
1 p.
|
artikel
|
| 1297 |
Likelihood of Use and Perception Towards Biosimilars in Rheumatoid Arthritis Arena: Survey of Rheumatologists in European Union, Brazil, Japan and China
|
Narayanan, S.
|
|
2013
|
16 |
7 |
p. A388-A389
nvt p.
|
artikel
|
| 1298 |
Linezolid for the Treatment of Patients with Confirmed MRSA Nosocomial Pneumonia in Nanjing, China: A Cost Effective Alternative to Vancomycin
|
Tan, S.C.
|
|
2013
|
16 |
7 |
p. A353-
1 p.
|
artikel
|
| 1299 |
Linguistic Translation and Cultural Adaptation of Functional Assessment of Chronic Illness Therapy-Tuberculosis Instrument into Arabic Language
|
Dujaili, J.A.
|
|
2013
|
16 |
7 |
p. A602-
1 p.
|
artikel
|
| 1300 |
Literature Review and Assessment to Populate a Decision-Analytic Model Evaluating a Novel Prognostic in Early Lung Cancer
|
Stenehjem, D.
|
|
2013
|
16 |
7 |
p. A589-A590
nvt p.
|
artikel
|
| 1301 |
Localization of Activities and Equivalence of Movement in Clinical Outcomes Assessments
|
Talbert, M.
|
|
2013
|
16 |
7 |
p. A597-
1 p.
|
artikel
|
| 1302 |
Long Term Analisys of the Hungarian Hospital Bed Capacities
|
Ágoston, I.
|
|
2013
|
16 |
7 |
p. A479-
1 p.
|
artikel
|
| 1303 |
Long-Term Benefits Over More Than 4 Years of Certolizumab Pegol Combination Therapy on Workplace and Household Productivity, and Participation in Social Activities in Rheumatoid Arthritis: Results from the Open-Label Extension Study of Rapid1
|
Kavanaugh, A.
|
|
2013
|
16 |
7 |
p. A570-
1 p.
|
artikel
|
| 1304 |
Long-Term Cost Comparison Between Paricalcitol and Calcitriol for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in Mexico
|
Sanchez-Casillas, J.L.
|
|
2013
|
16 |
7 |
p. A688-
1 p.
|
artikel
|
| 1305 |
Long Term Costs and Outcomes in Psoriatic Arthritis Patients Not Responding to Conventional Therapy Treated with Tumor Necrosis Factor Inhibitors: The Extension of Psoriatic Arthritis Cost Evaluation (PACE) Study
|
Cortesi, P.A.
|
|
2013
|
16 |
7 |
p. A566-
1 p.
|
artikel
|
| 1306 |
Long-Term Costs and Survival Associated with Immunosuppressant Following Liver Transplantation: A Markov Model
|
Bianic, F.
|
|
2013
|
16 |
7 |
p. A633-
1 p.
|
artikel
|
| 1307 |
Long-Term Fiscal Implications of Funding Assisted Reproductive Therapies: A Generational Accounting Model for Spain
|
Villoro, R.
|
|
2013
|
16 |
7 |
p. A339-
1 p.
|
artikel
|
| 1308 |
Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis with Certolizumab Pegol: 48-Week Patient-Reported Outcome Results of the Rapid-PsA Study
|
Gladman, D.
|
|
2013
|
16 |
7 |
p. A569-
1 p.
|
artikel
|
| 1309 |
Long-Term Maintenance of Improvements in Patient-Reported Outcomes with Certolizumab Pegol in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 48-Week Results of the Rapid-axSpA Study
|
Sieper, J
|
|
2013
|
16 |
7 |
p. A569-
1 p.
|
artikel
|
| 1310 |
Long-Term Outcomes of Chronic Hepatitis C in the Population of Newly Diagnosed Russian Patients
|
Ryazhenov, V.V.
|
|
2013
|
16 |
7 |
p. A341-
1 p.
|
artikel
|
| 1311 |
Long-Term Outcomes of Sofosbuvir (SOF) for the Treatment of Chronic Hepatitis C Infected (CHC) Patients
|
Cure, S.
|
|
2013
|
16 |
7 |
p. A357-
1 p.
|
artikel
|
| 1312 |
Long-Term Prolonged-Release Fampridine Treatment and Health-Related Quality of Life Outcomes: Interim Results of the Enable Study
|
Nagels, G.
|
|
2013
|
16 |
7 |
p. A627-
1 p.
|
artikel
|
| 1313 |
Long-Term Survival After Intensive Care Unit Discharge in Thailand: A Retrospective Study
|
Luangasanatip, N.
|
|
2013
|
16 |
7 |
p. A471-
1 p.
|
artikel
|
| 1314 |
¿Los Formularios Nacionales (Cuadros Básicos) Provocan Oligopolios E Incentivan a Tener Precios Altos?
|
Lechuga, D.
|
|
2013
|
16 |
7 |
p. A674-
1 p.
|
artikel
|
| 1315 |
Loss of Productivity in Polish Patients with Rheumatoid Arthritis
|
Szafraniec-Burylo, S.I.
|
|
2013
|
16 |
7 |
p. A566-
1 p.
|
artikel
|
| 1316 |
Lost in Translation: Translatability of Psychiatric Terms – The Example of the Mini–International Neuropsychiatric Interview (M.I.N.I.)
|
Boudrot, A.
|
|
2013
|
16 |
7 |
p. A599-
1 p.
|
artikel
|
| 1317 |
Lower Short-Term Health Care Cost with the Accu-Chek Aviva Expert System in Multiple Daily Insulin Injection (MDI) Treated Diabetes Patients - Learnings from the Automated Bolus Advisor Control and Usability Study (ABACUS)
|
Fortwaengler, K.
|
|
2013
|
16 |
7 |
p. A437-
1 p.
|
artikel
|
| 1318 |
Lymphedema – the Long Way to Diagnosis and Therapy
|
Blome, C.
|
|
2013
|
16 |
7 |
p. A511-
1 p.
|
artikel
|
| 1319 |
Managed Entry Agreements and Orphan Drugs: A European Comparative Study (2006-2012)
|
Morel, T.
|
|
2013
|
16 |
7 |
p. A391-
1 p.
|
artikel
|
| 1320 |
Management Costs of the First Five Years After Diagnosis in Breast Cancer by Stage in France
|
Atsou, K.
|
|
2013
|
16 |
7 |
p. A403-
1 p.
|
artikel
|
| 1321 |
Management of Obese Women During Pregnancy Across Europe According to Clinical Practice Guidelines
|
Callejo, D.
|
|
2013
|
16 |
7 |
p. A339-
1 p.
|
artikel
|
| 1322 |
Mapping and Analysing Pharmaceutical Policy Settings Worldwide
|
Maniadakis, N.
|
|
2013
|
16 |
7 |
p. A487-
1 p.
|
artikel
|
| 1323 |
Mapping from PDQ-39 and PDQ-8 Onto EQ-5D Utility Index in Patients with Parkinson’s Disease: Extended Analysis
|
Kalabina, S.
|
|
2013
|
16 |
7 |
p. A600-
1 p.
|
artikel
|
| 1324 |
Mapping the CCQ onto EQ-5D Scores (Im)Possible?
|
Boland, M.R.S.
|
|
2013
|
16 |
7 |
p. A329-A330
nvt p.
|
artikel
|
| 1325 |
Mapping the Oxford Hip Score (OHS) to EQ-5D: A Test of Model Performance
|
Sungher, D.K.
|
|
2013
|
16 |
7 |
p. A606-
1 p.
|
artikel
|
| 1326 |
Market Access of Cancer Drugs in European Countries: A Matter of Setting Priorities for Resource Allocation
|
Pauwels, K.
|
|
2013
|
16 |
7 |
p. A427-
1 p.
|
artikel
|
| 1327 |
Market Access of Implantable Medical Devices: Evidentiary Requirements Across Global Markets
|
Chawla, A.S.
|
|
2013
|
16 |
7 |
p. A328-
1 p.
|
artikel
|
| 1328 |
Market Access Risk Scoring: A Unified Framework for Cross Country Comparison of Diverse Market Access Systems and Processes
|
Mehta, P.
|
|
2013
|
16 |
7 |
p. A470-
1 p.
|
artikel
|
| 1329 |
Markov Models in Non Metastatic Prostate Cancer – Availability of Input Factors and Structurural Uncertainty
|
Jacobsen, J.
|
|
2013
|
16 |
7 |
p. A592-
1 p.
|
artikel
|
| 1330 |
Mathematical Models of Hepatitis B Vaccination and Screening Programmes in the United Kingdom: A Systematic Review
|
Keeping, S.T.
|
|
2013
|
16 |
7 |
p. A355-
1 p.
|
artikel
|
| 1331 |
Measurement of Societal Medical Care Preferences with the Same Cost Per Qaly: A Discrete Choice Study
|
Shiroiwa, T.
|
|
2013
|
16 |
7 |
p. A336-A337
nvt p.
|
artikel
|
| 1332 |
Measurements of Adherence to Oral Therapies Among Brazilian Patients: A Systematic Review
|
Takemoto, M.L.S.
|
|
2013
|
16 |
7 |
p. A710-A711
nvt p.
|
artikel
|
| 1333 |
Measuring Health-Related Quality of Life by Experiences: The Experience Sampling Method
|
Maes, I.H.
|
|
2013
|
16 |
7 |
p. A534-
1 p.
|
artikel
|
| 1334 |
Measuring Patient-relevant Treatment Benefit in Dermatology – Development and Validation of the Short Questionnaire “Patient Benefit Index 2.0”
|
Blome, C.
|
|
2013
|
16 |
7 |
p. A330-
1 p.
|
artikel
|
| 1335 |
Measuring Pros That Matter to Bariatric and Body Contouring Surgery: The Body-Q
|
Pusic, A.
|
|
2013
|
16 |
7 |
p. A386-
1 p.
|
artikel
|
| 1336 |
Measuring the Cost of Lost Productivity Due to Premature Cancer-related Mortality: A European Overview
|
Hanly, P.
|
|
2013
|
16 |
7 |
p. A324-
1 p.
|
artikel
|
| 1337 |
Measuring Treatment Effects on Rare Events Using Meta-Analysis: An Assessment of Existing Methods
|
Jamotte, A.
|
|
2013
|
16 |
7 |
p. A611-
1 p.
|
artikel
|
| 1338 |
Mechanism of Coordinated Access to Orphan Drugs
|
DeRidder, H.
|
|
2013
|
16 |
7 |
p. A490-
1 p.
|
artikel
|
| 1339 |
Medical and Pharmacy Claims-Based Algorithms for Identifying Relapses in Patients with Multiple Sclerosis
|
Capkun-Niggli, G.
|
|
2013
|
16 |
7 |
p. A582-
1 p.
|
artikel
|
| 1340 |
Medical Cards During Recession: How Many, for Whom and How Much?
|
Kenneally, M.
|
|
2013
|
16 |
7 |
p. A465-
1 p.
|
artikel
|
| 1341 |
Medical Costs of Patients with Rheumatoid Arthritis and Association with Global Disease Activity in Turkey
|
Hamuryudan, V.
|
|
2013
|
16 |
7 |
p. A560-
1 p.
|
artikel
|
| 1342 |
Medication Adherence and Adverse Health Outcomes in Community Dwelling Older Patients
|
Cahir, C.
|
|
2013
|
16 |
7 |
p. A335-
1 p.
|
artikel
|
| 1343 |
Medication Errors-Incidence, Causes and Possible Prevention Strategies in Indian Health Care Setting
|
Patel, H.
|
|
2013
|
16 |
7 |
p. A478-
1 p.
|
artikel
|
| 1344 |
Medication Treatment and Health Care Utilization for Attention-Deficit/Hyperactivity Disorder (ADHD) in Germany
|
Schlander, M.
|
|
2013
|
16 |
7 |
p. A340-
1 p.
|
artikel
|
| 1345 |
Medication Use Patterns and Adherence After Initiating Antipsychotics Treatment for Patients with Schizophrenia in Tianjin, China
|
Yao, X.
|
|
2013
|
16 |
7 |
p. A554-
1 p.
|
artikel
|
| 1346 |
Medición De La Calidad De Vida Por Medio Del “Dermatology Life Quality Index” En Pacientes Con Psoriasis: Una Revisión Sistemática
|
Ordoñez Molina, J.E.
|
|
2013
|
16 |
7 |
p. A701-
1 p.
|
artikel
|
| 1347 |
Medico-Economic Evaluation in France: Methodology and Impact on the Pricing and Reimbursement System
|
Furet, J.
|
|
2013
|
16 |
7 |
p. A456-
1 p.
|
artikel
|
| 1348 |
Meta-analysis of BCG Vaccine Efficacy for Infants in Ireland
|
Schmitz, S.
|
|
2013
|
16 |
7 |
p. A331-
1 p.
|
artikel
|
| 1349 |
Meta-Analysis of Efficacy of Etanercept for Treatment of Psoriatic Arthritis
|
Aggarwal, S.
|
|
2013
|
16 |
7 |
p. A555-
1 p.
|
artikel
|
| 1350 |
Meta-Analysis of Efficacy of Romiplostim for Treatment of Immune Idiopathic Thrombocytopenia
|
Aggarwal, S.
|
|
2013
|
16 |
7 |
p. A378-
1 p.
|
artikel
|
| 1351 |
Meta-Analysis of Quality of Life in Coronary Heart Disease
|
Stevanovic, J.
|
|
2013
|
16 |
7 |
p. A600-
1 p.
|
artikel
|
| 1352 |
Meta-Analysis of Safety of Dabigatran and Warfarin for Treatment of Atrial Fibrillation
|
Aggarwal, S.
|
|
2013
|
16 |
7 |
p. A515-
1 p.
|
artikel
|
| 1353 |
Methodological Approaches for Modeling Cardiovascular Events in Cost-Effectiveness Analyses Based on Outcome Trials
|
Kansal, A.R.
|
|
2013
|
16 |
7 |
p. A588-
1 p.
|
artikel
|
| 1354 |
Methodological Challenges in Comparing Topical Therapies in Dermatology in the Absence of Head to Head Studies
|
Greiner, R.A.
|
|
2013
|
16 |
7 |
p. A608-
1 p.
|
artikel
|
| 1355 |
Methodological Challenges in Multi-Criteria Decision Analysis (MCDA) for Health Policy Decision-Making: A Systematic Review
|
Wahlster, P.
|
|
2013
|
16 |
7 |
p. A454-
1 p.
|
artikel
|
| 1356 |
Methodological Challenges of Cost-Of-Illness Studies on Dementia: An International Systematic Review
|
Schaller, S.U.
|
|
2013
|
16 |
7 |
p. A545-
1 p.
|
artikel
|
| 1357 |
Methodology and Development of ‘Polish Dictionary of Quality of Life Terms’
|
Golicki, D.
|
|
2013
|
16 |
7 |
p. A606-
1 p.
|
artikel
|
| 1358 |
Methodology for Establishing Internal and External Validity When Propensity Score Matching Is Used
|
Eisenberg, D.
|
|
2013
|
16 |
7 |
p. A611-
1 p.
|
artikel
|
| 1359 |
Methodology of an Observational Study to Evaluate the Care Map of Women with Postmenopausal Osteoporosis (PMO) in Switzerland
|
Lippuner, K.
|
|
2013
|
16 |
7 |
p. A574-
1 p.
|
artikel
|
| 1360 |
Microsimulation or Cohort Modelling? A Case Study in Chronic Obstructive Pulmonary Disease (COPD)
|
Lin, F.
|
|
2013
|
16 |
7 |
p. A586-
1 p.
|
artikel
|
| 1361 |
Minimal Important Difference (MID) of Response to the Hepatitis-C Virus Patient Reported Outcomes (HCV-PRO) Instrument in a Trial of Pegylated Interferon/Ribavirin (pegIFN/RBV) and Direct-Acting-Antivirals (DAA)
|
Baran, R.W.
|
|
2013
|
16 |
7 |
p. A362-A363
nvt p.
|
artikel
|
| 1362 |
Mixed Treatment Comparison of Adverse Events for BG-12, Glatiramer, and Teriflunomide for the Treatment of Relapsing Forms of Multiple Sclerosis
|
Zagmutt, F.J.
|
|
2013
|
16 |
7 |
p. A720-
1 p.
|
artikel
|
| 1363 |
Mobile Phone Use in Patient Reported Outcomes – A Literature Search
|
O’Gorman, H.
|
|
2013
|
16 |
7 |
p. A596-
1 p.
|
artikel
|
| 1364 |
Mode Equivalence of Interactive Voice Response (IVR) and Paper Versions of the Brief Pain Inventory (BPI) “Worst Pain” Item in Metastatic Castrate Resistant Prostate Cancer (mCRPC) Evaluated Conceptually Using Qualitative Methods
|
Bennett, A.
|
|
2013
|
16 |
7 |
p. A601-
1 p.
|
artikel
|
| 1365 |
Model-Based Economic Evaluations in Alzheimer’s Disease : A Review of Modeling Methods
|
Marty, R.
|
|
2013
|
16 |
7 |
p. A587-
1 p.
|
artikel
|
| 1366 |
Modeling a Switch from Trivalent to Quadrivalent Influenza Vaccine in Canada and the United Kingdom
|
Thommes, E.W.
|
|
2013
|
16 |
7 |
p. A586-
1 p.
|
artikel
|
| 1367 |
Modeling Medication Adherence in Comparative Effectiveness Research
|
Slejko, J.F.
|
|
2013
|
16 |
7 |
p. A591-
1 p.
|
artikel
|
| 1368 |
Modeling the Cardiovascular Effects of Switching Patients from Rosuvastatin to Atorvastatin
|
Folse, H.
|
|
2013
|
16 |
7 |
p. A513-
1 p.
|
artikel
|
| 1369 |
Modeling the Impact of Disease Modifying Treatment on Time to Disability Health States in Multiple Sclerosis: An Evaluation of Oral Therapies Through Indirect Comparisons of 6-Month Confirmed Disability Progression
|
Bergvall, N.
|
|
2013
|
16 |
7 |
p. A619-
1 p.
|
artikel
|
| 1370 |
Modelización Económica Del Genotipado Del Citocromo P450 Con El Test Brainchip En El Tratamiento De La Depresión Mayor
|
Crespo, C.
|
|
2013
|
16 |
7 |
p. A695-
1 p.
|
artikel
|
| 1371 |
Modelling Staff Resource Use in Ambulatory HIV Care
|
Brennan, A.
|
|
2013
|
16 |
7 |
p. A364-
1 p.
|
artikel
|
| 1372 |
Modelling the Adenoma and Serrated Pathway to Colorectal Cancer (ASCCA)
|
Greuter, M.J.
|
|
2013
|
16 |
7 |
p. A586-
1 p.
|
artikel
|
| 1373 |
Modelling the Cost-Effectiveness of First-Line Biologics for Rheumatoid Arthritis in England and Wales
|
Righetti, C.
|
|
2013
|
16 |
7 |
p. A578-A579
nvt p.
|
artikel
|
| 1374 |
Modelling the Cost-Effectiveness of First Line Biologics for Rheumatoid Arthritis in Ireland
|
Righetti, C.
|
|
2013
|
16 |
7 |
p. A579-
1 p.
|
artikel
|
| 1375 |
Modelling the Health Technology Assessment (HTA) Process for Innovative Drug Technologies (IDTS) in the Turkish Health Care System
|
Kececioglu, S.
|
|
2013
|
16 |
7 |
p. A476-
1 p.
|
artikel
|
| 1376 |
Modelling the Natural History of Schizophrenia: Comparison of Naïve Versus Advanced Statistical Methods
|
Millier, A.
|
|
2013
|
16 |
7 |
p. A593-
1 p.
|
artikel
|
| 1377 |
Modelling the Predictive Value of Pain Intensity on Costs and Resources Utilization in Patients with Peripheral Neuropathic Pain
|
Pérez, C.
|
|
2013
|
16 |
7 |
p. A382-
1 p.
|
artikel
|
| 1378 |
Modelling the Relationship Between the WOMAC Osteoarthritis Index and EQ-5D
|
Wailoo, A.J.
|
|
2013
|
16 |
7 |
p. A606-
1 p.
|
artikel
|
| 1379 |
Modelling Uncertain Future Events in Cost-Effectiveness Analysis
|
Mahon, R.
|
|
2013
|
16 |
7 |
p. A592-
1 p.
|
artikel
|
| 1380 |
Modelo Predictivo Para La Identificación Temprana De Población En Riesgo De Cronificar En Una Administradora De Riesgos Laborales En Colombia
|
Romero, M.
|
|
2013
|
16 |
7 |
p. A676-
1 p.
|
artikel
|
| 1381 |
Models of Drug Safety Monitoring in England, Poland, Italy, Germany, Denmark and United States
|
Hermanowski, T.R.
|
|
2013
|
16 |
7 |
p. A463-
1 p.
|
artikel
|
| 1382 |
Monitoring Health Processes in the Real World: An Italian Population Database Experience
|
De Rosa, M.
|
|
2013
|
16 |
7 |
p. A677-
1 p.
|
artikel
|
| 1383 |
Mood Stabilizers and Atypical Antipsychotics in Maintenance Therapy for Bipolar Disorder: A Cost-Effectiveness Analysis
|
Zimmermann, I.R.
|
|
2013
|
16 |
7 |
p. A548-
1 p.
|
artikel
|
| 1384 |
Mortality and Medical Costs Associated with Liver-Related Diseases Among Patients with Hepatitis C Virus(HCV) Infection in Taiwan
|
Tang, C.H.
|
|
2013
|
16 |
7 |
p. A495-
1 p.
|
artikel
|
| 1385 |
Mortality and Survival in Inoperable or Residual/Recurrent Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Systematic Literature Review
|
Byrnes, M.J.
|
|
2013
|
16 |
7 |
p. A378-
1 p.
|
artikel
|
| 1386 |
Mothers’ Own Milk for the Feeding of Preterm Infants: A Systematic Literature Review
|
Garcia-Stewart, S.
|
|
2013
|
16 |
7 |
p. A330-
1 p.
|
artikel
|
| 1387 |
Multi-Criteria Benefit-Risk Assessment of Biological Agents in the Treatment of Moderate to Severe Psoriais: A Stochastical Approach
|
Riveros, B.S.
|
|
2013
|
16 |
7 |
p. A727-
1 p.
|
artikel
|
| 1388 |
Multi-Dimensional Capture of Patient-Relevant Endpoints in Regulatory Trials and Health Technology Assessments in Oncology Two Years After Introduction of the German Amnog Health Care Reform
|
Dintsios, C.M.
|
|
2013
|
16 |
7 |
p. A575-
1 p.
|
artikel
|
| 1389 |
Multinational Consistency of a Discrete Choice Model in Quantifying Health States for the Extended 5-Level EQ-5D
|
Krabbe, P.F.M.
|
|
2013
|
16 |
7 |
p. A326-
1 p.
|
artikel
|
| 1390 |
Multiple Imputation Techniques for Survey Data with Multiple Rating Scales
|
Plumpton, C.O.
|
|
2013
|
16 |
7 |
p. A611-
1 p.
|
artikel
|
| 1391 |
Multi-state Statistical Modelling to Quantify an Individual-based Micro Simulation Model for Radiotherapy Treatment in Lung Cancer Patients
|
Bongers, M.L.
|
|
2013
|
16 |
7 |
p. A325-
1 p.
|
artikel
|
| 1392 |
Multivariate Network Meta-Analysis of Progression Free Survival and Overall Survival
|
Jansen, J.P.
|
|
2013
|
16 |
7 |
p. A617-
1 p.
|
artikel
|
| 1393 |
Ánalise De Significância Do Banco De Dados De Hospitais Particulares Brasileiro
|
Ferreira, C.N.
|
|
2013
|
16 |
7 |
p. A700-
1 p.
|
artikel
|
| 1394 |
Natalizumab for 2nd Line Treatment in Relapsing-Remitting Multiple Sclerosis Patients: 5-Year Budget Impact Analysis (BIA) from the Brazilian Public Payer Perspective
|
Nishikawa, A.M.
|
|
2013
|
16 |
7 |
p. A720-
1 p.
|
artikel
|
| 1395 |
Natalizumab for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients: 5-Year Budget Impact Analysis (BIA) from the Brazilian Public Payer Perspective
|
Nishikawa, A.M.
|
|
2013
|
16 |
7 |
p. A621-
1 p.
|
artikel
|
| 1396 |
Natalizumab Treatment Is Associated with Reduced Neurology Outpatient Appointments, Unplanned Hospital Admissions and Length of Stay
|
Beadman, A
|
|
2013
|
16 |
7 |
p. A629-
1 p.
|
artikel
|
| 1397 |
National Spending with Screening, Diagnosis and Treatment of Cervical Cancer: Estimates Based on Health Information Systems, Brazil, 2006
|
Novaes, H.M.D.
|
|
2013
|
16 |
7 |
p. A669-
1 p.
|
artikel
|
| 1398 |
Naturalistic Disease Management Study of Patients with Alcohol Dependence in the Primary Care Setting in the United Kingdom (STREAM)
|
Coste, F.
|
|
2013
|
16 |
7 |
p. A551-
1 p.
|
artikel
|
| 1399 |
Needs Assessment of Patients Treated in Community Psychosocial Centers in São Paulo, Brazil
|
Nascimento, A.
|
|
2013
|
16 |
7 |
p. A695-
1 p.
|
artikel
|
| 1400 |
Network Meta-Analysis of Approved Biologic Interventions for the Induction of Response in Ulcerative Colitis
|
Chen, M.
|
|
2013
|
16 |
7 |
p. A493-
1 p.
|
artikel
|
| 1401 |
Network Meta-Analysis of Approved Biologic Interventions for the Maintenance of Response in Ulcerative Colitis
|
Chen, M.
|
|
2013
|
16 |
7 |
p. A493-
1 p.
|
artikel
|
| 1402 |
Network Meta-Analysis of Multiple Outcomes: A Simulation Study and Application
|
Achana, F.
|
|
2013
|
16 |
7 |
p. A609-
1 p.
|
artikel
|
| 1403 |
Network Meta-Analysis with Fractional Polynomials for Repeated Trough FEV1 Measures in COPD: Aclidinium Bromide 400 μG Bid Versus Tiotropium 18 μG QD
|
Karabis, A.
|
|
2013
|
16 |
7 |
p. A591-
1 p.
|
artikel
|
| 1404 |
New Estimates of the Direct Medical Cost of Attention-Deficit/Hyperactivity Disorder (ADHD) in Germany
|
Schlander, M.
|
|
2013
|
16 |
7 |
p. A546-
1 p.
|
artikel
|
| 1405 |
Nice STA Decisions: An Analysis of How Advice Differs Between Preliminary and Final Guidance
|
Murray, G.
|
|
2013
|
16 |
7 |
p. A482-
1 p.
|
artikel
|
| 1406 |
Non-Homogeneous Cost-Effectiveness Modeling of a New CHG-Dressing for Preventing Catheter-Related Bloodstream Infections for Patients in Intensive Care Units
|
Maunoury, F.
|
|
2013
|
16 |
7 |
p. A356-
1 p.
|
artikel
|
| 1407 |
Novel Market Access Models for Cancer Drugs
|
Aggarwal, S.
|
|
2013
|
16 |
7 |
p. A428-
1 p.
|
artikel
|
| 1408 |
Novel Oral Anticoagulants Versus Warfarin – A Business Case Analysis
|
You, J.
|
|
2013
|
16 |
7 |
p. A528-
1 p.
|
artikel
|
| 1409 |
Novel Pricing Strategies to Support Sustainable Access to Medicine in Latin America
|
Shankar, R.
|
|
2013
|
16 |
7 |
p. A681-
1 p.
|
artikel
|
| 1410 |
Novel Use of Multivariate Joint Modelling to Identify Patient Level Factors Associated with Treatment Failure – Example of Botox Treatment for Patients with Overactive Bladder
|
Owen, R.K.
|
|
2013
|
16 |
7 |
p. A612-
1 p.
|
artikel
|
| 1411 |
Number of Submissions Needed to Reach a Positive Reimbursement Decision from SMC, CADTH, and PBAC
|
Jaksa, A.
|
|
2013
|
16 |
7 |
p. A483-A484
nvt p.
|
artikel
|
| 1412 |
Nurses’ Preferences for Bone Metastases Treatments in the United States
|
Mohamed, A.F.
|
|
2013
|
16 |
7 |
p. A430-
1 p.
|
artikel
|
| 1413 |
Nutrieconomic Exploratory Assessment of a Daily Consumption of Plant Sterols-Enriched Dairy Products on Statin’s Initiation Delay: A Consumer Perspective Approach
|
Bruckert, E.
|
|
2013
|
16 |
7 |
p. A589-
1 p.
|
artikel
|
| 1414 |
Obesity Trends 2006-2012 in the United States: Results from the National Health and Wellness Survey
|
Pomerantz, D.
|
|
2013
|
16 |
7 |
p. A387-
1 p.
|
artikel
|
| 1415 |
Obtaining Optimal Personalized Surveillance Strategies for Patients with Screen-Detected Colorectal Adenomas Using Discrete Event Simulation
|
Comas, M.
|
|
2013
|
16 |
7 |
p. A489-
1 p.
|
artikel
|
| 1416 |
Off-Label Trastuzumab Usage in Breast Cancer Patient in Turkey
|
Kockaya, G.
|
|
2013
|
16 |
7 |
p. A396-A397
nvt p.
|
artikel
|
| 1417 |
One Line Does Not Make a Picture: Real-World Cost-Effectiveness of Multiple Myeloma Treatments Using a Full Disease Model
|
Blommestein, H.
|
|
2013
|
16 |
7 |
p. A408-
1 p.
|
artikel
|
| 1418 |
Oral Hypoglycaemic Medicine (OHM) Initiation in Newly Treated Type 2 Diabetes Mellitus (T2DM) in Ireland: An Analysis of Treatment Intensification and Switching Patterns
|
Grimes, R.
|
|
2013
|
16 |
7 |
p. A450-
1 p.
|
artikel
|
| 1419 |
Organizational and Economic Issues Related to the Introduction of Boceprevir in the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Italy
|
La Torre, G.
|
|
2013
|
16 |
7 |
p. A494-A495
nvt p.
|
artikel
|
| 1420 |
Orphan Drug Access: Risk/Reward Analysis of Local Clinical Development in Chile
|
Ismail, A.
|
|
2013
|
16 |
7 |
p. A727-A728
nvt p.
|
artikel
|
| 1421 |
Orphan Drug Legislations: Heyday or Had Their Day?
|
Palmer, M.
|
|
2013
|
16 |
7 |
p. A491-
1 p.
|
artikel
|
| 1422 |
Orphan Drugs in the German Early Benefit Assessment– Real World Versus G-Ba Bureaucracy
|
Lebioda, A.
|
|
2013
|
16 |
7 |
p. A485-
1 p.
|
artikel
|
| 1423 |
Osteotomia De Acortamiento Radial En La Enfermedad De Kienbock (Seguimiento De 5 Años)
|
Vazquez Alonso, F.
|
|
2013
|
16 |
7 |
p. A725-
1 p.
|
artikel
|
| 1424 |
O Uso De Temozolomida No Tratamento De Astrocitoma De Baixo Grau – Câncer No Cérebro
|
Gomes, R.M.
|
|
2013
|
16 |
7 |
p. A682-A683
nvt p.
|
artikel
|
| 1425 |
Outpatient Medical Costs, Indirect Costs, and Family Burden of Osteoporosis Fracture in China
|
Yang, Y.
|
|
2013
|
16 |
7 |
p. A561-
1 p.
|
artikel
|
| 1426 |
Overcoming the HTA Hurdle in Germany: Key Considerations for a Manufacturer’s Pricing and Market Access Strategy
|
Ratcliffe, M.
|
|
2013
|
16 |
7 |
p. A456-
1 p.
|
artikel
|
| 1427 |
Overview of Coverage with Evidence Development in Sweden
|
Schroeder, M.
|
|
2013
|
16 |
7 |
p. A329-
1 p.
|
artikel
|
| 1428 |
Overview of Health Economic Models in Type 2 Diabetes Mellitus (T2DM); A Systematic Literature Review
|
Charokopou, M.
|
|
2013
|
16 |
7 |
p. A591-
1 p.
|
artikel
|
| 1429 |
Overview on Cost-Effectiveness Results of Decision-Analytic Studies for the Treatment of Multiple Myeloma
|
Rochau, U.
|
|
2013
|
16 |
7 |
p. A410-A411
nvt p.
|
artikel
|
| 1430 |
Paediatric Gastroenteritis: Disease Burden, Cost and Loss of Productivity of Malaysian and Vietnamese Parents
|
Azmi, S.
|
|
2013
|
16 |
7 |
p. A501-
1 p.
|
artikel
|
| 1431 |
Paediatric Tuberculosis - Costs to the Irish Health Care Payer
|
Usher, C.
|
|
2013
|
16 |
7 |
p. A370-
1 p.
|
artikel
|
| 1432 |
Paper-Based and Electronic Assessment of Health-Related Quality of Life Specific to HIV Disease: A Reliability Study with the PROQOL-HIV Questionnaire
|
Lalanne, C.
|
|
2013
|
16 |
7 |
p. A362-
1 p.
|
artikel
|
| 1433 |
Parameter Importance Assessment in a Health Economic Evaluation Model for Heart Failure
|
Cagdas, B.uyukkaramikli N
|
|
2013
|
16 |
7 |
p. A610-
1 p.
|
artikel
|
| 1434 |
Parameter Uncertainty in Value Based Multi Criteria Decision Analysis: A Systematic Review of Methods
|
Groothuis-Oudshoorn, C.G.M.
|
|
2013
|
16 |
7 |
p. A475-
1 p.
|
artikel
|
| 1435 |
Parecer Técnico-Científico: Eficácia E Segurança Do Uso Do Rituximabe No Tratamento De Leucemia Linfocítica Crônica
|
Souza, K.M.
|
|
2013
|
16 |
7 |
p. A683-
1 p.
|
artikel
|
| 1436 |
Parental Preferences for Rotavirus Vaccination and Potential Vaccination Coveragein Young Children: A Discrete Choice Experiment
|
Veldwijk, J.
|
|
2013
|
16 |
7 |
p. A362-
1 p.
|
artikel
|
| 1437 |
Parent Ratings of Ability to Consent for Clinical Trials in Fragile X Syndrome
|
Bailey, D.
|
|
2013
|
16 |
7 |
p. A603-A604
nvt p.
|
artikel
|
| 1438 |
Pathological Gambling: A Growing Addiction
|
Dannon, P.
|
|
2013
|
16 |
7 |
p. A682-
1 p.
|
artikel
|
| 1439 |
Patient-Centered Outcomes in Upper Limb Spasticity: Results from a Large International Cohort Study (ULIS-2)
|
Balcaitiene, J.
|
|
2013
|
16 |
7 |
p. A626-
1 p.
|
artikel
|
| 1440 |
Patient Eligibility and Use of Biologics in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis in the United States
|
Narayanan, S.
|
|
2013
|
16 |
7 |
p. A572-
1 p.
|
artikel
|
| 1441 |
Patient Functioning in Generalized Anxiety Disorder Subjects with Partial Response to Prior SSRI Treatment: The Effect of Adjunctive Therapy with Pregabalin in Daily Medical Practice
|
Carrasco, J.L.
|
|
2013
|
16 |
7 |
p. A551-
1 p.
|
artikel
|
| 1442 |
Patient-Level Costs of Cardiovascular Events and Procedures: How Robust Is the Evidence?
|
Nicholson, G.
|
|
2013
|
16 |
7 |
p. A522-
1 p.
|
artikel
|
| 1443 |
Patient-Level Markov Model to Assess Economic Impact of New Antipsychotics Introduction in Schizophrenia
|
Millier, A.
|
|
2013
|
16 |
7 |
p. A548-
1 p.
|
artikel
|
| 1444 |
Patient Networks as a Data Source for Patient Reported Outcomes Research. Carenity Experience
|
Castejón, N.
|
|
2013
|
16 |
7 |
p. A608-
1 p.
|
artikel
|
| 1445 |
Patient Preference for Oral Versus Injectable and Intravenous Methods of Treatment for Rheumatoid Arthritis
|
Barclay, N.
|
|
2013
|
16 |
7 |
p. A568-
1 p.
|
artikel
|
| 1446 |
Patient Preferences and Priorities for Anti-Epileptic Drug Treatment
|
Fargher, E.A.
|
|
2013
|
16 |
7 |
p. A626-
1 p.
|
artikel
|
| 1447 |
Patient Preferences in the Choice of Disease Modifying Drugs for Multiple Sclerosis
|
Bergmann, A.
|
|
2013
|
16 |
7 |
p. A595-A596
nvt p.
|
artikel
|
| 1448 |
Patient Preferences on Treatments for Erectil Dysfunction Defined by Means of Different Attribute Groups: The Method of Administration Is the Most Valued Attribute and the Orodispersible Tablet Is the Most Preferred Level
|
Gutiérrez, P.
|
|
2013
|
16 |
7 |
p. A595-
1 p.
|
artikel
|
| 1449 |
Patient Preferences Regarding Monitoring and Treatment for the Management of Neovascular Age-Related Macular Degeneration
|
Ferreira, A.
|
|
2013
|
16 |
7 |
p. A508-
1 p.
|
artikel
|
| 1450 |
Patient-Reported Cognitive Dysfunction Negatively Impacts Functioning in Patients with Major Depressive Disorder – Preliminary Findings from the Perform Study
|
Saragoussi, D.
|
|
2013
|
16 |
7 |
p. A543-A544
nvt p.
|
artikel
|
| 1451 |
Patient-Reported Outcome Measures for Systemic Lupus Erythematosus Clinical Trials: A Content Validity and Psychometric Performance Review
|
Humphrey, L.
|
|
2013
|
16 |
7 |
p. A600-A601
nvt p.
|
artikel
|
| 1452 |
Patient-Reported Outcome (PRO) Claims in Products Approved for Chronic Obstructive Pulmonary Diseases (COPD) in Europe and the United States
|
Caron, M.
|
|
2013
|
16 |
7 |
p. A374-A375
nvt p.
|
artikel
|
| 1453 |
Patient-Reported Outcomes: Are They Worth It? An Examination in Pro Value Through Case Studies
|
DeMuro, C.
|
|
2013
|
16 |
7 |
p. A711-
1 p.
|
artikel
|
| 1454 |
Patient Reported Outcomes Asssesment of Thai Chronic Stable Angina Pectoris(CSAP)
|
Rojkajornnaphalai, S.
|
|
2013
|
16 |
7 |
p. A513-
1 p.
|
artikel
|
| 1455 |
Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer
|
Aggarwal, S.
|
|
2013
|
16 |
7 |
p. A421-
1 p.
|
artikel
|
| 1456 |
Patient Reported Outcomes with Multiple Sclerosis in Slovakia
|
Tomekova, K.
|
|
2013
|
16 |
7 |
p. A598-
1 p.
|
artikel
|
| 1457 |
Patients’ and Caregivers’ Preferences for Bone Metastases (BM) Treatments in the United States
|
Qian, Y.
|
|
2013
|
16 |
7 |
p. A420-
1 p.
|
artikel
|
| 1458 |
Patients as a Source for Cost of Rheumatoid Arthritis Study
|
Marinov, L.
|
|
2013
|
16 |
7 |
p. A560-
1 p.
|
artikel
|
| 1459 |
Patient Satisfaction with HIV Therapies: Focus on Adherence to Treatment
|
Murray, M.
|
|
2013
|
16 |
7 |
p. A361-A362
nvt p.
|
artikel
|
| 1460 |
Patients at the Center of Regulatory Decisions: Using Stated-Preference Data to Help Regulators Answer Difficult Questions
|
González, J.M.
|
|
2013
|
16 |
7 |
p. A387-
1 p.
|
artikel
|
| 1461 |
Patients’ Characteristics and Patterns of Use of Depot Antipsychotics in German Patients with Schizophrenia
|
Rouleau, A.
|
|
2013
|
16 |
7 |
p. A552-
1 p.
|
artikel
|
| 1462 |
Patients’ Characteristics and Patterns of Use of Depot Antipsychotics in Swedish Patients with Schizophrenia
|
Depont, F.
|
|
2013
|
16 |
7 |
p. A552-A553
nvt p.
|
artikel
|
| 1463 |
Patients Preferences for Long-Term Treatment After Acute Coronary Syndrome: A Discrete-Choice Experiment and Analytic Hierarchy Process
|
Mühlbacher, A.C.
|
|
2013
|
16 |
7 |
p. A534-
1 p.
|
artikel
|
| 1464 |
Patients Preferences Regarding the Treatment of Type II Diabetes Mellitus: Comparison of Best-Worst Scaling and Analytic Hierarchy Process
|
Mühlbacher, A.C.
|
|
2013
|
16 |
7 |
p. A446-
1 p.
|
artikel
|
| 1465 |
Patient Survey Data Results: Preferences for Reminders in Pro Studies
|
Ross, E.
|
|
2013
|
16 |
7 |
p. A338-
1 p.
|
artikel
|
| 1466 |
Patient Survey: Investigation on What Impacts Patient Satisfaction, Drop-Out and Compliance in Patient Diaries
|
Ross, J.
|
|
2013
|
16 |
7 |
p. A601-
1 p.
|
artikel
|
| 1467 |
Patients with Chronic Hepatitis C Virus Treated with Simeprevir Added to Peginterferon and Ribavirin Experienced Less Time with Fatigue, Depressive Symptoms, and Functional Limitations: Results from Patients in the Quest-1, Quest-2, and Promise Studies
|
Scott, J.
|
|
2013
|
16 |
7 |
p. A362-
1 p.
|
artikel
|
| 1468 |
Patients with Hypertension in Primary Care in Spain: Management, Self-Perception and Satisfaction
|
Sánchez-Piedra, C.
|
|
2013
|
16 |
7 |
p. A534-
1 p.
|
artikel
|
| 1469 |
Patterns in Asthma Medicationtreatment in the United States
|
Li, Y.
|
|
2013
|
16 |
7 |
p. A376-A377
nvt p.
|
artikel
|
| 1470 |
Patterns of Disease Remission Among Patients with Rheumatoid Arthritis Receiving Their First Biologic in European Union
|
Narayanan, S.
|
|
2013
|
16 |
7 |
p. A571-A572
nvt p.
|
artikel
|
| 1471 |
Patterns of Generic and Proprietary Prescribing of Statins Over Time in England
|
Leonard, S.A.
|
|
2013
|
16 |
7 |
p. A328-
1 p.
|
artikel
|
| 1472 |
Patterns of Use of Tests to Diagnose and Assess Disease Progression in Multiple Sclerosis (MS): A Multicountry Comparison
|
Narayanan, S.
|
|
2013
|
16 |
7 |
p. A628-
1 p.
|
artikel
|
| 1473 |
Payer and Physicians Evidence and Discount Expectations for Biosimilars in Six Latin American Countries
|
Sandorff, E.
|
|
2013
|
16 |
7 |
p. A667-
1 p.
|
artikel
|
| 1474 |
Payer Assessment and Reimbursement Policy for Rare Diseases: A Review of the Literature
|
Hutchings, A.
|
|
2013
|
16 |
7 |
p. A391-
1 p.
|
artikel
|
| 1475 |
Perception of Country-Specific Health Care Reform and Consideration of Real World Evidence in Routine Practice: Survey of Oncologists in European Union, United States, China and Brazil
|
Narayanan, S.
|
|
2013
|
16 |
7 |
p. A424-
1 p.
|
artikel
|
| 1476 |
Perception of Users of Drug Distribution Program in Brazil
|
Carraro, W.H.
|
|
2013
|
16 |
7 |
p. A680-
1 p.
|
artikel
|
| 1477 |
Perfil De Adesão Aos Planos De Benefício Em Medicamentos
|
Santana, C.F.S.D.
|
|
2013
|
16 |
7 |
p. A672-
1 p.
|
artikel
|
| 1478 |
Peritonitis Fluid Treatment in Russian Federation: Evaluation of Economical Burden in Real Clinical Practice
|
Yagudina, R.
|
|
2013
|
16 |
7 |
p. A494-
1 p.
|
artikel
|
| 1479 |
Permanent Transvenous Lead Extraction: Factors Influencing the Difficulty of the Procedure
|
Bontempi, L.
|
|
2013
|
16 |
7 |
p. A702-A703
nvt p.
|
artikel
|
| 1480 |
Persistence & Compliance to Treatment for Osteoporosis in Postmenopausal Women in Hungary: A Retrospective Cohort Study
|
Lakatos, P.
|
|
2013
|
16 |
7 |
p. A567-A568
nvt p.
|
artikel
|
| 1481 |
Persistence in Patients with Breast Cancer Treated with Tamoxifen or Aromatase Inhibitors- Analysis Based on Oncology Analyzer Database
|
Schmidt, N.
|
|
2013
|
16 |
7 |
p. A418-A419
nvt p.
|
artikel
|
| 1482 |
Persistence Patterns with Oral Hypoglycaemic Medicines (OHM) in Newly Treated Irish Patients with Type 2 Diabetes Mellitus (T2DM)
|
Grimes, R.
|
|
2013
|
16 |
7 |
p. A444-
1 p.
|
artikel
|
| 1483 |
Persistence with Medications: A Discrete Choice Experiment of Preferences Among Hypertensive Patients
|
Fargher, E.A.
|
|
2013
|
16 |
7 |
p. A532-
1 p.
|
artikel
|
| 1484 |
Personalized Health Care in France, Germany and the United Kingdom: Are Health Technology Assessment Agencies Ready?
|
Walzer, S.
|
|
2013
|
16 |
7 |
p. A475-
1 p.
|
artikel
|
| 1485 |
Personalized Treatment in Heart Failure Disease Management Improves Outcomes and Reduces Costs
|
Cao, Q.
|
|
2013
|
16 |
7 |
p. A526-
1 p.
|
artikel
|
| 1486 |
Pertussis in Brazilian Children: Mortality, Length of Stay, and Costs in Hospitalized Patients
|
Fernandes, R.A.
|
|
2013
|
16 |
7 |
p. A348-
1 p.
|
artikel
|
| 1487 |
Pet-Based Radiotherapy Treatment Planning Is Highly Cost-Effective Compared to CT-Based Planning: A Model-Based Evaluation
|
Bongers, M.L.
|
|
2013
|
16 |
7 |
p. A414-
1 p.
|
artikel
|
| 1488 |
Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community
|
Romero, M.
|
|
2013
|
16 |
7 |
p. A691-
1 p.
|
artikel
|
| 1489 |
Pharmaceutical Expenditure, Clinical Outcomes and Expenditures on Other Health Services
|
Siskou, O.
|
|
2013
|
16 |
7 |
p. A466-A467
nvt p.
|
artikel
|
| 1490 |
Pharmaceutical Policies, Regulation and Efficiency
|
Maniadakis, N.
|
|
2013
|
16 |
7 |
p. A329-
1 p.
|
artikel
|
| 1491 |
Pharmaceutical Regulation in Europe and Its Impact on Corporate R&D
|
Mahlich, J.
|
|
2013
|
16 |
7 |
p. A487-
1 p.
|
artikel
|
| 1492 |
Pharmacists’ Satisfaction with Different Pharmaceutical Distribution Models in Five European Countries
|
Dragosits, A.
|
|
2013
|
16 |
7 |
p. A472-
1 p.
|
artikel
|
| 1493 |
Pharmacoeconomic Analysis of Abatacept for Treatment of Adults with Rheumatoid Arthritis in Russia
|
Gerasimova, K.
|
|
2013
|
16 |
7 |
p. A564-
1 p.
|
artikel
|
| 1494 |
Pharmacoeconomic Analysis of Anti-Inhibitor Coagulant Complex (AICC) in the Treatment of Inhibitor Hemophilia
|
Yagudina, R.
|
|
2013
|
16 |
7 |
p. A379-
1 p.
|
artikel
|
| 1495 |
Pharmacoeconomic Analysis of Diferent Anti-Parkinsonian Drugs Used in Monopherapy During Early Stages of Parkinson Disease
|
Belousov, D.Y.
|
|
2013
|
16 |
7 |
p. A623-
1 p.
|
artikel
|
| 1496 |
Pharmacoeconomic Analysis of Different Antiviral Therapies in the Treatment of Russian Patients with Chronic Hepatitis C
|
Ryazhenov, V.V.
|
|
2013
|
16 |
7 |
p. A345-
1 p.
|
artikel
|
| 1497 |
Pharmacoeconomic Analysis of Intravenous Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Multiforme in Russia
|
Krysanov, I.
|
|
2013
|
16 |
7 |
p. A413-
1 p.
|
artikel
|
| 1498 |
Pharmacoeconomic Analysis of Ioversol Versus Iohexol for Diagnostic Procedures
|
Ivakhnenko, O.
|
|
2013
|
16 |
7 |
p. A468-
1 p.
|
artikel
|
| 1499 |
Pharmacoeconomic Analysis of Ivabradine Use in Belarus
|
Kozhanova, I.
|
|
2013
|
16 |
7 |
p. A531-
1 p.
|
artikel
|
| 1500 |
Pharmacoeconomic Analysis of Progestogen Preparations for Threatened Abortion Treatment in Ukraine
|
Tkachova, O.
|
|
2013
|
16 |
7 |
p. A334-
1 p.
|
artikel
|
| 1501 |
Pharmacoeconomic Analysis of Using Aprepitant Plus Standard Antiemetic Therapy for Prevention of Nausea and Vomiting Associated with Highly and Moderately Emetogenic Cancer Chemotherapy in Russia
|
Krysanov, I.
|
|
2013
|
16 |
7 |
p. A413-A414
nvt p.
|
artikel
|
| 1502 |
Pharmacoeconomic Aspects of Actovegin and Solcoseryl in the Treatment of Russian Patients with Acute Cerebrovascular Accidents
|
Ryazhenov, V.V.
|
|
2013
|
16 |
7 |
p. A519-
1 p.
|
artikel
|
| 1503 |
Pharmacoeconomic Aspects of Chronic Pain Management in Russian Cancer Patients
|
Ryazhenov, V.V.
|
|
2013
|
16 |
7 |
p. A401-
1 p.
|
artikel
|
| 1504 |
Pharmacoeconomic Aspects of the First-Line Biologic Therapies in Russian Patients with Rheumatoid Arthritis
|
Ryazhenov, V.V.
|
|
2013
|
16 |
7 |
p. A563-
1 p.
|
artikel
|
| 1505 |
Pharmacoeconomic Assessment of Different Tactics of COPD Treatment in Russia
|
Belevskiy, A.S.
|
|
2013
|
16 |
7 |
p. A370-
1 p.
|
artikel
|
| 1506 |
Pharmacoeconomic Assessment of Ranibizumab in the Treatment of the Diabetic Retinopathy in the Russian Federation
|
Serpik, V.G.
|
|
2013
|
16 |
7 |
p. A503-
1 p.
|
artikel
|
| 1507 |
Pharmacoeconomic Benefits of Citicoline in the Treatment of Acute Ischemic Stroke in Russia
|
Ryazhenov, V.V.
|
|
2013
|
16 |
7 |
p. A519-A520
nvt p.
|
artikel
|
| 1508 |
Pharmacoeconomic Education for Health Care Students in Bosnia and Herzegovina
|
Catic, T.
|
|
2013
|
16 |
7 |
p. A479-
1 p.
|
artikel
|
| 1509 |
Pharmaco-Economic Education Needs Investigated by ISPOR Chapter – Example from Bulgaria
|
Nikolov, I.
|
|
2013
|
16 |
7 |
p. A479-
1 p.
|
artikel
|
| 1510 |
Pharmacoeconomic Evaluation Acceptability of Clopidogrel Versus Acetylsalicylic Acid in Patients with Cardiovascular Disease for Stroke Prevention in Ukraine
|
Mishchenko, O.
|
|
2013
|
16 |
7 |
p. A525-
1 p.
|
artikel
|
| 1511 |
Pharmacoeconomic Evaluation of Abiraterone Acetate Versus Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer in Kazakhstan
|
Kostyuk, A.
|
|
2013
|
16 |
7 |
p. A412-
1 p.
|
artikel
|
| 1512 |
Pharmacoeconomic Evaluation of Intravenous Ferric Carboxymaltose and Iron Sucrose in Correction of Preoperative Anaemia in Patients Undergoing Major Elective Surgery
|
Gorokhova, S.G.
|
|
2013
|
16 |
7 |
p. A379-A380
nvt p.
|
artikel
|
| 1513 |
Pharmacoeconomic Evaluation of the Fixed-Dose Combination of Abacavir/Lamivudine in the Antiretroviral Therapy of Naïve HIV Infected Patients in Russia
|
Pyadushkina, E.
|
|
2013
|
16 |
7 |
p. A345-A346
nvt p.
|
artikel
|
| 1514 |
Pharmacoeconomic Evaluation of the Oral Hypoglycemic Agents in the Treatment of Type 2 Diabetes Mellitus Patients in the Russian Federation
|
Ryazhenov, V.V.
|
|
2013
|
16 |
7 |
p. A440-
1 p.
|
artikel
|
| 1515 |
Pharmacoeconomic Peculiarities of Thyroid Disease Treatment in Ukraine
|
Vadziuk, I.
|
|
2013
|
16 |
7 |
p. A437-
1 p.
|
artikel
|
| 1516 |
Pharmacoeconomics of Cervarix Vaccines Against Human Papilloma Virus in the Republic of Kazakhstan
|
Nurgozhin, T.
|
|
2013
|
16 |
7 |
p. A714-A715
nvt p.
|
artikel
|
| 1517 |
Pharmacoeconomic Study of Nutrition Support (NS) Usage During Intensive Treatment
|
Metelkin, I.
|
|
2013
|
16 |
7 |
p. A379-
1 p.
|
artikel
|
| 1518 |
Pharmacoepidemiological Study of HMG CoA Reductase Inhibitor Prescribing: Impact of Generic Prescribing on Cost
|
Truter, I.
|
|
2013
|
16 |
7 |
p. A516-
1 p.
|
artikel
|
| 1519 |
Pharmacotherapeutic Monitoring of Patients Using Immunobiological in a Health Insurance Company in Brazil: To Know to Better Manage
|
Reis, H.P.L.C.
|
|
2013
|
16 |
7 |
p. A562-
1 p.
|
artikel
|
| 1520 |
Pharmacotherapy Costs of Multiple Myeloma in the Czech Republic: A Retrospective Analysis
|
Baloghova, K.
|
|
2013
|
16 |
7 |
p. A389-
1 p.
|
artikel
|
| 1521 |
Physician Experience with Rituximab to Treat Pemphigus Vulgaris in Canada: A Questionnaire-Based Study
|
Mittmann, N.
|
|
2013
|
16 |
7 |
p. A510-
1 p.
|
artikel
|
| 1522 |
Physician Panels Supporting Clinical Trials and Post-Approval Studies in Oncology: A Willingness-To-Participate Study
|
Potthoff, P.
|
|
2013
|
16 |
7 |
p. A577-A578
nvt p.
|
artikel
|
| 1523 |
Physicians’ Preferences for Bone Metastases Treatments in France, Germany and the United Kingdom
|
Qian, Y.
|
|
2013
|
16 |
7 |
p. A430-
1 p.
|
artikel
|
| 1524 |
Physicians’ Preferences for Bone Metastases Treatments in the United States
|
Arellano, J.
|
|
2013
|
16 |
7 |
p. A430-
1 p.
|
artikel
|
| 1525 |
Pilot Testing of the Polish Pre-Final Version of “Disabilities of the Arm, Shoulder and Hand” (Dash) Questionnaire
|
Golicki, D.
|
|
2013
|
16 |
7 |
p. A598-A599
nvt p.
|
artikel
|
| 1526 |
Pivotal Studies of Orphan Medicinal Products – an Analysis of Quality of Clinical Evidence
|
Picavet, E.
|
|
2013
|
16 |
7 |
p. A390-
1 p.
|
artikel
|
| 1527 |
Placebo-Controlled Trials: Are They Acceptable to Health Technology Assessment Bodies?
|
Casamayor, M.
|
|
2013
|
16 |
7 |
p. A476-
1 p.
|
artikel
|
| 1528 |
Podcasts as a Learning Tool in a Research Methods Course for Pharmacy Students
|
Nguyen, T.L.
|
|
2013
|
16 |
7 |
p. A613-
1 p.
|
artikel
|
| 1529 |
Poder Popular Y Regulación Del Precio De Los Medicamentos En Venezuela
|
Adesso, G.
|
|
2013
|
16 |
7 |
p. A681-
1 p.
|
artikel
|
| 1530 |
Point of Care Tests: The Long and Winding Road to Reimbursement
|
Hogue, S.
|
|
2013
|
16 |
7 |
p. A476-A477
nvt p.
|
artikel
|
| 1531 |
Points to Consider in Multiregional Trials Using PHQ-9: A Meta-Analysis on PHQ-9
|
Ueki, H.
|
|
2013
|
16 |
7 |
p. A541-
1 p.
|
artikel
|
| 1532 |
Population Based Utilization of Radiation Therapy by a Canadian Breast Cancer Cohort
|
Mittmann, N.
|
|
2013
|
16 |
7 |
p. A430-
1 p.
|
artikel
|
| 1533 |
Potential Economic Impact of Using Sugammadex for the Routine Reversal of Neuromuscular Blockade in Russian Health Care Setting
|
Derkach, E.V.
|
|
2013
|
16 |
7 |
p. A558-A559
nvt p.
|
artikel
|
| 1534 |
Potential Financial Impact of Sugammadex in Anaesthetic Departments: A Budget Impact Analysis on Potentially Short Procedures Requiring Neuromuscolar Blockade
|
Povero, M.
|
|
2013
|
16 |
7 |
p. A379-
1 p.
|
artikel
|
| 1535 |
Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia
|
Walzer, S.
|
|
2013
|
16 |
7 |
p. A400-A401
nvt p.
|
artikel
|
| 1536 |
Potentially Inappropriate Prescribing (PIP) and Its Association with Instrumental Activities of Daily Living (IADL) Impairment in Older People
|
Moriarty, F.
|
|
2013
|
16 |
7 |
p. A337-
1 p.
|
artikel
|
| 1537 |
Potential of Omega-3 Fatty Acid in Parenteral Nutrition in Germany: A Budget Impact Analysis
|
Pradelli, L.
|
|
2013
|
16 |
7 |
p. A368-
1 p.
|
artikel
|
| 1538 |
Potential Predictors of Alzheimer’s Disease: An Analysis with the Quebec Provincial Drug Reimbursement Program Database
|
Lachaine, J.
|
|
2013
|
16 |
7 |
p. A618-
1 p.
|
artikel
|
| 1539 |
Practice of Cerebroprotectors Consumption in Ukraine
|
Kuznetsov, I.
|
|
2013
|
16 |
7 |
p. A619-A620
nvt p.
|
artikel
|
| 1540 |
Predicting EQ-5D Utility Scores from SF-36 Scores in Patients with Rheumatoid Arthritis in Japan
|
Moriwaki, K.
|
|
2013
|
16 |
7 |
p. A568-
1 p.
|
artikel
|
| 1541 |
Predicting Health Care Costs in Asthma Using the EQ-5D Index Score
|
Gu, N.Y.
|
|
2013
|
16 |
7 |
p. A370-A371
nvt p.
|
artikel
|
| 1542 |
Predicting the Frequency of Severe and Non-Severe Hypoglycaemia in Insulin Treated Type-2 Diabetes Subjects
|
McEwan, P.
|
|
2013
|
16 |
7 |
p. A435-
1 p.
|
artikel
|
| 1543 |
Predictor Factors for the Presence of Post Herpetic Neuralgia at 3 Months in Herpes Zoster Patients Aged 50 and Over in Italy: Results from a Gp-Based Observational Prospective Multicenter Study
|
Bricout, H.
|
|
2013
|
16 |
7 |
p. A343-
1 p.
|
artikel
|
| 1544 |
Predictors of Costs of Antiretrovirals for HIV Infection in Italy: A Multicentric Retrospection in 2012
|
Tontodonati, M.
|
|
2013
|
16 |
7 |
p. A350-
1 p.
|
artikel
|
| 1545 |
Preference Structure of Clinicians in the Use of Electronic Medical Records; Quantifying the Relative Importance of Barriers and Facilitators of an Innovation
|
Struik, M.H.L.
|
|
2013
|
16 |
7 |
p. A471-
1 p.
|
artikel
|
| 1546 |
Pre-Financing Function of the Pharmaceutical Full-Line Wholesale Sector in the European Union
|
Said, M.
|
|
2013
|
16 |
7 |
p. A472-
1 p.
|
artikel
|
| 1547 |
Pregnancy After Breast Cancer in 2000-2002 and 2010-2012: A Retrospective Database Analysis
|
Kalousidou, N.
|
|
2013
|
16 |
7 |
p. A393-
1 p.
|
artikel
|
| 1548 |
Preliminary Italian Archive of Eq-5d Data on Individuals from the General Population and with Different Disease Conditions
|
Cortesi, P.A.
|
|
2013
|
16 |
7 |
p. A336-
1 p.
|
artikel
|
| 1549 |
Preliminary Results Quality of Life, Physical Activity, and Sedentary Behavior in College Students
|
Mendoza, F.J.
|
|
2013
|
16 |
7 |
p. A711-
1 p.
|
artikel
|
| 1550 |
Preliminary Testing of the Sagit Tool: A Tool to Help Endocrinologists in Their Management of Patients with Acromegaly in Clinical Practice
|
Giustina, A.
|
|
2013
|
16 |
7 |
p. A447-
1 p.
|
artikel
|
| 1551 |
Prescribing Patterns of Parkinson’s Disease
|
Tomita, N.
|
|
2013
|
16 |
7 |
p. A629-
1 p.
|
artikel
|
| 1552 |
Prescription Patterns of Antihypertensive Agents in T2DM Patients Visiting Tertiary Care Centre in North India
|
Raval, A.
|
|
2013
|
16 |
7 |
p. A538-
1 p.
|
artikel
|
| 1553 |
Prevalence and Risk Factors of Actinic Keratoses
|
Schaefer, I.
|
|
2013
|
16 |
7 |
p. A503-
1 p.
|
artikel
|
| 1554 |
Prevalence and Risk Factors of Depression in Patients with Chronic Obstructive Pulmonary Disease in India
|
Negi, H.
|
|
2013
|
16 |
7 |
p. A550-A551
nvt p.
|
artikel
|
| 1555 |
Prevalence of Comorbidities Among Chronic COPD Patients in the United States
|
Mannino, M.
|
|
2013
|
16 |
7 |
p. A377-
1 p.
|
artikel
|
| 1556 |
Prevalence of Physicians Causing Potential Drug Interactions in Ambulatory Care in Switzerland: A Representative National Survey
|
Bucher, H.C.
|
|
2013
|
16 |
7 |
p. A461-
1 p.
|
artikel
|
| 1557 |
Prevalence of Risk Factors of St Elevated Myocardial Infarction
|
Rasool, F.
|
|
2013
|
16 |
7 |
p. A704-
1 p.
|
artikel
|
| 1558 |
Prevelance of Hydeted Disease in Sugicaly Operated Patient in Some Libyan General Hospital
|
Hadida, E.
|
|
2013
|
16 |
7 |
p. A343-
1 p.
|
artikel
|
| 1559 |
Prevention of Gram-Positive Infections in Peritoneal Dialysis Patients – A Cost-Effectiveness Analysis
|
You, J.
|
|
2013
|
16 |
7 |
p. A358-
1 p.
|
artikel
|
| 1560 |
Price Differences Triggered by the Availability of Biosimilars in Developed Countries
|
Reinaud, F.
|
|
2013
|
16 |
7 |
p. A329-
1 p.
|
artikel
|
| 1561 |
Pricing and Reimbursement Analysis of Lifestyle Medicines in Serbia
|
Baltezarevic, D.
|
|
2013
|
16 |
7 |
p. A458-
1 p.
|
artikel
|
| 1562 |
Pricing and Reimbursement System of Orphan Drugs in the Czech Republic
|
Prochazkova, M.
|
|
2013
|
16 |
7 |
p. A474-
1 p.
|
artikel
|
| 1563 |
Pricing and Reimbursment of Pharmaceuticals in Iran
|
Moradi, M.
|
|
2013
|
16 |
7 |
p. A474-A475
nvt p.
|
artikel
|
| 1564 |
Pricing of “Follow-On” Drugs and Competition Within Pharmaceutical Classes: Evidence from Germany 1993-2008
|
Mueller, M.T.
|
|
2013
|
16 |
7 |
p. A457-A458
nvt p.
|
artikel
|
| 1565 |
Probabilistic Sensitivity Analysis to Analyze the Cost-Effectiveness of Oral Hypoglycemic Agents in the Initial Oral Drug Treatment of Outpatients Diagnosed with Type 2 Diabetes in Primary Care
|
Diaz de León-Castañeda, C.
|
|
2013
|
16 |
7 |
p. A689-
1 p.
|
artikel
|
| 1566 |
Pro Claims in Japanese Oncology Product Labeling
|
Crawford, B.
|
|
2013
|
16 |
7 |
p. A421-
1 p.
|
artikel
|
| 1567 |
Productivity Loss in Population of Informal Caregivers to Diabetic Foot Syndrome Patients in Poland
|
Macioch, T.
|
|
2013
|
16 |
7 |
p. A443-
1 p.
|
artikel
|
| 1568 |
Profile of Back Pain Sufferers Across 5EU Countries
|
Annunziata, K.
|
|
2013
|
16 |
7 |
p. A388-
1 p.
|
artikel
|
| 1569 |
Projeção De Gastos Com Medicamentos De Uso Crônico (Ambulatorial)
|
Paloni, E.D.M.P.
|
|
2013
|
16 |
7 |
p. A707-
1 p.
|
artikel
|
| 1570 |
Prometex - Promevoz, Tool Support of Pharmaceutical Care for the Scope of Proper Adhesion in Colombia, 2009-2012
|
Estrada, J.I.
|
|
2013
|
16 |
7 |
p. A711-
1 p.
|
artikel
|
| 1571 |
Proposal of Economic Evaluation Guideline in Japan
|
Fukuda, T.
|
|
2013
|
16 |
7 |
p. A613-A614
nvt p.
|
artikel
|
| 1572 |
Protective Factors for University Students’ Health
|
Višnjić, A.
|
|
2013
|
16 |
7 |
p. A339-
1 p.
|
artikel
|
| 1573 |
Prototype Model in Metastatic Castrate-Resistant Prostate Cancer (mCRPC): A Tool to Position New Treatments in the Patient Pathway?
|
Karcher, H.
|
|
2013
|
16 |
7 |
p. A593-
1 p.
|
artikel
|
| 1574 |
Proxy Utility Assessment in Acute Heart Failure
|
Swinburn, P.
|
|
2013
|
16 |
7 |
p. A707-
1 p.
|
artikel
|
| 1575 |
Psoriasis Patients’ Tolerance for Therapeutic Risks in Return for Symptom Improvement in the United Kingdom
|
González, J.M.
|
|
2013
|
16 |
7 |
p. A508-
1 p.
|
artikel
|
| 1576 |
Psychoactive Drug Use, Polypharmacy and Co-Morbidities in Newly Diagnosed Patients with Pervasive Development Disorder in the Province of Quebec
|
Croteau, C.
|
|
2013
|
16 |
7 |
p. A552-
1 p.
|
artikel
|
| 1577 |
Psychometric Properties of the Hypoglycemia Perspectives Questionnaire (HPQ) in Type 2 Diabetes Mellitus
|
Kawata, A.K.
|
|
2013
|
16 |
7 |
p. A691-
1 p.
|
artikel
|
| 1578 |
Psychometric Validation of Perceived Deficits Questionnaire – Depression (PDQ-D) in Patients with Major Depressive Disorder (MDD)
|
Lam, R.W.
|
|
2013
|
16 |
7 |
p. A330-
1 p.
|
artikel
|
| 1579 |
Psychosocial Adjustment in Diabetic Patients with and without Diabetic Foot-Ulcers-A Comparative Study
|
Prabhu, V.A.
|
|
2013
|
16 |
7 |
p. A445-
1 p.
|
artikel
|
| 1580 |
Public Health Impact and Cost Effectiveness of Pneumococcal Vaccination for Adults in Puerto Rico
|
Yang, H.K.
|
|
2013
|
16 |
7 |
p. A714-
1 p.
|
artikel
|
| 1581 |
Public Health Impacts of Probiotics in Controlling Upper Respiratory Tract Infections in France
|
Gerlier, L.
|
|
2013
|
16 |
7 |
p. A341-
1 p.
|
artikel
|
| 1582 |
Public Preference Elicitation in Drug Reimbursement Using Multi-Criteria Decision Analysis (MCDA) for Universal Health Insurance System in South Korea
|
Cho, H.Y.
|
|
2013
|
16 |
7 |
p. A473-
1 p.
|
artikel
|
| 1583 |
¿Puede un Cambio del 2003 en el Reglamento en el Cuadro Básico (CBM) en México Impactar la Cantidad de Estudios Científicos Publicados de Evaluación Económica Completos de Medicamentos (EECM) en los Últimos 10 Años?
|
Márquez Cruz, M.
|
|
2013
|
16 |
7 |
p. A669-A670
nvt p.
|
artikel
|
| 1584 |
Pulse Pressure and Stroke Risk: Development and Validation of a Stroke Risk Equation
|
Ayyagari, R.
|
|
2013
|
16 |
7 |
p. A666-
1 p.
|
artikel
|
| 1585 |
Quadrivalent Versus Trivalent Influenza Vaccine: Is It Good Value for Money?
|
Barbieri, M.
|
|
2013
|
16 |
7 |
p. A357-
1 p.
|
artikel
|
| 1586 |
Qualidade De Vida Dos Pacientes Que Utilizam Medicamentos Anti-TNF Para O Tratamento De Doenças Reumáticas No Sistema Único De Saúde Em Minas Gerais, Brasil
|
Oliveira Junior, H.A.
|
|
2013
|
16 |
7 |
p. A718-A719
nvt p.
|
artikel
|
| 1587 |
Qualidade De Vida Em Pacientestransplantados Renais
|
Maia, R.C.F.
|
|
2013
|
16 |
7 |
p. A699-
1 p.
|
artikel
|
| 1588 |
Quality Assessment of Observational Studies for Systematic Reviews
|
Kiss, N.
|
|
2013
|
16 |
7 |
p. A614-
1 p.
|
artikel
|
| 1589 |
Quality Assurance of Fourth Hurdle Concerning to Drugs and Medical Devices
|
Tesar, T.
|
|
2013
|
16 |
7 |
p. A462-
1 p.
|
artikel
|
| 1590 |
Quality Criteria for the Development of Implant Registries
|
Niederländer, C.S.
|
|
2013
|
16 |
7 |
p. A328-A329
nvt p.
|
artikel
|
| 1591 |
Quality Improvement Initiatives for Patients on Warfarin in Primary Care
|
Molony, S.
|
|
2013
|
16 |
7 |
p. A541-
1 p.
|
artikel
|
| 1592 |
Quality Indicators of the Fourth Screening Round (2008-2009) of the Hungarian Organized, Nationwide Breast Cancer Screening Programme
|
Boncz, I.
|
|
2013
|
16 |
7 |
p. A396-
1 p.
|
artikel
|
| 1593 |
Quality of Care for Type 2 Diabetes Mellitus Patients in Dubai
|
Donato, B.M.K.
|
|
2013
|
16 |
7 |
p. A453-
1 p.
|
artikel
|
| 1594 |
Quality of Life Benefits and Cost Impact of Prolonged Release Oxycodone/Naloxone Versus Prolonged Release Oxycodone in Patients with Moderate to Severe Pain and Opioid-Induced Constipation Despite the Use of 2 Laxatives: A UK Cost Utility Analysis
|
Dunlop, W.
|
|
2013
|
16 |
7 |
p. A384-
1 p.
|
artikel
|
| 1595 |
Quality of Life Improvement with Etanercept in Patients with Moderate/Severe Psoriasis from Central and Eastern Europe, Latin America and Asia
|
Kemeny, L.
|
|
2013
|
16 |
7 |
p. A509-
1 p.
|
artikel
|
| 1596 |
Quality of Life in Patients with Gastroesophageal Reflux Disease in Slovakia
|
Bielik, J.
|
|
2013
|
16 |
7 |
p. A693-
1 p.
|
artikel
|
| 1597 |
Quality of Life in Patients with Metastatic Colorectal Cancer (mCRC): A Utilities Study in the United Kingdom and the Netherlands
|
Stein, D.
|
|
2013
|
16 |
7 |
p. A420-
1 p.
|
artikel
|
| 1598 |
Quality of Life in Patients with Multiple Sclerosis in Slovakia
|
Bielik, J.
|
|
2013
|
16 |
7 |
p. A627-
1 p.
|
artikel
|
| 1599 |
Quality of Life in Patients with Ostomy in Poland: Multicentre Cross-Sectional Study Using WHOQOL-BREF Questionnaire
|
Golicki, D.
|
|
2013
|
16 |
7 |
p. A421-
1 p.
|
artikel
|
| 1600 |
Quality of Life in Patients with Type 2 Diabetes in Poland: Comparison with General Population Using EQ-5D Questionnaire
|
Golicki, D.
|
|
2013
|
16 |
7 |
p. A445-
1 p.
|
artikel
|
| 1601 |
Quality of Life in Patients with Venous Thromboemoblism: A Systematic Literature Review
|
Rao, N.
|
|
2013
|
16 |
7 |
p. A533-
1 p.
|
artikel
|
| 1602 |
Quality of Life of Patients Suffering from Exudative Age-Related Macular Degeneration and Treated by Intravitreal Injections and Its Predictors: The Equade Study
|
Leveziel, N.
|
|
2013
|
16 |
7 |
p. A509-A510
nvt p.
|
artikel
|
| 1603 |
Quality of Life Outcomes in Multiple Sclerosis: A Review of the Literature
|
Rouse, M.
|
|
2013
|
16 |
7 |
p. A626-
1 p.
|
artikel
|
| 1604 |
Quality of Life (QOL) and Resources Consumption in Insulin-Dependent Diabetic Patients with A1CNOW+ and CONTOUR USB. Comet Study
|
Graefenhain, R.
|
|
2013
|
16 |
7 |
p. A448-
1 p.
|
artikel
|
| 1605 |
Quality of Life (QOL) During Treatment of Newly Diagnosed Locally Confined Low-Risk Prostate Cancer (LCLRPC) in Germany: Results of the Harow Study
|
Schädlich, P.K.
|
|
2013
|
16 |
7 |
p. A422-
1 p.
|
artikel
|
| 1606 |
Quantifying Health Care Efficiency: A Review of Published Time and Motion Study Design Parameters Referenced in Pubmed Between 2008-2013
|
Kritikou, P.
|
|
2013
|
16 |
7 |
p. A610-
1 p.
|
artikel
|
| 1607 |
Quantifying the Direct and Indirect Costs Associated with Severe and Non-Severe Hypoglycaemia in Subjects with Type-2 Diabetes Who Are Treated with Insulin
|
Foos, V.
|
|
2013
|
16 |
7 |
p. A436-A437
nvt p.
|
artikel
|
| 1608 |
Racial Disparities in Diffusion, Comparative Morbidity, and Disease Control of Intensity-Modulated Radiation Therapy Compared to Conformal Radiation Therapy for Localized Prostate Cancer
|
Cobran, E.K.
|
|
2013
|
16 |
7 |
p. A396-
1 p.
|
artikel
|
| 1609 |
Racial Disparity in Health Care Access and Outcomes Associated with Prostate Cancer in the United States
|
Roy, D.
|
|
2013
|
16 |
7 |
p. A426-
1 p.
|
artikel
|
| 1610 |
Rationale for Initiating and Switching Biologic Therapy in Patients with Rheumatoid Arthritis: Results of a European Chart Review Study
|
Emery, P.
|
|
2013
|
16 |
7 |
p. A573-
1 p.
|
artikel
|
| 1611 |
Reaching the Middle of the Pyramid: Implications for the P&MA of Pharmaceutical Drugs with the Expanding Middle Class in Brasil, Chile and Colombia
|
Severi Bruni, D.
|
|
2013
|
16 |
7 |
p. A674-
1 p.
|
artikel
|
| 1612 |
Real Life Applications of Social Security Institution (SSI) Regulations; A Case Study of DPP4 Inhibitors in Treatment of Diabetes in Turkish Health Care System
|
Kececioglu, S.
|
|
2013
|
16 |
7 |
p. A451-A452
nvt p.
|
artikel
|
| 1613 |
Real Life Effects of Liraglutide Supports Those Shown in RCTs
|
Karasik, A.
|
|
2013
|
16 |
7 |
p. A432-
1 p.
|
artikel
|
| 1614 |
Real World Incidence of Type 2 Diabetes (T2D) Complications Leading to Hospitalization in France: The Recode Study
|
Bouee, S.
|
|
2013
|
16 |
7 |
p. A434-
1 p.
|
artikel
|
| 1615 |
Real World Management and Costs in Unresectable Metastatic Melanoma (MM) Patients: Update of a Pilot Study Based on an Institutional Patient Registry
|
Strens, D.
|
|
2013
|
16 |
7 |
p. A403-
1 p.
|
artikel
|
| 1616 |
Real World Outcomes in Type 2 Diabetes: Lower Cost of Treating Patients to A1c<7% with Liraglutide Versus Exenatide
|
Dekoven, M.
|
|
2013
|
16 |
7 |
p. A438-
1 p.
|
artikel
|
| 1617 |
Real World Resource Use Associated with Transcatheter Aortic Valve Implantation and Conventional Aortic Valve Replacement Surgery
|
Awad, W.
|
|
2013
|
16 |
7 |
p. A531-A532
nvt p.
|
artikel
|
| 1618 |
Real-World Utilization Data Over 4 Years of Ranibizumab Injections for the Treatment of Wet Age-Related Macular Degeneration in Canada
|
Lebel, K.
|
|
2013
|
16 |
7 |
p. A510-
1 p.
|
artikel
|
| 1619 |
Real World Utilization of Biological Agents in Rheumatoid Arthritis Patients: A French National Claims Database Analysis Over the Period 2009-2011
|
Fautrel, B.
|
|
2013
|
16 |
7 |
p. A572-A573
nvt p.
|
artikel
|
| 1620 |
Reanalyzing Using Bayesian Methods and Updated Data the Cost-Efectiveness Assumptions of Carotid Artery Stenosis Treatments
|
Smolen, H.J.
|
|
2013
|
16 |
7 |
p. A523-A524
nvt p.
|
artikel
|
| 1621 |
Reasons Given by the European Medicines Agency for Revising Disease-Specific Scientific Guidelines
|
Caron, M.
|
|
2013
|
16 |
7 |
p. A486-
1 p.
|
artikel
|
| 1622 |
Recent Trends in Hospital Costs, Length of Stay, and Mortality Associated with Pediatric Meningococcal Disease in the United States
|
Davis, K.L.
|
|
2013
|
16 |
7 |
p. A349-
1 p.
|
artikel
|
| 1623 |
Recent Trends in Incidence and Demographics of Pediatric Meningococcal Disease in the United States
|
Davis, K.L.
|
|
2013
|
16 |
7 |
p. A342-
1 p.
|
artikel
|
| 1624 |
Recommendations for the Successful Linguistic Validation of Clinical Outcome Assessments for Limited Patient Populations
|
Moravec, H.
|
|
2013
|
16 |
7 |
p. A604-
1 p.
|
artikel
|
| 1625 |
Recruting Physicians for Health Outcome and Post-Approval Studies: Benefits of a Managed Physician Panel
|
Potthoff, P.
|
|
2013
|
16 |
7 |
p. A511-
1 p.
|
artikel
|
| 1626 |
Reducing the Length of Antibiotic Prophylaxis in Clinical Conditions
|
Djozic, M.
|
|
2013
|
16 |
7 |
p. A412-
1 p.
|
artikel
|
| 1627 |
Reduction in Fixation Time and Related Surgical Stress with the Use of Ethicon Securestrap™ Open Absorbable Strap Fixation Device in the Deployment of Intra-Peritoneal Onlay Mesh (IPOM) for Open Ventral Hernia Repair
|
Roy, S.
|
|
2013
|
16 |
7 |
p. A486-
1 p.
|
artikel
|
| 1628 |
Reduction in NSAIDS Consumption After Viscosupplementation with HA: Is It Costs Saving?
|
Migliore, A.
|
|
2013
|
16 |
7 |
p. A562-
1 p.
|
artikel
|
| 1629 |
Reduction of Costs Associated with a New Dry-Powder Inhaler Formulation with Beclomethasone Dipropionate and Formoterol Combination for the Treatment of Asthma
|
Sanz-Granda, Á
|
|
2013
|
16 |
7 |
p. A368-
1 p.
|
artikel
|
| 1630 |
Re-Engineering of the Distribution of Drugs in the Hospital. TOC Application and TRZ
|
Alonso, H.erreros J
|
|
2013
|
16 |
7 |
p. A616-
1 p.
|
artikel
|
| 1631 |
Re-Establishing the Societal Value of Pediatric Combination Vaccines
|
Maman, K.
|
|
2013
|
16 |
7 |
p. A360-
1 p.
|
artikel
|
| 1632 |
Register Based Analysis of Treatment Costs of Second Generation Antipsychotics in Schizophrenia
|
Borsi, A.
|
|
2013
|
16 |
7 |
p. A546-A547
nvt p.
|
artikel
|
| 1633 |
Regulating the Access to an Adequate and an Integral Assistance in Brazilian Private Health Plans
|
Silva, F.H.C.V.
|
|
2013
|
16 |
7 |
p. A680-
1 p.
|
artikel
|
| 1634 |
Regulatory and General Epidemiological Knowledge About Rare Diseases and Access to Treatment for Rare Diseases: Health Professionals’ View in Serbia
|
Krajnovic, D.
|
|
2013
|
16 |
7 |
p. A478-
1 p.
|
artikel
|
| 1635 |
Relación Del Índice De Masa Corporal Y Gasto En Medicamentos En Personas Con Diabetes En Argentina
|
Prestes, M.
|
|
2013
|
16 |
7 |
p. A691-
1 p.
|
artikel
|
| 1636 |
Relationship Between Body Mass Index and Health Care Costs by Place of Service in Employed Adults
|
Abouzaid, S.
|
|
2013
|
16 |
7 |
p. A380-
1 p.
|
artikel
|
| 1637 |
Relationship Between Falls and CNS Drugs at a Acute Care Teaching Hospital in Japan
|
Egami, K.
|
|
2013
|
16 |
7 |
p. A677-
1 p.
|
artikel
|
| 1638 |
Relationship Between Medication Adherence and Quality of Life in COPD – Systematic Review
|
Ágh, T.
|
|
2013
|
16 |
7 |
p. A374-
1 p.
|
artikel
|
| 1639 |
Relationship Between Modelling Approach and Reported Outcomes: Case Studies of Models for the Treatment of Schizophrenia
|
von Schéele, B.
|
|
2013
|
16 |
7 |
p. A589-
1 p.
|
artikel
|
| 1640 |
Relative Clinical and Economic Value of Ipilimumab in Mexico
|
Juarez-Garcia, A.
|
|
2013
|
16 |
7 |
p. A402-
1 p.
|
artikel
|
| 1641 |
Relative Clinical Value in Advanced Cancer Treatments
|
Preto, M.C.
|
|
2013
|
16 |
7 |
p. A683-
1 p.
|
artikel
|
| 1642 |
Relative Efficacy and Acceptability of Vortioxetine Versus Marketed Antidepressants
|
Llorca, P.M.
|
|
2013
|
16 |
7 |
p. A543-
1 p.
|
artikel
|
| 1643 |
Relevance of a National Forecast Growth Rate, as a Regulation Tool of the Expensive Hospital Drug Spending, in France
|
Monnier, R.
|
|
2013
|
16 |
7 |
p. A459-
1 p.
|
artikel
|
| 1644 |
Relevance of Indirect Comparisons in the German Early Benefit Assessment (AMNOG)
|
Lebioda, A.
|
|
2013
|
16 |
7 |
p. A484-A485
nvt p.
|
artikel
|
| 1645 |
Relevant Decision-Making Criteria in German Hospital Formularies
|
Rübesam, T.
|
|
2013
|
16 |
7 |
p. A456-
1 p.
|
artikel
|
| 1646 |
Reliability and Validity of a Thai Version of Lam Employment Absence and Productivity Scale (LEAPS)
|
Pumpaisalchai, W.
|
|
2013
|
16 |
7 |
p. A596-
1 p.
|
artikel
|
| 1647 |
Reliability and Validity of the Pediatric Quality of Life Inventory Generic Core Scales for Dutch Children with Functional Constipation
|
Hartman, E.E.
|
|
2013
|
16 |
7 |
p. A598-
1 p.
|
artikel
|
| 1648 |
Remote Patient Monitoring in CRT-D Recipients May Reduce Use of Hospital-Based Care
|
Stern, S.
|
|
2013
|
16 |
7 |
p. A520-
1 p.
|
artikel
|
| 1649 |
Requirement of Cancer Help Lines in India and the Perception of All the Stake Holders
|
Kurian, S.
|
|
2013
|
16 |
7 |
p. A687-
1 p.
|
artikel
|
| 1650 |
Research in Haemophilia B – Studies in a Rare Disease in Times of Requirements for High Evidence Levels
|
Schopohl, D.
|
|
2013
|
16 |
7 |
p. A612-A613
nvt p.
|
artikel
|
| 1651 |
Resource Consumption Evaluation Associated with Rituximab Administration in Portugal
|
Pereira, C.
|
|
2013
|
16 |
7 |
p. A386-
1 p.
|
artikel
|
| 1652 |
Resources Saved by the Introduction of Day Surgery in the Greek National Health System
|
Skroumpelos, A.
|
|
2013
|
16 |
7 |
p. A469-
1 p.
|
artikel
|
| 1653 |
Resource Use and Cost of Diagnosis and Management of Breast Cancer by Stage in an Irish Teaching Hospital
|
Tierney, P.
|
|
2013
|
16 |
7 |
p. A406-
1 p.
|
artikel
|
| 1654 |
Resource Use and Disease Progression Among HCV-Positive Patients
|
Degli Esposti, L.
|
|
2013
|
16 |
7 |
p. A494-
1 p.
|
artikel
|
| 1655 |
Resource Use and Outcomes of Patients Treated with Vancomycin or Linezolid in a Tertiary Hospital in Shanghai
|
Yang, Y.
|
|
2013
|
16 |
7 |
p. A360-
1 p.
|
artikel
|
| 1656 |
Resource Use Due to Disability in Polish Rheumatoid Arthritis Patients: Significant Increase of Transportation Needs and Home Visits
|
Szafraniec-Burylo, S.I.
|
|
2013
|
16 |
7 |
p. A566-A567
nvt p.
|
artikel
|
| 1657 |
Resource Use of Non-Small Cell Lung Cancer in Slovakia
|
Ondrusova, M.
|
|
2013
|
16 |
7 |
p. A418-
1 p.
|
artikel
|
| 1658 |
Resource Utilisation and Costs of Total Hip Arthroplasty in the United Kingdom: A Descriptive Analysis
|
Raluy, M.
|
|
2013
|
16 |
7 |
p. A561-
1 p.
|
artikel
|
| 1659 |
Resource Utilization and Costs Associated with Rituximab Treatment in Patients with Pemphigus and Pemphigoid: A Comparison of 6 Months Before and 6 Months After Treatment
|
Heelan, K.
|
|
2013
|
16 |
7 |
p. A382-
1 p.
|
artikel
|
| 1660 |
Resource Utilization and Costs for Patients with Inflammatory Bowel Diseases in Italy: A Population-Based Assessment
|
Madotto, F.
|
|
2013
|
16 |
7 |
p. A495-
1 p.
|
artikel
|
| 1661 |
RESPIRATORY Syncytial Virus Hospitalization in Infants with Congenital Airway Anomalies in the Canadian Registry of Synagis® (CARESS) Following Prophylaxis (2005-2012)
|
Paes, B.A.
|
|
2013
|
16 |
7 |
p. A366-A367
nvt p.
|
artikel
|
| 1662 |
Respiratory Syncytial Virus Hospitalizations in the Canadian Registry for Synagis (CARESS)
|
Paes, B.A.
|
|
2013
|
16 |
7 |
p. A366-
1 p.
|
artikel
|
| 1663 |
Responder Analysis of Functional Health and Well-Being in MDD: A Pooled Analysis of SF-36 Results from Three Phase III Trials with Levomilnacipran SR
|
Blum, S.I.
|
|
2013
|
16 |
7 |
p. A542-
1 p.
|
artikel
|
| 1664 |
Responsiveness of the EQ-5D in Oncology: A Meta-Analysis
|
Smith, A.B.
|
|
2013
|
16 |
7 |
p. A323-A324
nvt p.
|
artikel
|
| 1665 |
Resultados De La Encuesta “Change Pain” Latinoamericana: Diagnostico Y Tratamiento Actual De Los Pacientes Con Dolor Crónico
|
Amescua, C.
|
|
2013
|
16 |
7 |
p. A669-
1 p.
|
artikel
|
| 1666 |
Results from a Two-Stage Delphi Process to Identify Cardiometabolic Risk Factors in Adrenal Insufficiency Patients and Understand Current Treatment in Italy
|
Elvidge, J.
|
|
2013
|
16 |
7 |
p. A434-
1 p.
|
artikel
|
| 1667 |
Results from the “Autor” Study, a European Observational Study in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder
|
Haynes, V.
|
|
2013
|
16 |
7 |
p. A541-A542
nvt p.
|
artikel
|
| 1668 |
Results of a Study Using a Tablet PC to Collect PROs in Elderly Population
|
Pau, D.
|
|
2013
|
16 |
7 |
p. A604-
1 p.
|
artikel
|
| 1669 |
Results of Galata Study: Galvus Efficacy and Safety Assessment in Turkish Population
|
Keskin, L.
|
|
2013
|
16 |
7 |
p. A433-
1 p.
|
artikel
|
| 1670 |
Results of the Post-Marketing Survey of Vildagliptin in France
|
Eschwège, E.
|
|
2013
|
16 |
7 |
p. A433-
1 p.
|
artikel
|
| 1671 |
Retrospective Analysis of Oncology Indications Utilizing Drug Expenditures from 2005 to 2012 in the Republic of Srpska
|
Guzvic, V.
|
|
2013
|
16 |
7 |
p. A427-
1 p.
|
artikel
|
| 1672 |
Retrospective Costing Study to Estimate Burden of Heart Failure in Spain
|
Llorens, P.
|
|
2013
|
16 |
7 |
p. A521-
1 p.
|
artikel
|
| 1673 |
Review of Cost of Diabetes Complications in Four European Countries
|
Beaudet, A.
|
|
2013
|
16 |
7 |
p. A443-A444
nvt p.
|
artikel
|
| 1674 |
Review of Economic Principles of Branded “Me-Too” Drugs Market
|
Hren, R.
|
|
2013
|
16 |
7 |
p. A491-A492
nvt p.
|
artikel
|
| 1675 |
Review of Meta-Analysis Methods for Multinomial Data
|
Bennison, C.
|
|
2013
|
16 |
7 |
p. A576-A577
nvt p.
|
artikel
|
| 1676 |
Review of Nice Technology Appraisals in Oncology: How Does Clinical Evidence Change Over Time?
|
Dequen, P.
|
|
2013
|
16 |
7 |
p. A429-
1 p.
|
artikel
|
| 1677 |
Review of the Use of Resource Use Instruments Based on Patient Recall in Relation to Other Methods of Cost Estimation
|
Ridyard, C.
|
|
2013
|
16 |
7 |
p. A466-
1 p.
|
artikel
|
| 1678 |
Revised Scoring of the WPAI:Hep C Improves Assessment of Missed Work and Work Impairment in HCV Clinical Trials
|
Gilles, L.
|
|
2013
|
16 |
7 |
p. A363-
1 p.
|
artikel
|
| 1679 |
Revisión De Estudios Del Coste De La Enfermedad
|
Crespo, C.
|
|
2013
|
16 |
7 |
p. A678-
1 p.
|
artikel
|
| 1680 |
Riociguat for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH): Responder Analysis of Who Functional Class III Patients from the Patent-1 Study
|
Grünig, E.
|
|
2013
|
16 |
7 |
p. A513-
1 p.
|
artikel
|
| 1681 |
Risk Factors for Discontinuation of Insulin Pump Therapy in Pediatric and Young Adult Patient Groups
|
Kostev, K.
|
|
2013
|
16 |
7 |
p. A444-
1 p.
|
artikel
|
| 1682 |
Risk Factors Influencing the Viral Transmission and the Potential Development of HPV-Induced Pathologies
|
Marcellusi, A.
|
|
2013
|
16 |
7 |
p. A343-
1 p.
|
artikel
|
| 1683 |
Risk of Psychiatric and Neurological Diseases in Patients with Workspace Mobbing Experience in Germany: A Retrospective Database Analysis
|
Kostev, K.
|
|
2013
|
16 |
7 |
p. A541-
1 p.
|
artikel
|
| 1684 |
Risk Sharing for Innovative Pharmaceuticals Within Social Health Insurance: Experiences from China
|
Chen, W.
|
|
2013
|
16 |
7 |
p. A488-
1 p.
|
artikel
|
| 1685 |
Role of Antioxidants in Recurrent Pregnancy Losses, Low Birth Weight, and Gestational Duration
|
Bhatti, T.A.
|
|
2013
|
16 |
7 |
p. A709-
1 p.
|
artikel
|
| 1686 |
Ruling Out IBD in the United Kingdom and Brazil: Is the Usage of F-Calprotectin in Primary Care Cost-Effective?
|
Mascialino, B.
|
|
2013
|
16 |
7 |
p. A692-
1 p.
|
artikel
|
| 1687 |
Ruling Out IBD in the United Kingdom and Spain: Is the Usage of F-Calprotectin in Primary Care Cost-Effective?
|
Mascialino, B.
|
|
2013
|
16 |
7 |
p. A493-
1 p.
|
artikel
|
| 1688 |
Safety in National Care - Real World Data from the German Psoriasis-Registry “Psobest”
|
Rustenbach, S.J.
|
|
2013
|
16 |
7 |
p. A511-
1 p.
|
artikel
|
| 1689 |
Safety Profile and Costs of Related Adverse Events of Trastuzumab Emtansine Compared to Other Regimens in the Canadian Health Care System
|
Piwko, C.
|
|
2013
|
16 |
7 |
p. A401-
1 p.
|
artikel
|
| 1690 |
Scandinavian Drug Reimbursement and Coverage Decisions: The Role of HTA
|
Grepstad, M.L.
|
|
2013
|
16 |
7 |
p. A483-
1 p.
|
artikel
|
| 1691 |
Schizophrenia and Negative Symptoms – Burden of the Disease in Seven Central and Eastern European (CEE) Countries: THE Results of the Literature Review
|
Walczak, J.
|
|
2013
|
16 |
7 |
p. A545-A546
nvt p.
|
artikel
|
| 1692 |
Scoring the Center for Epidemiologic Studies – Depression Scale: Which Items Go Where?
|
Cole, J.C.
|
|
2013
|
16 |
7 |
p. A550-
1 p.
|
artikel
|
| 1693 |
Screening Characteristics and Diabetes Biomarkers in French and UK Patient-Level Databases
|
Cabrera, C.
|
|
2013
|
16 |
7 |
p. A582-
1 p.
|
artikel
|
| 1694 |
Screening Strategies for Heart Failure in Patients with Type 2 Diabetes: Assessing Cost-Effectiveness in Those Aged 60 Years or Over
|
van Giessen, A.
|
|
2013
|
16 |
7 |
p. A523-
1 p.
|
artikel
|
| 1695 |
Screen or Not to Screen for Peripheral Arterial Disease: Guidance from a Decision Model
|
Vaidya, A.
|
|
2013
|
16 |
7 |
p. A528-
1 p.
|
artikel
|
| 1696 |
Second-Line Treatment of Metastatic Colorectal Cancer (mCRC): A Systematic Literature Review (SLR) and Feasibility Assessment of Conducting Indirect Treatment Comparison (ITC) Analysis
|
Xu, Y.
|
|
2013
|
16 |
7 |
p. A395-A396
nvt p.
|
artikel
|
| 1697 |
Selective Internal Radiotherapy (SIRT) Using Resin Yttrium-90 Microspheres for Chemotherapy-Refractory Metastatic Colorectal Cancer: An Italian Cost-Effectiveness Analysis
|
Cosimelli, M.
|
|
2013
|
16 |
7 |
p. A409-
1 p.
|
artikel
|
| 1698 |
Selective Internal Radiotherapy (SIRT) Using Resin Yttrium-90 Microspheres for Chemotherapy-Refractory Metastatic Colorectal Cancer: A UK Cost-Effectiveness Analysis
|
Bester, L.
|
|
2013
|
16 |
7 |
p. A413-
1 p.
|
artikel
|
| 1699 |
Self- Assesment of Health Professionals’ Communication Skills with Patients
|
Jocic, D.
|
|
2013
|
16 |
7 |
p. A478-
1 p.
|
artikel
|
| 1700 |
Self-Monitoring of Blood Glucose with Insulin Analogues: Nice to Have or Need to Have? Analysis of Phase III Registration Trials and European Public Assessment Reports of Insulin Analogues
|
Caruso, A.
|
|
2013
|
16 |
7 |
p. A450-
1 p.
|
artikel
|
| 1701 |
Self-Reported Health Status and EQ-5D-3L Values of the Argentine Population: Comparing 2005 Versus 2009 National Risk Factor Surveys
|
Augustovski, F.
|
|
2013
|
16 |
7 |
p. A671-
1 p.
|
artikel
|
| 1702 |
Self-Reported Population Health: An International Perspective Based on EQ-5D
|
Szende, A.
|
|
2013
|
16 |
7 |
p. A464-
1 p.
|
artikel
|
| 1703 |
Serious Adverse Events for Biologic Response Modifiers Indicated for the Prophylaxis Against Transplant Rejection. an Insight from Spontaneous Adverse Event Reporting System
|
Ali, A.K.
|
|
2013
|
16 |
7 |
p. A677-
1 p.
|
artikel
|
| 1704 |
Short and Long-Term Cost-Effectiveness of Switching Therapy from Insulin Glargine to Insulin Detemir in People with Type 2 Diabetes
|
Malek, R.
|
|
2013
|
16 |
7 |
p. A690-
1 p.
|
artikel
|
| 1705 |
Short and Long-Term Cost-Effectiveness of Switching Therapy from NPH Insulin to Insulin Detemir in People with Type 2 Diabetes
|
Home, P.D.
|
|
2013
|
16 |
7 |
p. A690-
1 p.
|
artikel
|
| 1706 |
Short Run Dynamics of Inadequate Pain Relief (IPR): Evidence from a European Multinational Survey of Real World Therapies (SORT)
|
Mavros, P.
|
|
2013
|
16 |
7 |
p. A569-
1 p.
|
artikel
|
| 1707 |
Short-Term Disability (STD) Associated with Skeletal Related Events (SRES) in Commercially Insured Patients with Bone Metastases (BM) Secondary to Solid Tumors
|
Qian, Y.
|
|
2013
|
16 |
7 |
p. A417-
1 p.
|
artikel
|
| 1708 |
Should There Be an Option to “Unrefer” Nice Single Technology Appraisals: Case Study of Aripiprazole for Bipolar I Disorder in Adolescents
|
Uttley, L.
|
|
2013
|
16 |
7 |
p. A615-A616
nvt p.
|
artikel
|
| 1709 |
Side-Effects of Antiepileptic Drugs: The Economic Burden
|
de Kinderen, R.J.A.
|
|
2013
|
16 |
7 |
p. A622-
1 p.
|
artikel
|
| 1710 |
Similarities and Differences Across Same Language Questionnaires for Different Countries: Linguistic Validation of the Asthma Symptom Diary (ASD) and Kidney Disease and Quality of Life (KD-QOL-36)
|
Neewoor, S.
|
|
2013
|
16 |
7 |
p. A603-
1 p.
|
artikel
|
| 1711 |
Simulated Treatment Comparisons – An Alternative Approach to Indirect Comparison When Standard Methods Are Not Feasible or Appropriate
|
Ishak, K.J.
|
|
2013
|
16 |
7 |
p. A615-
1 p.
|
artikel
|
| 1712 |
Simulating Patient Populations – Difficulties in Controlling the Roll of the Dice
|
Teljeur, C.
|
|
2013
|
16 |
7 |
p. A586-
1 p.
|
artikel
|
| 1713 |
Simulating the Potential Impact of Improved Blood Pressure Control on Clinical and Economic Outcomes in Russia
|
Kontsevaya, A.
|
|
2013
|
16 |
7 |
p. A539-
1 p.
|
artikel
|
| 1714 |
Single Use Devices in Argentina: Economic Evaluation of a “Reuse” Versus a “Single Use” Policy
|
Garay, O.U.
|
|
2013
|
16 |
7 |
p. A677-
1 p.
|
artikel
|
| 1715 |
Skeletal-Related Events Have a Significant Impact on Health-Related Quality of Life in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC) Following Docetaxel Therapy Failure
|
Ivanescu, C.
|
|
2013
|
16 |
7 |
p. A392-
1 p.
|
artikel
|
| 1716 |
Small Molecule Targeted Therapies for the Second Line Treatment of Metastatic Renal Cell Carcinoma (mRCC): A Systematic Review and Indirect Comparison of Safety and Efficacy
|
Dranitsaris, G.
|
|
2013
|
16 |
7 |
p. A394-
1 p.
|
artikel
|
| 1717 |
Social Network Analysis of Authorship Networks and the Identification of Expert Advisors
|
Stoddart, S.D.R.
|
|
2013
|
16 |
7 |
p. A614-
1 p.
|
artikel
|
| 1718 |
Societal Burden of Hysterectomy in Reproductive-Aged Women with Uterine Fibroids
|
Vámossy, I.
|
|
2013
|
16 |
7 |
p. A339-
1 p.
|
artikel
|
| 1719 |
Societal Unmet Needs in Brazil: Examining Prevalence, Treatment Rates, and Health Outcomes
|
de Renteria, J.
|
|
2013
|
16 |
7 |
p. A676-
1 p.
|
artikel
|
| 1720 |
Socio-Economic Impact of Alzheimer’s Disease in Greece: Pilot Study
|
Kaitelidou, D.
|
|
2013
|
16 |
7 |
p. A545-
1 p.
|
artikel
|
| 1721 |
Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Glimepiride (GLIM) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting
|
Girod, I.
|
|
2013
|
16 |
7 |
p. A441-A442
nvt p.
|
artikel
|
| 1722 |
Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Sitagliptin (SITA) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting
|
Willis, M.
|
|
2013
|
16 |
7 |
p. A440-A441
nvt p.
|
artikel
|
| 1723 |
Specific Attributes of Pharmaceutical Care in England, Poland, Germany, Denmark, Italy and United States
|
Hermanowski, T.R.
|
|
2013
|
16 |
7 |
p. A463-
1 p.
|
artikel
|
| 1724 |
Spectacle Independence and Vision-Related Quality of Life in Cataract Surgery Patients Following Implantation of a Multifocal Intraocular Lens
|
Samiian, A.
|
|
2013
|
16 |
7 |
p. A503-A504
nvt p.
|
artikel
|
| 1725 |
Squaring the Circle: Innovative Contracting to Achieve Market Access for Innovative Products
|
Street-Docherty, L.M.
|
|
2013
|
16 |
7 |
p. A488-
1 p.
|
artikel
|
| 1726 |
Stage-Based Utilization of Chemotherapy Agents in a Canadian Breast Cancer Population
|
Mittmann, N.
|
|
2013
|
16 |
7 |
p. A426-
1 p.
|
artikel
|
| 1727 |
Standardized Tool for Measurement of Health Services Costs and Utilization in a Sample with Mental Disorders: Translation, Cultural Adaptation and Interrater Reliability of the Client Sociodemografic and Service Receipt Inventory Brazilian Version
|
Sousa, A.
|
|
2013
|
16 |
7 |
p. A696-
1 p.
|
artikel
|
| 1728 |
Statin Cost-Effectiveness in Patients with Previous Coronary Heart Disease: A Systematic Review of the Cost-Effectiveness Analysis Derived from Single Randomised Clinical Trials
|
Luque, A.
|
|
2013
|
16 |
7 |
p. A529-
1 p.
|
artikel
|
| 1729 |
Statins in Canada: The Case for Disinvestment
|
Richter, T.
|
|
2013
|
16 |
7 |
p. A539-
1 p.
|
artikel
|
| 1730 |
StratafixTM Knotless Tissue Control Device: A Budget Impact Analysis from Italian Health Service Perspective
|
Perrone, F.
|
|
2013
|
16 |
7 |
p. A559-
1 p.
|
artikel
|
| 1731 |
Stroke Prevention in Non-Valvular Atrial Fibrillation: Systematic Review of Cost-Effectiveness Studies
|
Costa, S.
|
|
2013
|
16 |
7 |
p. A531-
1 p.
|
artikel
|
| 1732 |
Structural Failure Time Modeling of Overall Survival Effects in Oncology Trials with Subsequent Therapies
|
Jonsson, L.
|
|
2013
|
16 |
7 |
p. A611-
1 p.
|
artikel
|
| 1733 |
Structural Validation of the Chronic Venous Insufficiency Quality of Life Questionnaire-14 (CIVIQ-14) : A Confirmatory Factor Analysis
|
Le Moine, J.G.
|
|
2013
|
16 |
7 |
p. A598-
1 p.
|
artikel
|
| 1734 |
Structural Validity of a 14-Item Abridged Version of the Menopause Cervantes Health-Related-Quality-Of-Life Scale
|
Coronado, P.
|
|
2013
|
16 |
7 |
p. A338-
1 p.
|
artikel
|
| 1735 |
Study and Evaluation of Medication Errors in Diabetic Patients in Medicine Ward of a Secondary Care Community Hospital at Mumbai, India
|
Lokhande, A.K.
|
|
2013
|
16 |
7 |
p. A434-
1 p.
|
artikel
|
| 1736 |
Study of Antibiotic Consumption Pattern in Hospital Acquired Pneumonia
|
Kunhikatta, V.
|
|
2013
|
16 |
7 |
p. A346-
1 p.
|
artikel
|
| 1737 |
Study of Quality of Life and Costs for CML Patients in Bulgaria
|
Kamusheva, M.
|
|
2013
|
16 |
7 |
p. A388-
1 p.
|
artikel
|
| 1738 |
Study of Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Symptom Assessment Differences Between Patients and Family Members
|
Fernández-Lahera, J.
|
|
2013
|
16 |
7 |
p. A375-
1 p.
|
artikel
|
| 1739 |
Supplementary Health Insurance in Turkey
|
Deger, C.C.
|
|
2013
|
16 |
7 |
p. A454-
1 p.
|
artikel
|
| 1740 |
Survey Design in the Assessment of the Implementation of Risk Minimisation Measures for Medicinal Products
|
Prieto, L.
|
|
2013
|
16 |
7 |
p. A618-
1 p.
|
artikel
|
| 1741 |
Survival Analysis Used in Company Submissions to the National Centre for Pharmacoeconomics, Ireland
|
McCullagh, L.
|
|
2013
|
16 |
7 |
p. A398-
1 p.
|
artikel
|
| 1742 |
Survival Analysis with Covariates in Combination with Multinomial Analysis to Parametrize Time to Event for Multi-State Models
|
Feenstra, T.L.
|
|
2013
|
16 |
7 |
p. A593-
1 p.
|
artikel
|
| 1743 |
Sustained Improvements in Productivity at Paid Work and Within Household, and Increased Participation in Daily Activities Over Time with Certolizumab Pegol in Patients with Psoriatic Arthritis: 48-Week Results from the Rapid-PsA Study
|
Kavanaugh, A.
|
|
2013
|
16 |
7 |
p. A570-
1 p.
|
artikel
|
| 1744 |
Symptoms of COPD in Urban Russia Among Adults 40 Years and Older
|
Vietri, J.
|
|
2013
|
16 |
7 |
p. A375-
1 p.
|
artikel
|
| 1745 |
Systematic Literature Review and Cost-effectiveness Analysis of Fetal Fibronectin Test for Predicting Preterm in Brazil
|
Decimoni, T.C.
|
|
2013
|
16 |
7 |
p. A333-A334
nvt p.
|
artikel
|
| 1746 |
Systematic Literature Review and Validity Evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in Patients with Multiple Sclerosis
|
Meyer-Moock, S.
|
|
2013
|
16 |
7 |
p. A576-
1 p.
|
artikel
|
| 1747 |
Systematic Literature Review in Moderate to Severe Ulcerative Colitis
|
Huisman, E.
|
|
2013
|
16 |
7 |
p. A500-A501
nvt p.
|
artikel
|
| 1748 |
Systematic Literature Review of Economic Burden of Chronic Plaque Psoriasis
|
Feldman, S.R.
|
|
2013
|
16 |
7 |
p. A504-
1 p.
|
artikel
|
| 1749 |
Systematic Literature Reviews at the Heart of Health Technology Assessment: A Comparison Across Markets
|
Rycroft, C.E.
|
|
2013
|
16 |
7 |
p. A481-
1 p.
|
artikel
|
| 1750 |
Systematic Review Approaches for HTA: Horses for Courses?
|
Kenworthy, J.
|
|
2013
|
16 |
7 |
p. A614-A615
nvt p.
|
artikel
|
| 1751 |
Systematic Review Comparing the Efficacy and Safety of Collagenase Clostridium Histolyticum (Xiaflex®) Injection with Surgical Fasciectomy for the Treatment of Dupuytren’s Contracture
|
Sugden, P.
|
|
2013
|
16 |
7 |
p. A556-
1 p.
|
artikel
|
| 1752 |
Systematic Review of Colistimethate Sodium Dry Powder and Tobramycin Dry Powder Antibiotics for Pseudomonas Aeruginosa Lung Infection in Cystic Fibrosis
|
Harnan, S.E.
|
|
2013
|
16 |
7 |
p. A367-
1 p.
|
artikel
|
| 1753 |
Systematic Review of Patient Reported Outcomes in Chronic Myeloid Leukemia
|
Aggarwal, S.
|
|
2013
|
16 |
7 |
p. A420-A421
nvt p.
|
artikel
|
| 1754 |
Systematic Review on the Cost-Effectiveness of Therapeutic Education to Prevent the Development and Progression of Type 2 Diabetes
|
Odnoletkova, I.
|
|
2013
|
16 |
7 |
p. A452-
1 p.
|
artikel
|
| 1755 |
Systematic Review on the Impacts of Strict Pharmaceutical Price Controls
|
Relakis, J.
|
|
2013
|
16 |
7 |
p. A486-
1 p.
|
artikel
|
| 1756 |
Systematic Review on Use of Economic Evidence by Clinical Guidelines
|
Aggarwal, S.
|
|
2013
|
16 |
7 |
p. A485-A486
nvt p.
|
artikel
|
| 1757 |
Systematic Review: The Economic Burden of Crohn’s Disease in Europe in Adults and Children
|
Floyd, D.
|
|
2013
|
16 |
7 |
p. A496-
1 p.
|
artikel
|
| 1758 |
Table of Contents
|
|
|
2013
|
16 |
7 |
p. i-iv
nvt p.
|
artikel
|
| 1759 |
Targeted Therapy in Triple-Negative Metastatic Breast Cancer (TNBC) - A Systematic Review and Meta-Analysis
|
Clark, O.A.C.
|
|
2013
|
16 |
7 |
p. A394-
1 p.
|
artikel
|
| 1760 |
Tecepoc Study. How to Improve the Inhalation Techniques in Patient with COPD. The Influence of Preferences
|
Leiva-Fernandez, F.
|
|
2013
|
16 |
7 |
p. A374-
1 p.
|
artikel
|
| 1761 |
Technical Errors in Cost-Effectiveness Models: Evidence from the Single Technology Appraisal Programme in England and Wales
|
Trueman, D.
|
|
2013
|
16 |
7 |
p. A592-
1 p.
|
artikel
|
| 1762 |
Telemonitoring After Discharge from Hospital with Heart Failure – Cost-Effectiveness Modelling of Alternative Service Designs
|
Thokala, P.
|
|
2013
|
16 |
7 |
p. A530-
1 p.
|
artikel
|
| 1763 |
Telling the Inside Story: Activity and Performance Metrics for a Typical International Multi-Language Multi-Center Non-Interventional Study with the Intrial Data Capature System
|
Eichmann, F.
|
|
2013
|
16 |
7 |
p. A585-
1 p.
|
artikel
|
| 1764 |
Testing the Eunethta Internal Validity of Randomized Controlled Trials Guideline and Tool in Hungary
|
Huszti, Z.
|
|
2013
|
16 |
7 |
p. A575-
1 p.
|
artikel
|
| 1765 |
The Adoption of Health Technologies: A Survey of Brazilian Policy Makers
|
Elias, F.T.S.
|
|
2013
|
16 |
7 |
p. A485-
1 p.
|
artikel
|
| 1766 |
The Affordability of Oncology and HIV/AIDS Technologies in Brazil Compared to the United States and Other OECD Countries
|
Zueger, P.
|
|
2013
|
16 |
7 |
p. A684-
1 p.
|
artikel
|
| 1767 |
The Analysis of Costs and Reimbursements for Lung Cancer Treatment in the Czech Republic
|
Rogalewicz, V.
|
|
2013
|
16 |
7 |
p. A407-
1 p.
|
artikel
|
| 1768 |
The Annual Treatment and Rehabillitation Costs of Patients with Paraplegia in the Private Health Care Setting in Greece
|
Tzovolou, K.
|
|
2013
|
16 |
7 |
p. A621-A622
nvt p.
|
artikel
|
| 1769 |
The Association Between Adherence to Antiretroviral Therapy and Economic Outcomes Among Commercially Insured and Medicaid HIV Patients in the United States
|
Korsnes, J.S.
|
|
2013
|
16 |
7 |
p. A348-A349
nvt p.
|
artikel
|
| 1770 |
The Association Between European Medicines Agency Approval and Health Technology Assessment Recommendation
|
Lipska, I.
|
|
2013
|
16 |
7 |
p. A455-
1 p.
|
artikel
|
| 1771 |
The Association Between Severity of ‘Average’ Pain (NPRS) and the EQ-5D Index in Patients with Neuropathic Pain
|
Chambers, C.
|
|
2013
|
16 |
7 |
p. A386-
1 p.
|
artikel
|
| 1772 |
The Attendance of the Fourth Screening Round (2008-2009) of the Hungarian Organized, Nationwide Breast Cancer Screening Program
|
Boncz, I.
|
|
2013
|
16 |
7 |
p. A396-
1 p.
|
artikel
|
| 1773 |
The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany
|
Sroczynski, G.
|
|
2013
|
16 |
7 |
p. A574-A575
nvt p.
|
artikel
|
| 1774 |
The Budget Impact Analysis of Deferasirox for the Treatment of Iron Overload Due to Frequent Blood Transfusions in Children and Adolescents (Age ≤18 Years)
|
Walczak, J.
|
|
2013
|
16 |
7 |
p. A379-
1 p.
|
artikel
|
| 1775 |
The Budget Impact of Introducing Bg-12 (Dimethyl Fumarate) for Treatment of Relapse-Remitting Multiple Sclerosis (RRMS) in Canada
|
Dorman, E.
|
|
2013
|
16 |
7 |
p. A620-
1 p.
|
artikel
|
| 1776 |
The Budget Impact of Introducing Ranibizumab in England and Wales for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
|
Malcolm, W.A.
|
|
2013
|
16 |
7 |
p. A503-
1 p.
|
artikel
|
| 1777 |
The Budget Impact of Qutenza® for the Treatment of Neuropathic Pain in Sweden
|
Chambers, C.
|
|
2013
|
16 |
7 |
p. A379-
1 p.
|
artikel
|
| 1778 |
The Burden Imposed by Atopic Dermatitis on Families: Creation of a Specific Questionnaire
|
Taieb, C.
|
|
2013
|
16 |
7 |
p. A508-A509
nvt p.
|
artikel
|
| 1779 |
The Burden of Caregiving in Cancer: The Status of Clinical Research
|
Foster, R.E.
|
|
2013
|
16 |
7 |
p. A324-
1 p.
|
artikel
|
| 1780 |
The Burden of Clostridium Difficile in Spain: A Retrospective Matched-Cohort Study
|
Hart, W.M.
|
|
2013
|
16 |
7 |
p. A349-
1 p.
|
artikel
|
| 1781 |
The Burden of Disease Attributable to Physical Inactivity in the Austrian Region of Burgenland
|
Walter, E.
|
|
2013
|
16 |
7 |
p. A465-
1 p.
|
artikel
|
| 1782 |
The Burden of Illness of Chronic Thromboembolic Pulmonary Hypertension: A Managed Care Perspective in the United States
|
Joish, V.N.
|
|
2013
|
16 |
7 |
p. A521-
1 p.
|
artikel
|
| 1783 |
The Burden of Illness of Pulmonary Arterial Hypertension: A Managed Care Perspective in the United States
|
Joish, V.N.
|
|
2013
|
16 |
7 |
p. A521-
1 p.
|
artikel
|
| 1784 |
The Burden of Pneumonia in Malaysia, Indonesia and Philippines
|
Aljunid, S.
|
|
2013
|
16 |
7 |
p. A369-
1 p.
|
artikel
|
| 1785 |
The Burden of Resistant Hypertension in 5 European Countries
|
Sapoval, M.
|
|
2013
|
16 |
7 |
p. A520-A521
nvt p.
|
artikel
|
| 1786 |
The Burden of Treatment Change in Major Depressive Disorder: Comparison of Switch Versus Non-Switch Patients in the Perform Study
|
Boulenger, J.P.
|
|
2013
|
16 |
7 |
p. A543-
1 p.
|
artikel
|
| 1787 |
The Burden of Untreated Patients Experiencing Symptoms of Overactive Bladder
|
Pedersini, R.
|
|
2013
|
16 |
7 |
p. A635-
1 p.
|
artikel
|
| 1788 |
The Cost-Effectiveness and Cost-Utility of Paliperidone Palmitate in the Treatment of Schizophrenia in Guatemala
|
Obando, C.A.
|
|
2013
|
16 |
7 |
p. A695-
1 p.
|
artikel
|
| 1789 |
The Cost-Effectiveness of Apixaban Compared to Warfarin, Aspirin, Rivaroxaban and Dabigatran in Ireland
|
Kelly, J.
|
|
2013
|
16 |
7 |
p. A529-
1 p.
|
artikel
|
| 1790 |
The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in Colombia
|
Bertwistle, D.
|
|
2013
|
16 |
7 |
p. A408-
1 p.
|
artikel
|
| 1791 |
The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in Mexico
|
Bertwistle, D.
|
|
2013
|
16 |
7 |
p. A411-
1 p.
|
artikel
|
| 1792 |
The Cost-Effectiveness of Bendamustine Versus Fludarabine for the First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Mexico
|
Bertwistle, D.
|
|
2013
|
16 |
7 |
p. A409-
1 p.
|
artikel
|
| 1793 |
The Cost Effectiveness of BG-12 (Dimethyl Fumarate) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada
|
Su, W.
|
|
2013
|
16 |
7 |
p. A623-
1 p.
|
artikel
|
| 1794 |
The Cost-Effectiveness of Bimatoprost 0.03%/Timolol 0.05% Preservative-Free Fixed Combination Compared with Dorzolamide/Timolol Preservative-Free Fixed Combination and 2-Bottle Unfixed Combinations for the Treatment of Primary Open-Angle Glaucoma in the United Kingdom
|
Hirst, A.
|
|
2013
|
16 |
7 |
p. A506-A507
nvt p.
|
artikel
|
| 1795 |
The Cost-Effectiveness of Catheter Ablation as First-Line Treatment
|
Aronsson, M.
|
|
2013
|
16 |
7 |
p. A529-
1 p.
|
artikel
|
| 1796 |
The Cost-Effectiveness of Dabigatran and the Opportunity Cost of Delayed Subsidised Access in Australia
|
Tilden, D.
|
|
2013
|
16 |
7 |
p. A526-A527
nvt p.
|
artikel
|
| 1797 |
The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus a DPP-4 Inhibitor in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales
|
Charokopou, M.
|
|
2013
|
16 |
7 |
p. A440-
1 p.
|
artikel
|
| 1798 |
The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Glipizide in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales
|
Charokopou, M.
|
|
2013
|
16 |
7 |
p. A441-
1 p.
|
artikel
|
| 1799 |
The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Insulin in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales
|
Charokopou, M.
|
|
2013
|
16 |
7 |
p. A441-
1 p.
|
artikel
|
| 1800 |
The Cost-Effectiveness of Dry Powder Antibiotics for the Treatment of Pseudomonas Aeruginosa in Patients with Cystic Fibrosis
|
Tappenden, P.
|
|
2013
|
16 |
7 |
p. A372-
1 p.
|
artikel
|
| 1801 |
The Cost-Effectiveness of Intravitreal Aflibercept (IVT-AFL) in Treating Neovascular Age-Related Macular Degeneration in an Italian Setting
|
D’Ausilio, A.
|
|
2013
|
16 |
7 |
p. A505-
1 p.
|
artikel
|
| 1802 |
The Cost Effectiveness of Peginterferon Alfa and Ribavirin for the Treatment of Hepatitis C in Children and Young People
|
Cooper, K.
|
|
2013
|
16 |
7 |
p. A499-
1 p.
|
artikel
|
| 1803 |
The Cost-Effectiveness of Periodic Safety Update Reports (PSURS) for Biologicals in Europe
|
Bouvy, J.
|
|
2013
|
16 |
7 |
p. A487-
1 p.
|
artikel
|
| 1804 |
The Cost-Effectiveness of Screening for Silent Atrial Fibrillation After Ischaemic Stroke
|
Levin, L.Å
|
|
2013
|
16 |
7 |
p. A527-
1 p.
|
artikel
|
| 1805 |
The Cost-Effectiveness of Sequential First- and Second-Line Treatments in Metastatic Renal Cell Carcinoma Using Real-World Data and a Patient-Level Simulation Model
|
de Groot, S.
|
|
2013
|
16 |
7 |
p. A587-
1 p.
|
artikel
|
| 1806 |
The Cost Implications of Renal Denervation Therapy at the Hospital Level in the United Kingdom
|
Smith, T.A.
|
|
2013
|
16 |
7 |
p. A633-
1 p.
|
artikel
|
| 1807 |
The Cost of Clostridium Difficile Infection in Hungary
|
Strbak, B.
|
|
2013
|
16 |
7 |
p. A348-
1 p.
|
artikel
|
| 1808 |
The Cost of NSCLC in France
|
Martin, M.
|
|
2013
|
16 |
7 |
p. A404-
1 p.
|
artikel
|
| 1809 |
The Cost of Osteoporotic Fractures in the Romanian Postmenopausal Women Population
|
Mihalache, M.
|
|
2013
|
16 |
7 |
p. A560-
1 p.
|
artikel
|
| 1810 |
The Cost of Producing a Unit of Blood in Hospitals: A Nationwide Economic Analysis for the Case of Greece
|
Fragoulakis, V.
|
|
2013
|
16 |
7 |
p. A384-
1 p.
|
artikel
|
| 1811 |
The Cost of Specialized Hospital Care for Patients with Diabetic Foot Ulcers in Russia
|
Ignatyeva, V.
|
|
2013
|
16 |
7 |
p. A444-
1 p.
|
artikel
|
| 1812 |
The Cost of Stopping (Futility) Rules Telaprevir and Boceprevir in the Treatment of Genotype 1 Hepatitis C Patients in Brazil
|
Morais, A.D.
|
|
2013
|
16 |
7 |
p. A345-
1 p.
|
artikel
|
| 1813 |
The Cost of Treating Squamous Cell Carcinoma of the Anus (SCCA) in England: Results from an Empirically Calibrated Model
|
Keeping, S.T.
|
|
2013
|
16 |
7 |
p. A406-
1 p.
|
artikel
|
| 1814 |
The Cost Saving Potential of Utilizing Biosimilar Medicines in Biologic Naive Severe Rheumatoid Arthritis Patients
|
Whitehouse, J.
|
|
2013
|
16 |
7 |
p. A573-
1 p.
|
artikel
|
| 1815 |
The Costs of Managing Genital Warts in the UK by Devolved Nation: England, Scotland, Wales and Northern Ireland
|
Chapman, R.
|
|
2013
|
16 |
7 |
p. A350-
1 p.
|
artikel
|
| 1816 |
The Costs of Surgical Aortic Valve Replacement in France
|
Goodall, G.
|
|
2013
|
16 |
7 |
p. A522-
1 p.
|
artikel
|
| 1817 |
The Cost-Utility of Catheter-Based Renal Denervation as Compared to Current Standard of Care for Resistant Hypertension in Belgium
|
Jugrin, A.V.
|
|
2013
|
16 |
7 |
p. A527-A528
nvt p.
|
artikel
|
| 1818 |
The Cost-Utility of Fidaxomicin as Compared to Current Standard Treatment in the Management of Clostridium Difficile Infections in Belgium
|
Lamotte, M.
|
|
2013
|
16 |
7 |
p. A498-
1 p.
|
artikel
|
| 1819 |
The Cost-Utility of Insulin Degludec Compared with Current Standard of Care in the Management of Type One and Type Two Diabetes Mellitus in Belgium
|
Jugrin, A.V.
|
|
2013
|
16 |
7 |
p. A442-A443
nvt p.
|
artikel
|
| 1820 |
The Current Management and Costs of Irritable Bowel Syndrome with Constipation in Belgium: A 2-Round Expert Survey
|
Caekelbergh, K.
|
|
2013
|
16 |
7 |
p. A499-
1 p.
|
artikel
|
| 1821 |
The Determinants of Innovation – A Brief Study of Issues Influencing Innovation in the Pharmaceutical Industry
|
Ghouse, R.
|
|
2013
|
16 |
7 |
p. A594-
1 p.
|
artikel
|
| 1822 |
The Development and Validation of a Quality of Life Measure for People with Mild Cognitive Impairment (The MCQ)
|
Dean, K.
|
|
2013
|
16 |
7 |
p. A550-
1 p.
|
artikel
|
| 1823 |
The Diabetic Peripheral Neuropathic Pain Impact (DPNPI) Measure – Psychometric Validation of a New Patient Reported Outcome Measure
|
Brod, M.
|
|
2013
|
16 |
7 |
p. A446-
1 p.
|
artikel
|
| 1824 |
The Direct Costs of Drug-Induced Skin Reactions in Poland
|
Wisniewska, N.
|
|
2013
|
16 |
7 |
p. A696-
1 p.
|
artikel
|
| 1825 |
The Disease Burden of Influenza in Germany
|
Ehlken, B.
|
|
2013
|
16 |
7 |
p. A365-
1 p.
|
artikel
|
| 1826 |
The 3D O-Arm Surgical Imaging System with Navigation Effectively and Economically Addresses the Challenges of Spinal Stabilization Procedures
|
Annoni, E.
|
|
2013
|
16 |
7 |
p. A556-
1 p.
|
artikel
|
| 1827 |
The Ecology of Medical Care in Poor Settings: Self Reported Health Care Utilization in Santiago Del Estero, Argentina
|
Insua, J.T.
|
|
2013
|
16 |
7 |
p. A678-
1 p.
|
artikel
|
| 1828 |
The Economic Assessment of an Environmental Intervention: Discrete Deployment of Copper for Infection Control in ICUs
|
Taylor, M.
|
|
2013
|
16 |
7 |
p. A353-
1 p.
|
artikel
|
| 1829 |
The Economic Footprint of the Greek Pharmaceutical Industry
|
Tserkezis, E.
|
|
2013
|
16 |
7 |
p. A580-A581
nvt p.
|
artikel
|
| 1830 |
The Economics of Reproduction: How ‘Primacy of Succession’ Has Influenced Acceptance and Provision of Assisted Fertility Treatments Throughout History
|
Jones, C.
|
|
2013
|
16 |
7 |
p. A682-
1 p.
|
artikel
|
| 1831 |
The Effectiveness of Statins in the Treatment of Cardiovascular Disease: Cross-Sectional Study with Paired Groups from Electronic Patient Records
|
Abrahão, M.T.
|
|
2013
|
16 |
7 |
p. A518-
1 p.
|
artikel
|
| 1832 |
The Effect of Medical Devices with Dose-Memory and Reminder Functions on Patients’ Treatment Adherence, Confidence and Disease Self-management
|
Hall, R.
|
|
2013
|
16 |
7 |
p. A336-
1 p.
|
artikel
|
| 1833 |
The Effect of Positive Margins on Outcomes in Breast Cancer
|
Ling, C.S.
|
|
2013
|
16 |
7 |
p. A394-
1 p.
|
artikel
|
| 1834 |
The Effect of Reduced or Removed Copayments for Prescription Medicines on Adherence – A Systematic Review
|
Sinnott, S.J.
|
|
2013
|
16 |
7 |
p. A461-
1 p.
|
artikel
|
| 1835 |
The Efficacy of the Extra Front Loading Smoking Cessation Counselling Sessions on the Abstinence Rate Compared with Usual Care Used in Quit Smoking Clinic in Penang, Malaysia
|
Blebil, A.Q.
|
|
2013
|
16 |
7 |
p. A366-
1 p.
|
artikel
|
| 1836 |
The Efficiency of Preoperative Physiotherapy in Patients with Chronic Obstructive Pulmonary Disease Undergoing Open Heart Surgery
|
Sió, E.
|
|
2013
|
16 |
7 |
p. A366-
1 p.
|
artikel
|
| 1837 |
The E-Health Impact Questionnaire: Developing a Tool to Measure the Effects of Using Health-Related Websites
|
Kelly, L.
|
|
2013
|
16 |
7 |
p. A605-
1 p.
|
artikel
|
| 1838 |
The Estimated Survival of Patients with Double Refractory Chronic Lymphocytic Leukaemia; A Reanalysis of NICE TA202 Using Bayesian Methodology to Model Observed Data
|
Almond, C.
|
|
2013
|
16 |
7 |
p. A397-
1 p.
|
artikel
|
| 1839 |
The Expanding Scope of Comparative Effectiveness Reviews Requires Collaborative Information Systems Solutions
|
van Valkenhoef, G.
|
|
2013
|
16 |
7 |
p. A492-
1 p.
|
artikel
|
| 1840 |
The Expected Health Economic Value of Using Circulating Tumor Cells to Personalize Cancer Treatment
|
Schreuder, K.
|
|
2013
|
16 |
7 |
p. A424-
1 p.
|
artikel
|
| 1841 |
The Financial Impact of Increasing Home-Based High Dose Haemodialysis and Peritoneal Dialysis
|
Liu, F.X.
|
|
2013
|
16 |
7 |
p. A631-
1 p.
|
artikel
|
| 1842 |
The First Experiences with Reassessments and Appraisals of Conditionally Approved Expensive and Orphan Drugs in the Netherlands (2006-2013)
|
van der Meijden, C.M.J.
|
|
2013
|
16 |
7 |
p. A376-
1 p.
|
artikel
|
| 1843 |
The Framework for Health Economic Modeling and Multi-Criteria Decision Analysis (MCDA) on the Example of the Mobile Stroke Unit (MSU)
|
Wahlster, P.
|
|
2013
|
16 |
7 |
p. A489-A490
nvt p.
|
artikel
|
| 1844 |
The French Public Health Care System: An Original Way for Cost Saving
|
Karouby, D.
|
|
2013
|
16 |
7 |
p. A400-
1 p.
|
artikel
|
| 1845 |
The Funding of Orphan Medicines in Europe: Payers Achilles’ Heel?
|
Rietveld, A.
|
|
2013
|
16 |
7 |
p. A490-
1 p.
|
artikel
|
| 1846 |
The Future of Individual Funding Requests in Clinical Commissioning Groups Era
|
Chaudhari, S.D.
|
|
2013
|
16 |
7 |
p. A472-
1 p.
|
artikel
|
| 1847 |
The Geographic Correlation Between Lyme Disease Incidence and Degenerative Neurological Disease Mortality: An Ecological Study
|
Veley, K.M.
|
|
2013
|
16 |
7 |
p. A340-A341
nvt p.
|
artikel
|
| 1848 |
The German Quota System as a Model for Biosimilar Cost Savings in Epoetin Treatment
|
Walsh, K.
|
|
2013
|
16 |
7 |
p. A427-
1 p.
|
artikel
|
| 1849 |
The Global Burden, Incidence, and Prevalence of Chronic Hepatitis C
|
Ainsworth, C.M.
|
|
2013
|
16 |
7 |
p. A342-
1 p.
|
artikel
|
| 1850 |
The Growing Role of Qualitative Interviews in Health Outcomes Research
|
Guillemot, J.
|
|
2013
|
16 |
7 |
p. A325-
1 p.
|
artikel
|
| 1851 |
The Health and Economic Effects on Public Health Due to Patients’ Default in Tuberculosis Treatment in Malaysia
|
Fun, W.H
|
|
2013
|
16 |
7 |
p. A365-
1 p.
|
artikel
|
| 1852 |
The Health and Economic Impact of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) in Columbia: A Transmission Dynamic Model-Based Evaluation
|
Kothari, S.
|
|
2013
|
16 |
7 |
p. A713-A714
nvt p.
|
artikel
|
| 1853 |
The Health of Health Technology Assessment in Ireland: Five Points for Improvement
|
O’Mahony, J.
|
|
2013
|
16 |
7 |
p. A488-
1 p.
|
artikel
|
| 1854 |
The Humanistic and Economic Burden of Venous Thromboembolism in Cancer Patients: A Systematic Review
|
Kourlaba, G.
|
|
2013
|
16 |
7 |
p. A403-A404
nvt p.
|
artikel
|
| 1855 |
The Humanistic and Economic Burden of Venous Thromboembolism in Pregnant Women: A Systematic Review
|
Kourlaba, G.
|
|
2013
|
16 |
7 |
p. A517-
1 p.
|
artikel
|
| 1856 |
The Hybrid Purchaser-Provider Split in England: Should Europe Follow Suit?
|
Sewak, N.P.S.
|
|
2013
|
16 |
7 |
p. A462-
1 p.
|
artikel
|
| 1857 |
The Impact of Amnog on Drug Reimbursement in Germany
|
Heeg, B.
|
|
2013
|
16 |
7 |
p. A459-
1 p.
|
artikel
|
| 1858 |
The Impact of Amnog on Oncology Drugs
|
Walker, S.
|
|
2013
|
16 |
7 |
p. A424-
1 p.
|
artikel
|
| 1859 |
The Impact of Antipsychotics Polypharmacy on Health Care Costs of People with Mental Disorders in São Paulo City, Brazil
|
Razzouk, D.
|
|
2013
|
16 |
7 |
p. A694-A695
nvt p.
|
artikel
|
| 1860 |
The Impact of Chlamydia and Gonorrhoea Point of Care Nucleic Acid Amplification Tests on Clinical Pathways and Costs in Genito-Urinary Medicine Clinics in the United Kingdom
|
Adams, E.J.
|
|
2013
|
16 |
7 |
p. A346-
1 p.
|
artikel
|
| 1861 |
The Impact of Commodities and Extra-Articular Manifestations in Rheumatoid Arthritis Patients
|
Doddapaneni, S.
|
|
2013
|
16 |
7 |
p. A554-A555
nvt p.
|
artikel
|
| 1862 |
The Impact of Comorbidities on Utility Changes in Lower-Limb Osteoarthritis : Khoala Study
|
Hosseini, K.
|
|
2013
|
16 |
7 |
p. A554-
1 p.
|
artikel
|
| 1863 |
The Impact of Cost Effectiveness on Reimbursement Approvals in France: A Comparison of France and the United Kingdom
|
Purchase, J.L.
|
|
2013
|
16 |
7 |
p. A484-
1 p.
|
artikel
|
| 1864 |
The Impact of Daytime and Nocturnal Non-Severe Hypoglycaemic Events on People with Diabetes in Brazil
|
Fraige Filho, F.
|
|
2013
|
16 |
7 |
p. A449-
1 p.
|
artikel
|
| 1865 |
The Impact of DSM-5 on the Development of Drugs to Treat Attention-Deficit/Hyperactivity Disorder
|
Meyers, O.I.
|
|
2013
|
16 |
7 |
p. A607-A608
nvt p.
|
artikel
|
| 1866 |
The Impact of DSM-5 on the Development of Drugs to Treat Autism Spectrum Disorder
|
Meyers, O.I.
|
|
2013
|
16 |
7 |
p. A607-
1 p.
|
artikel
|
| 1867 |
The Impact of DSM-5 on the Development of Drugs to Treat Major Depressive Disorder
|
Meyers, O.I.
|
|
2013
|
16 |
7 |
p. A608-
1 p.
|
artikel
|
| 1868 |
The Impact of DSM-5 on the Development of Drugs to Treat Schizophrenia
|
Meyers, O.I.
|
|
2013
|
16 |
7 |
p. A607-
1 p.
|
artikel
|
| 1869 |
The Impact of Generic Substitution on Health Outcomes and Costs: A Systematic Review
|
Schall, I.
|
|
2013
|
16 |
7 |
p. A458-
1 p.
|
artikel
|
| 1870 |
The Impact of Increasing Pain Severity on Impairment of Regular Daily Activities
|
Poole, C.D.
|
|
2013
|
16 |
7 |
p. A387-A388
nvt p.
|
artikel
|
| 1871 |
The Impact of Indication Extensions on Pharmaceutical Prices
|
Genane, C.
|
|
2013
|
16 |
7 |
p. A455-
1 p.
|
artikel
|
| 1872 |
The Impact of Memory Problems on Diabetes Treatment in Canada
|
Brod, M.
|
|
2013
|
16 |
7 |
p. A444-
1 p.
|
artikel
|
| 1873 |
The Impact of Memory Problems on Diabetes Treatment in Germany
|
Brod, M.
|
|
2013
|
16 |
7 |
p. A449-A450
nvt p.
|
artikel
|
| 1874 |
The Impact of Memory Problems on Diabetes Treatment in the United Kingdom
|
Brod, M.
|
|
2013
|
16 |
7 |
p. A444-
1 p.
|
artikel
|
| 1875 |
The Impact of Persistence and Compliance with Oral Bisphosphonates on Fracture Rates Assessed Using the Clinical Practice Research Datalink (CPRD) in the United Kingdom
|
Feudjo Tepie, M.
|
|
2013
|
16 |
7 |
p. A555-
1 p.
|
artikel
|
| 1876 |
The Impact of Public Formularies & Guidelines on Community Acquired Pneumonia (CAP) Drugs in Mexico
|
Stevens, C.A.
|
|
2013
|
16 |
7 |
p. A724-
1 p.
|
artikel
|
| 1877 |
The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation: A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need
|
Dionne, P.A.
|
|
2013
|
16 |
7 |
p. A492-
1 p.
|
artikel
|
| 1878 |
The Impact of Sacral Neuromodulation on EQ-5D Index Scores and Costs to Manage Overactive Bladder
|
Hinnenthal, J.
|
|
2013
|
16 |
7 |
p. A634-A635
nvt p.
|
artikel
|
| 1879 |
The Impact of Smoking on Hospital Costs in Times of Crisis; An Additional Burden to the Vulnerable Greek Health Care System
|
Tsalapati, K.
|
|
2013
|
16 |
7 |
p. A369-
1 p.
|
artikel
|
| 1880 |
The Impact of the Blind Bid Procedure in Hungary
|
Komáromi, T.
|
|
2013
|
16 |
7 |
p. A465-
1 p.
|
artikel
|
| 1881 |
The Impact of the Economic Recession and Pharmaceutical-Health Service Agreement on the Probability and Time of Reimbursement of New Medicines in Ireland
|
Carney, P.
|
|
2013
|
16 |
7 |
p. A476-
1 p.
|
artikel
|
| 1882 |
The Impact of the Polish Human Insulin (Gensulin) on Public Payer’s Expenditure in 2001-2013
|
Orlewski, J.
|
|
2013
|
16 |
7 |
p. A451-
1 p.
|
artikel
|
| 1883 |
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life
|
Cortesi, P.A.
|
|
2013
|
16 |
7 |
p. A500-
1 p.
|
artikel
|
| 1884 |
The Implications of Demographic Changes for GMS Costs in Ireland Through to 2026
|
Conway, A.
|
|
2013
|
16 |
7 |
p. A464-
1 p.
|
artikel
|
| 1885 |
The Importance of Patient Reported Outcomes in Reimbursement of Orphan Products in Europe
|
Lyons, E.J.
|
|
2013
|
16 |
7 |
p. A326-
1 p.
|
artikel
|
| 1886 |
The Importance of Safety Aspects in the Amnog Process in Germany: Is the G-Ba Assessment Consistent with That of the CHMP?
|
Kuphal, L.
|
|
2013
|
16 |
7 |
p. A483-
1 p.
|
artikel
|
| 1887 |
The Importance of Sensitivity Analyses in Health Technology Assessments
|
Hren, R.
|
|
2013
|
16 |
7 |
p. A617-A618
nvt p.
|
artikel
|
| 1888 |
The Influence of Choice Task Layout on the Outcomes of a Discrete Choice Experiment
|
Veldwijk, J.
|
|
2013
|
16 |
7 |
p. A603-
1 p.
|
artikel
|
| 1889 |
The Influence of HAQ Utility Mapping Algorithms on the Cost-Effectiveness of Second Line Biologics for Treatment of Rheumatoid Arthritis
|
Pennington, B.
|
|
2013
|
16 |
7 |
p. A605-
1 p.
|
artikel
|
| 1890 |
The Influence of Improved Adherence and Persistence in Chronic Obstructive Pulmonary Disease (COPD) Costs: Systematic Review of the Literature
|
Pérez, M.
|
|
2013
|
16 |
7 |
p. A368-A369
nvt p.
|
artikel
|
| 1891 |
The List of Medicines for COPD Treatment in State Formulary of Ukraine and Related Costs
|
Tolubaiev, V.
|
|
2013
|
16 |
7 |
p. A371-
1 p.
|
artikel
|
| 1892 |
The Measurement of Health-related Quality of Life: German Findings from the Multi-Instrument Comparison (MIC) Study
|
Schlander, M.
|
|
2013
|
16 |
7 |
p. A330-
1 p.
|
artikel
|
| 1893 |
The Minimal Important Decrease of Health Utility in Living Kidney Donors
|
Hosseini, K.
|
|
2013
|
16 |
7 |
p. A635-
1 p.
|
artikel
|
| 1894 |
The Multimodel Ensemble Approach to Reducing Structural Uncertainty in Decision Analytical Modelling
|
Parham, P.E.
|
|
2013
|
16 |
7 |
p. A324-A325
nvt p.
|
artikel
|
| 1895 |
The New Italian Health Care Reform: Introducing New Measures to Speed Up Market Access
|
Palombi, M.
|
|
2013
|
16 |
7 |
p. A490-
1 p.
|
artikel
|
| 1896 |
The Nice Medical Technology Evaluation Programme (MTEP) – Insights for Manufacturers Considering Notification
|
McLeod, C.
|
|
2013
|
16 |
7 |
p. A483-
1 p.
|
artikel
|
| 1897 |
The Notification of Preliminary Investigation (NIP) of the Federal Regulatory Agency of Private Health and Insurance and Plans (ANS): A Tool to Facilitate the Access to the Mandatory Coverage
|
Silva, F.H.C.V.
|
|
2013
|
16 |
7 |
p. A681-
1 p.
|
artikel
|
| 1898 |
The Patient-Reported Outcomes Measurement Information System in Spanish
|
Arnold, B.J.
|
|
2013
|
16 |
7 |
p. A711-
1 p.
|
artikel
|
| 1899 |
The Pharmacoeconomic of Cardiology in Russia
|
Popov, V.V.
|
|
2013
|
16 |
7 |
p. A539-
1 p.
|
artikel
|
| 1900 |
The Potential Cost-Effectiveness of Obinutuzumab (Ga101) in Combination with Chlorambucil in Chronic Lymphocytic Leukemia
|
Walzer, S.
|
|
2013
|
16 |
7 |
p. A412-
1 p.
|
artikel
|
| 1901 |
The Potential Impact of Amnog-Triggered International Referenc Pricing: A Scenario from DPP-IV Inhibitors
|
Ando, G.
|
|
2013
|
16 |
7 |
p. A452-
1 p.
|
artikel
|
| 1902 |
The Potential of a Reduction in the Risk of Opioid-Related Fractures to Drive the Cost-Effectivness of an Analgesic
|
Cawson, M.
|
|
2013
|
16 |
7 |
p. A383-A384
nvt p.
|
artikel
|
| 1903 |
The Presence of Metabolic and Other Risk Factors in Adrenal Insufficiency Patients Compared to an Unmatched Background Population from the Same Region in the United Kingdom
|
Teneishvili, M.
|
|
2013
|
16 |
7 |
p. A433-A434
nvt p.
|
artikel
|
| 1904 |
The Qualitative Profile of the Coverage Complaints Made By Health Plan Users to the Federal Regulatory Agency for Private Health Insurance and Plans (ANS)
|
Silva, F.H.C.V.
|
|
2013
|
16 |
7 |
p. A681-
1 p.
|
artikel
|
| 1905 |
The Rand Negative Impact of Asthma on Quality of Life Item Bank and Short-Forms
|
Sherbourne, C.
|
|
2013
|
16 |
7 |
p. A375-A376
nvt p.
|
artikel
|
| 1906 |
Therapy Escalation Thresholds and the Potential for Biased Cost Effectiveness Analysis When Failing to Sample Baseline HbA1c in Type 2 Diabetes
|
McEwan, P.
|
|
2013
|
16 |
7 |
p. A592-
1 p.
|
artikel
|
| 1907 |
Therapy Sequences in Multiple Myeloma – A Clinical Model Study in Regards of a German Cost Context
|
Wirth, D.
|
|
2013
|
16 |
7 |
p. A397-
1 p.
|
artikel
|
| 1908 |
There Is More to Decision Making Than Costs and Effects: Handling Practical Constraints in the Value of Information Framework
|
Koffijberg, H.
|
|
2013
|
16 |
7 |
p. A611-
1 p.
|
artikel
|
| 1909 |
The Relation Between the Modified Rankin Scale (mRS) Scores and Utility Weights: Results from a Survey Among Community Dwelling Long Term Stroke Survivors
|
Greenberg, D.
|
|
2013
|
16 |
7 |
p. A533-A534
nvt p.
|
artikel
|
| 1910 |
The Relationship Between Asthma-Specific Quality of Life and Measures of Asthma Control and Generic Quality of Life
|
Stucky, B.
|
|
2013
|
16 |
7 |
p. A375-
1 p.
|
artikel
|
| 1911 |
The Relationship Between COPD Assessment Test (CAT) and EQ-5D in a Real World Patient Population
|
Wood, R.
|
|
2013
|
16 |
7 |
p. A375-
1 p.
|
artikel
|
| 1912 |
The Relationship Between Irritable Bowel Syndrome with Constipation Symptoms and Health-Related Quality of Life
|
Buono, J.L.
|
|
2013
|
16 |
7 |
p. A500-
1 p.
|
artikel
|
| 1913 |
The Relationship Between Scientific Research, Clinical Trials and FDA Drug Approval
|
Burgon, J.
|
|
2013
|
16 |
7 |
p. A478-
1 p.
|
artikel
|
| 1914 |
The Relationship Between Specific Annual Bleed Rates and Health Outcomes Among Children with Severe Hemophilia a in Latin America
|
Perez Bianco, P.R.
|
|
2013
|
16 |
7 |
p. A725-
1 p.
|
artikel
|
| 1915 |
The Relationship Between Submitted Line of Therapy and Reimbursement Decisions in Solid State Tumor Cancer Drugs
|
Jao, R.
|
|
2013
|
16 |
7 |
p. A428-
1 p.
|
artikel
|
| 1916 |
The Relationship Between Treatment Satisfaction and Adherence in COPD Patients in 5 Countries
|
Vietri, J.
|
|
2013
|
16 |
7 |
p. A373-
1 p.
|
artikel
|
| 1917 |
The Relative Economic Value of Ipilumumab in Colombia
|
Garrido, S.
|
|
2013
|
16 |
7 |
p. A402-
1 p.
|
artikel
|
| 1918 |
The Relative Efficacy and Safety of Simeprevir and Telaprevir in Treatment-Naïve Hepatitis C Infected Patients in a Japanese Population – A Bayesian Network Meta-Analysis
|
Bryden, P.A.
|
|
2013
|
16 |
7 |
p. A341-
1 p.
|
artikel
|
| 1919 |
The Resource Use Related to Hip Fractures Based on Data from ICUROS
|
Wintzell, V.
|
|
2013
|
16 |
7 |
p. A573-A574
nvt p.
|
artikel
|
| 1920 |
The Review of Publications of Pharmacoeconomic Research in Russia During 2007-2012
|
Yagudina, R.
|
|
2013
|
16 |
7 |
p. A580-
1 p.
|
artikel
|
| 1921 |
The 2013 Revision to Nice’s Discounting Guidelines: Differential Discounting Has Gone But Unjustified Selective Application Remains
|
Paulden, M.
|
|
2013
|
16 |
7 |
p. A616-
1 p.
|
artikel
|
| 1922 |
The Role of Communication and Health Literacy on Patient Safety in Public Pharmacies in the Republic of Srpska
|
Janjic, Z.
|
|
2013
|
16 |
7 |
p. A454-
1 p.
|
artikel
|
| 1923 |
The Role of DSM in the EMA and FDA Authorization Process for Psychiatric Drugs
|
Meyers, O.I.
|
|
2013
|
16 |
7 |
p. A613-
1 p.
|
artikel
|
| 1924 |
The Role of Half-Cycle Correction in the Models Used for Health Technology Assessment
|
Nemeth, B.
|
|
2013
|
16 |
7 |
p. A592-A593
nvt p.
|
artikel
|
| 1925 |
The Role of Simulation Modeling in Planning Long-Term Clinical Trials in Type 2 Diabetes
|
Foos, V.
|
|
2013
|
16 |
7 |
p. A587-A588
nvt p.
|
artikel
|
| 1926 |
The Short-Term Impact of Particulate Matter Exposure on the Risk of Prescription of Cardiorespiratory Drugs in Italy
|
Conti, S.
|
|
2013
|
16 |
7 |
p. A540-
1 p.
|
artikel
|
| 1927 |
The Structure and Process of Work of Spanish Regional Comittees Assessing Medicines: Preliminary Results
|
Sarría-Santamera, A.
|
|
2013
|
16 |
7 |
p. A460-
1 p.
|
artikel
|
| 1928 |
The Survey of the Japan-Style Premium Scheme in Pharmaceutical Pricing Decisions
|
Kamae, I.
|
|
2013
|
16 |
7 |
p. A460-
1 p.
|
artikel
|
| 1929 |
The Sustainability of Irish Pharmaceutical Expenditure
|
Walshe, V.
|
|
2013
|
16 |
7 |
p. A469-
1 p.
|
artikel
|
| 1930 |
The Transparency of National Health Care Costs in the ‘European Union Five (EU-5)’
|
Firth, Z.A.
|
|
2013
|
16 |
7 |
p. A465-
1 p.
|
artikel
|
| 1931 |
The United States Physican Survey to Populate a Decision-Analytic Model for the Treatment of Chronic Myeloid Leukemia
|
Rochau, U.
|
|
2013
|
16 |
7 |
p. A423-
1 p.
|
artikel
|
| 1932 |
The Use of Biologic Drugs for the Treatment of Rheumatoid Arthritis in Italy
|
Heiman, F.
|
|
2013
|
16 |
7 |
p. A557-
1 p.
|
artikel
|
| 1933 |
The Use of Data from Published Kaplan-Meier Survival Curves in NICE HTAs
|
Taylor, M.
|
|
2013
|
16 |
7 |
p. A594-
1 p.
|
artikel
|
| 1934 |
The Use of Dexa Scans in Postmenopausal Osteoporosis Is Associated with Reduced Long Term Fracture Risk
|
Burke, T.P.
|
|
2013
|
16 |
7 |
p. A567-
1 p.
|
artikel
|
| 1935 |
The Use of European Electronic Health Records to Investigate Cancer Treatment Pathways
|
Langham, J.
|
|
2013
|
16 |
7 |
p. A615-
1 p.
|
artikel
|
| 1936 |
The Use of Oral Anticoagulation Drugs for Stroke Prevention in Nonvalvular Atrial Fibrilation in France, Italy, Germany, Spain and the United Kingdom: Is Current Practice Consistent with the 2012 ESC Recommendations?
|
Carrasco, J.
|
|
2013
|
16 |
7 |
p. A516-
1 p.
|
artikel
|
| 1937 |
The Use of Preference Based Measures in Haemophilia: Is the Current Evidence Base Useful for Evidence Based Decision Making?
|
Tolley, K.
|
|
2013
|
16 |
7 |
p. A386-A387
nvt p.
|
artikel
|
| 1938 |
The Value of Pilot Testing Pro Symptom Diaries Prior to Conducting Cognitive Debriefing Interviews in Children/Adolescents: Qualitative and Quantitative Insights
|
Arbuckle, R.
|
|
2013
|
16 |
7 |
p. A607-
1 p.
|
artikel
|
| 1939 |
The Volume-Outcome Relationship and Minimum Volume Standards – Empirical Evidence for Germany
|
Mennicken, R.
|
|
2013
|
16 |
7 |
p. A539-A540
nvt p.
|
artikel
|
| 1940 |
The ‘Wound-QoL’: A Short Questionnaire Measuring Quality of Life in Patients with Chronic Wounds
|
Blome, C.
|
|
2013
|
16 |
7 |
p. A600-
1 p.
|
artikel
|
| 1941 |
Three TNF-A-Inhibitors for Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis
|
Ivakhnenko, O.
|
|
2013
|
16 |
7 |
p. A564-
1 p.
|
artikel
|
| 1942 |
Three Tools to Reduce the Impact of Common Decision-Making Biases When Considering Subgroup Analyses
|
Hawkins, N.
|
|
2013
|
16 |
7 |
p. A610-
1 p.
|
artikel
|
| 1943 |
Three-Year Health Care Expenditures in Diabetic Patients Receiving Rapid-Acting Insulin Analogues Versus Those on Human Regular Insulin
|
Cammarota, S.
|
|
2013
|
16 |
7 |
p. A451-
1 p.
|
artikel
|
| 1944 |
Three Years of the Gefitinib UK Single Patient Access (SPA) Scheme: Duration of Treatment for Patients with EGFR Mutation Positive NSCLC in NHS Clinical Practice
|
Vioix, H.
|
|
2013
|
16 |
7 |
p. A425-
1 p.
|
artikel
|
| 1945 |
Threshold Selection in Biomarkers Using Cox Regression. An Application to Non-Small-Cell Lung Cancer
|
Luaces, P.
|
|
2013
|
16 |
7 |
p. A575-A576
nvt p.
|
artikel
|
| 1946 |
Thyroid Dysfunction Detection in Pregnancy: Universal Screening or Targeted High-Risk Case Finding? A Meta-Analysis
|
Gudala, K.
|
|
2013
|
16 |
7 |
p. A701-
1 p.
|
artikel
|
| 1947 |
Time Dependent Resource Use and Costs Associated with Different States of Disease in Patients Diagnosed with HER-2 Positive Metastatic Breast Cancer
|
Frederix, G.W.
|
|
2013
|
16 |
7 |
p. A578-
1 p.
|
artikel
|
| 1948 |
Time Savings with Once-Monthly C.E.R.A.: A Time and Motion Study Conducted in 13 Hemodialysis Centres in Italy
|
De Cock, E.
|
|
2013
|
16 |
7 |
p. A636-
1 p.
|
artikel
|
| 1949 |
Timing of Discharge Makes a Difference: The Effects of Length of Stay and Day of Discharge on 30-Day Readmissions
|
Flaks-Manov, N.
|
|
2013
|
16 |
7 |
p. A478-
1 p.
|
artikel
|
| 1950 |
Tobramycin Powder for Inhalation for the Treatment of Cystic Fibrosis: Analysis of the RAMQ Data
|
Lachaine, J.
|
|
2013
|
16 |
7 |
p. A361-
1 p.
|
artikel
|
| 1951 |
Tocilizumab in Polyarticular Juvenile Idiopathic Arthritis – A Cost-Utility Model for the United Kingdom
|
Chang, S.
|
|
2013
|
16 |
7 |
p. A564-
1 p.
|
artikel
|
| 1952 |
Too Early or Too Late? Impact of Different Herpes Zoster Vaccine’s Waning Rates on Age-Specific Incremental Cost-Effectiveness Ratio
|
Ultsch, B.
|
|
2013
|
16 |
7 |
p. A357-
1 p.
|
artikel
|
| 1953 |
Total and Low-Density Lipoprotein Cholesterol Levels in High Risk Patients Treated with Atorvastatin Monotherapy in the United Kingdom
|
Jameson, K.
|
|
2013
|
16 |
7 |
p. A514-
1 p.
|
artikel
|
| 1954 |
Total Costs and Outcomes of Drug-Eluting Stent Placement with Intravascular Ultrasound (IVUS) Compared with Angiography Alone: A Cost-Effectiveness Analysis from the Perspective of the Italian Health System
|
Wasserman, M.
|
|
2013
|
16 |
7 |
p. A525-
1 p.
|
artikel
|
| 1955 |
Towards Evidence-Based European Policy in Clinical Trials the Survey of Attitudes Towards Trial Sites in Europe - The SAT-EU StudyTm
|
Gehring, M.
|
|
2013
|
16 |
7 |
p. A477-
1 p.
|
artikel
|
| 1956 |
To What Extent Can Biosimilars Compete with Brand Name Biologics? A EU-5 Granulocyte-Colony Stimulating Factors Markets Analysis
|
Bocquet, F.
|
|
2013
|
16 |
7 |
p. A455-
1 p.
|
artikel
|
| 1957 |
Toxocariasis: A Disease of High Prevalence But Forgotten
|
Passeri, L.A.
|
|
2013
|
16 |
7 |
p. A728-
1 p.
|
artikel
|
| 1958 |
Translation and Cultural Adaptation of Patient Perception of Arrhythmia Questionnaire in Poland
|
Farkowski, M.M.
|
|
2013
|
16 |
7 |
p. A536-
1 p.
|
artikel
|
| 1959 |
Translation and Cultural Adaptation of the Polish Version of “Disabilities of the Arm, Shoulder and Hand” (DASH) and Quickdash Questionnaires
|
Golicki, D.
|
|
2013
|
16 |
7 |
p. A602-
1 p.
|
artikel
|
| 1960 |
Translation and Cultural Adaptation of the SF-6D Questionnaire for Use in Arabic-Speaking Countries
|
Dawoud, D.M.
|
|
2013
|
16 |
7 |
p. A606-
1 p.
|
artikel
|
| 1961 |
Translation and Validation of Hindi Version of Diabetes Quality of Life – Measure (DQOL-M) in Indian Type 2 Diabetes Patients
|
Pawar, S.
|
|
2013
|
16 |
7 |
p. A691-
1 p.
|
artikel
|
| 1962 |
Transparency of the Medicines Reimbursement System in Ireland: A Quantative Analysis of the Influences on Reimbursement Decisions [2006-2013]
|
Mahon, S.
|
|
2013
|
16 |
7 |
p. A459-
1 p.
|
artikel
|
| 1963 |
Trastuzumabe No Câncer De Mama Metastático: Uma Revisão Sistemática De Análises Custo-Efetividade
|
Andrade, T.S.D.
|
|
2013
|
16 |
7 |
p. A687-
1 p.
|
artikel
|
| 1964 |
Trastuzumabe Para Câncer De Mama Com Superexpressão De HER-2: Evidência De Eficácia, Segurança E Estimativa De Custo
|
Alvares, J.
|
|
2013
|
16 |
7 |
p. A682-
1 p.
|
artikel
|
| 1965 |
Tratamento Do Câncer Colorretal Metastático Com Bevacizumabe E Cetuximabe: Acesso E Impacto Econômico Em Um Hospital Universitário
|
Ungari, A.Q.
|
|
2013
|
16 |
7 |
p. A686-A687
nvt p.
|
artikel
|
| 1966 |
Treating Psoriatic Arthritis with Biological Disease Modifying Antirheumatic Drugs: Systematic Review and Meta-Analysis to Evaluate Efficacy and Safety
|
Lemos, L.L.P.
|
|
2013
|
16 |
7 |
p. A715-
1 p.
|
artikel
|
| 1967 |
Treatment Adherence and Costs in Multiple Sclerosis: A Narrative Review of the Literature
|
Paz, S.
|
|
2013
|
16 |
7 |
p. A624-A625
nvt p.
|
artikel
|
| 1968 |
Treatment and Outcome Analysis of Rodenticide Poisoning in Tertiary Care Hospital in South India
|
Harika, C.
|
|
2013
|
16 |
7 |
p. A677-
1 p.
|
artikel
|
| 1969 |
Treatment Costs of Ischemic Stroke Prevention and Management in Patients with Atrial Fibrillation (AF) in Latin America: Argentina, Brazil, Chile, and Venezuela
|
Soriano, M.A.
|
|
2013
|
16 |
7 |
p. A705-
1 p.
|
artikel
|
| 1970 |
Treatment Disparity Among Patients Diagnosed with Depressive Disorder in Working Population Based on Claims Database in Japan
|
Onishi, Y.
|
|
2013
|
16 |
7 |
p. A543-
1 p.
|
artikel
|
| 1971 |
Treatment of Type 2 Diabetes with Saxagliptin/Metformin Extended-Release (XR): Budget Impact Analysis in Argentina
|
Elgart, J.
|
|
2013
|
16 |
7 |
p. A665-
1 p.
|
artikel
|
| 1972 |
Treatment Patterns Among Type 2 Diabetes Mellitus Patients in Dubai
|
Osenenko, K.M.
|
|
2013
|
16 |
7 |
p. A453-
1 p.
|
artikel
|
| 1973 |
Treatment Patterns and Burden of Illness of Acromegaly in the United Kingdom: Real World (RW) Data from Clinical Practice Research Datalink (CPRD)
|
Murray, R.D.
|
|
2013
|
16 |
7 |
p. A452-
1 p.
|
artikel
|
| 1974 |
Treatment Patterns and Burden of Illness of Cushing’s Disease in the United Kingdom: Real World (RW) Data from Clinical Practice Research Datalink (CPRD)
|
Murray, R.D.
|
|
2013
|
16 |
7 |
p. A452-
1 p.
|
artikel
|
| 1975 |
Treatment Patterns and Costs Associated with Chronic Lymphocytic Leukemia Chemotherapy Under the Brazilian Private Health Care Perspective: A Retrospective Analysis of the Orizon Database
|
Ferreira, C.N.
|
|
2013
|
16 |
7 |
p. A407-
1 p.
|
artikel
|
| 1976 |
Treatment Patterns and Health Care Resource Utilization of Patients with Acromegaly in the United States
|
Chuang, C.C.
|
|
2013
|
16 |
7 |
p. A450-
1 p.
|
artikel
|
| 1977 |
Treatment Patterns for Parkinson’s Disease: Real-World Evidence from the EU5 (France, Germany, Italy, Spain, and the United Kingdom)
|
Sung, A.H.
|
|
2013
|
16 |
7 |
p. A630-
1 p.
|
artikel
|
| 1978 |
Treatment Patterns of Atrial Fibrillation (AF) in Latin America
|
Leyva-Bravo, V.
|
|
2013
|
16 |
7 |
p. A708-
1 p.
|
artikel
|
| 1979 |
Treatment Patterns of Chronic Lymphocytic Leukemia Patients Under the Brazilian Public Health Care Perspective
|
Vitale, V.
|
|
2013
|
16 |
7 |
p. A425-
1 p.
|
artikel
|
| 1980 |
Treatment Patterns of Indolent Non-Hodgkin Lymphoma Patients Under the Brazilian Public Health Care Perspective
|
Vitale, V.
|
|
2013
|
16 |
7 |
p. A425-
1 p.
|
artikel
|
| 1981 |
Treatment Patterns of Ranibizumab and Aflibercept for the Management of Wet Age-Related Macular Degeneration in Routine Clinical Practice in the United States
|
Ferreira, A.
|
|
2013
|
16 |
7 |
p. A512-
1 p.
|
artikel
|
| 1982 |
Treatment Persistence in Swedish Women Initiating Denosumab Treatment for Postmenopausal Osteoporosis
|
Karlsson, L.
|
|
2013
|
16 |
7 |
p. A567-
1 p.
|
artikel
|
| 1983 |
Treatment Satisfaction and Its Association with Health Outcomes in Patients with Neuropathic Pain
|
Holbrook, T.
|
|
2013
|
16 |
7 |
p. A388-
1 p.
|
artikel
|
| 1984 |
Treatment Satisfaction in Patients with Atrial Fibrillation on New Oral Anticoagulants as Measured with Pact-Q2: Prefer in AF Registry
|
Brüggenjürgen, B.
|
|
2013
|
16 |
7 |
p. A536-
1 p.
|
artikel
|
| 1985 |
Treatments for EGFR Mutation Positive NSCLC – A Network Meta-Analysis
|
Fonseca, T.
|
|
2013
|
16 |
7 |
p. A396-
1 p.
|
artikel
|
| 1986 |
Trends in Chemotherapy Setting and Costs from 2005 to 2012: A Case Study Using Bevacizumab
|
Foley, K.
|
|
2013
|
16 |
7 |
p. A428-
1 p.
|
artikel
|
| 1987 |
Trends in Health Care Resources Utilization, Cost and Medication Selection in the Treatment of Diabetes
|
Lachaine, J.
|
|
2013
|
16 |
7 |
p. A689-
1 p.
|
artikel
|
| 1988 |
Trends in Hospital Admissions Among Men and Women Above the Age of 60 Living in Stockholm and Uppsala Counties in Sweden
|
Karampampa, K.
|
|
2013
|
16 |
7 |
p. A340-
1 p.
|
artikel
|
| 1989 |
Trends in Reimbursement Decisions in Ireland: An Analysis of the NCPE Database from an Industry Perspective
|
Redmond, S.
|
|
2013
|
16 |
7 |
p. A475-
1 p.
|
artikel
|
| 1990 |
Trends in the Cost-Effectiveness of Stroke Care
|
Urbina-Valdespino, E.
|
|
2013
|
16 |
7 |
p. A520-
1 p.
|
artikel
|
| 1991 |
Troika in Portugal: Pharmaceutical Sector from Paper to Reality
|
Teixeira, I.
|
|
2013
|
16 |
7 |
p. A456-
1 p.
|
artikel
|
| 1992 |
Two Simple Methods of Measuring Adherence in Hypertensive Patients Are Predictive of Blood Pressure Control: Pooled Analysis of 17,516 Patients from Seven Valsartan Studies
|
Villa, L.
|
|
2013
|
16 |
7 |
p. A532-
1 p.
|
artikel
|
| 1993 |
Two-Way Sensitivity Analysis: Showing the Impact of Correlated Parameters in Cost-Effectiveness Analyses
|
Heemstra, L.
|
|
2013
|
16 |
7 |
p. A588-
1 p.
|
artikel
|
| 1994 |
UK Quality Outcomes Framework (QOF) Thresholds and Elevated HbA1c Levels Among Patients with Type II Diabetes - A Longitudinal Study Using the Clinical Practice Research Datalink (CPRD)
|
Jameson, K.
|
|
2013
|
16 |
7 |
p. A450-
1 p.
|
artikel
|
| 1995 |
Uncertainty and Cost-Effectiveness Analysis of the Sequential Application of Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia
|
Rochau, U.
|
|
2013
|
16 |
7 |
p. A409-
1 p.
|
artikel
|
| 1996 |
Uncertainty Quantification of Large-Scale Health Economic Simulation Models
|
Zheng, P.
|
|
2013
|
16 |
7 |
p. A595-
1 p.
|
artikel
|
| 1997 |
Unchartered Territory – Analysis of Cross-Border Service Provision Within Public Health Systems
|
Moran, P.
|
|
2013
|
16 |
7 |
p. A579-
1 p.
|
artikel
|
| 1998 |
Uncovering the Gap Between Model Validation Recommendations and Practice
|
Kleintjens, J.
|
|
2013
|
16 |
7 |
p. A581-
1 p.
|
artikel
|
| 1999 |
Understanding Patterns of Monitoring of Appropriate Prescribing in Europe
|
Schroeder, C.
|
|
2013
|
16 |
7 |
p. A461-
1 p.
|
artikel
|
| 2000 |
Understanding the Effect of Clostridium Difficile Infection on Hospital Mortality in England, the Netherlands, and Spain
|
Wasserman, M.
|
|
2013
|
16 |
7 |
p. A492-A493
nvt p.
|
artikel
|
Tijdschrift beschrijving